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Introducción 
 
Los polihidroxialcanoatos (PHA), conocidos comúnmente como “bioplásticos”, son 
polímeros biodegradables que se acumulan en forma de gránulos en el interior celular 
de algunas bacterias. Son biopolímeros sintetizados a partir de fuentes renovables, que 
pueden ser biodegradados en condiciones controladas, y que presentan características 
físico-químicas similares a las de los plásticos derivados de la industria petroleoquímica 
(Rehm, 2010). Dado que los PHA no son tóxicos, son biodegradables y biocompatibles, 
estos compuestos tienen un gran potencial para múltiples aplicaciones debido a su 
posible uso como biomateriales. Por tanto, la síntesis de nuevos PHA es de gran interés 
desde los puntos de vista industrial y biomédico, ya que los nuevos biopolímeros, así 
como los monómeros que los componen, presentan  propiedades físico-químicas y 
mecánicas diferentes a los PHA convencionales.  
Las infecciones asociadas a los implantes y un incremento alarmante de la 
resistencia a los antibióticos justifica la necesidad de generar nuevas superficies 
antimicrobianas para el desarrollo de los biomateriales en el campo de la ingeniera de 
los tejidos. Los poliésteres bacterianos, PHA, son una de las clases más importantes de 
biomateriales debido a sus propiedades biocompatibles y biodegradables. Entre otras, 
una de las posibles aplicaciones requeridas para algunos materiales de uso clínico o 
alimentario, es su capacidad para actuar como materiales bacteriostáticos o 
bactericidas, de tal manera que los objetos, embases o dispositivos construidos con 
estos materiales puedan evitar la proliferación de las bacterias (propiedad 
bacteriostática) o puedan incluso provocar la muerte de las bacterias en contacto 
(propiedad bactericida). Los polímeros antimicrobianos representan una clase de 
biocidas cada vez más importante como una alternativa a los biocidas existentes y en 
algunos casos incluso a los antibióticos (Siedenbiedel y Tiller, 2012). 
En este sentido, en esta Tesis Doctoral se han utilizado dos estrategias para la 
funcionalización de PHA con alto valor añadido con aplicaciones en los sectores 
industrial y biomédico. La primera estrategia consiste en la producción bacteriana in 
vivo de nano-particulas functionalizadas, las cuáles han sido diseñadas para exponer 
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proteínas de fusión en su superficie. Los gránulos de PHA pueden ser utilizados como 
nano-particulas para inmovilización de proteínas recombinantes mediante el sistema 
BioF, previamente establecido en el laboratorio. Este sistema se basa en el uso del N-
terminal de fasina PhaF de Pseudomonas putida KT2440 como tag de afinidad, lo que 
permite anclar proteínas recombinantes al granulo de PHA (Moldes et al., 2004). Uno 
de los inconvenientes del sistema BioF para purificar e inmovilizar proteínas es el bajo 
rendimiento, dado que no toda la proteína fusionada se une al gránulo, y que gran 
parte de la superficie del gránulo está ocupada por las fasinas naturales. Este sistema 
ha sido mejorado mediante el estudio del proceso de unión del tag al gránulo de PHA y 
la identificación de los requerimientos mínimos que permiten la formación y 
segregación del gránulo del PHA entre las células hijas durante la división celular. 
 La segunda estrategia aplicada se basa en el uso de la ingeniería metabólica para 
diseñar las cepas bacterianas capaces de producir nuevos poliésteres.  Se estudiaron 
las propiedades de los nuevos PHA obtenidos por fermentación, denominados 
PHACOS, que contienen monómeros con grupos tioéster en la cadena lateral (Escapa 
et al., 2011). 
 
Resultados y discusión 
Para optimizar el sistema BioF de inmovilización de proteínas in vivo a gránulos de PHA se 
ha estudiado primeramente la función fisiológica de fasina PhaF, determinándose que 
interviene en la segregación de los gránulos durante la división celular y en la localización de 
los gránulos en el citoplasma. Se han identificado dos funciones diferentes de los dominios C- y 
N-terminal de esta proteína. Se demostró que el C-terminal que contiene AAKP-like tandem 
repeats y se une a ADN de forma inespecífica, lo que está de acuerdo con su similitud con la 
famila de Histonas tipo H1. El N-terminal es responsable de la unión al gránulo y coincide con 
la secuencia del tag de afinidad BioF. Mediante microscopía  electrónica de transmisión (TEM), 
láser confocal y multidimensional in vivo, se ha demostrado en las primeras fases de 
crecimiento de células que producen PHA, que la fasina PhaF dirige los gránulos al centro de la 
célula generando una distribución característica en forma de aguja en el citoplasma de P. 
putida KT2440. Además nuestros estudios de citometria de flujo en células mutantes en el gen 
phaF han demostrado la existencia de dos populaciones diferentes de células (la que contiene 
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y la que no contiene PHA). Estudios de complementación han demostrado que, además de su 
función en la localización celular de los gránulos, PhaF está implicada en segregación de los 
gránulos entre las células hijas durante la división celular. Los estudios in vivo de la proteína de 
fusión entre la proteína fluorescente verde (GFP) y el C-terminal de PhaF mediante 
microscopía  confocal han demostrado la unión de C-terminal al nucleoide. Por lo tanto se ha 
hipotetizado el mecanismo de esta fasina en su función distribuidora de gránulos mediante la 
interacción del C-terminal con el cromosoma que se está segregando, y de forma simultánea, 
su unión al gránulo de PHA mediante el N-terminal o dominio BioF.  
En esta Tesis doctoral, también se ha estudiado la implicación de la otra fasina de P. 
putida KT2440, la proteína PhaI, en la maquinaria de formación del gránulo de PHA. La fasina 
PhaI completa y el módulo BioF de la fasina PhaF son similares en su estructura primaria. En 
este trabajo se demuestra una función coordinada de los módulos de las fasinas (PhaI y N-
terminal de PhaF) para la formación y distribución óptima de los gránulos de PHA. Por una 
parte, se estudió la producción de las proteínas recombinantes en distintas condiciones de 
crecimiento, tanto en la estirpe salvaje como en diferentes mutantes en fasinas de P. putida. 
Las construcciones de estos mutantes se llevaron acabo mediante la técnica de deleción con el 
plásmido pK18mobsac. Este sistema tiene la ventaja de que provoca deleciones géneticas 
dirigidas sin incorporar marcadores antibióticos, lo cual conlleva una ventaja desde el punto de 
vista medioambiental. Por otra, se estudió la localización de las fasinas fusionadas a la proteína 
GFP en presencia y ausencia del gránulo de PHA. Estas construcciones se llevaron acabo en el 
plásmido pCNB5 que contiene un mini-transposon, lo que facilita la inserción estable de la 
construcción genética en monocopia en el cromosoma de P. putida. Estos experimentos nos 
permitieron seleccionar la cepa y las condiciones más idóneas para la producción in vivo de 
nanopartículas de bioplásticos activas. Los estudios hechos mediante microscopía  
epifluorescente y citometria de flujo de los mutantes en fasinas de P. putida que producen la 
proteína recombinante BioF::GFP han demostrado que la distribución equilibrada después de 
la división celular se recupera cuando PhaF, y BioF o PhaI son sintetizados al mismo tiempo, 
demostrando la propiedad intercambiable de los módulos de las fasinas.  Mediante western 
blot se ha confirmado que concentraciones muy bajas de la fasina natural PhaF son suficientes 
para asegurar la segregación de los gránulos entre las células hijas durante la división celular. 
Todos estos estudios han permitido construir y diseñar la cepa huésped óptima para ser 
utilizada en el sistema BioF, derivada de la cepa modelo P. putida KT2440 con las 
modificaciones genéticas mínimas que le han hecho idónea para producir nanopartículas de 
bioplásticos activas. La cuantificación de la proteína recombinante se llevo acabo mediante 
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citometria de flujo y fluorimetría. Este sistema representa una herramienta muy útil para la 
inmovilización in vivo de las proteínas activas a un soporte biodegradable para su uso en  
diagnóstico, liberación de antígenos y otros.  
La segunda estrategia aplicada en esta Tesis doctoral para diseñar biomateriales 
funcionalizados consiste en el estudio de las propiedades de los nuevos PHA obtenidos por 
fermentación bacteriana, denominados PHACOS, que contienen monómeros con grupos 
tioéster en la cadena lateral. Se conoce muy poco sobre si los monómeros derivados de los 
PHAs convencionales pueden poseer actividad antibacteriana. Así por ejemplo, se ha descrito 
que algunos hidroxiácidos monoméricos derivados de PHAs tienen actividad sobre 
Staphylococcus aureus (Ruth et al., 2007). Sin embargo, la potencia antibacteriana de estos 
compuestos es baja ya que presentan unas MICs (Concentración Mínima Inhibitoria) muy altas, 
del orden de 1-5 mM.  
Para investigar posible actividad antibacteriana de PHACOS, se produjo el poliéster 
siguiendo el protocolo de fermentación bacteriana previamente descrito (Escapa et al., 2011). 
La actividad antibacteriana de PHACOS y el PHA control no funcionalizado (PHO) frente 
diferentes cepas bacterianas se determino según la norma ISO 22196:2007 (E) (Medida de la 
actividad antibacteriana en superficies de plástico) con ciertas modificaciones. El resultado 
obtenido indicó que PHACOS inhibe el crecimiento de las cepas de S. aureus incluyendo tres 
aislados clínicos MRSA, de forma que sólo sobreviven un 10% de las células cuando se 
comparan con el control. 
Además, se estudió la capacidad de PHACOS para evitar la formación de biopelículas 
bacterianas en su superficie en comparación con otros materiales. A tal fin se utilizó como 
modelo las bacterias S. aureus CECT 86 y P. aeruginosa CECT 4122 que son capaces de formar 
biopelículas en la superficie de distintos materiales. La capacidad de las bacterias para formar 
biopelículas en las superficies de los materiales biopolíméricos, se examinó mediante dos 
procedimientos: i) la tinción de la biopelícula con el colorante cristal violeta; y ii) el contaje de 
las unidades formadoras de colonia (UFC) de bacterias adheridas a los discos. Los resultados 
obtenidos demostraron que la presencia de PHACOS provoca una disminución de dos veces en 
la formación de biopelículas de S. aureus y no de P. aeruginosa comparado con el polímero 
control. Además, se estudió la capacidad de PHACOS para matar las bacterias adheridas a su 
superficie en comparación con otros materiales. El número y la viabilidad de las bacterias 
adheridas a la superficie de los biopolímeros se determinaron por microscopía de 
fluorescencia utilizando la prueba de viabilidad bacteriana el BacLightTM LIVE / DEAD 
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(Invitrogen L13152). Los resultados demostraron que el 80% de las células de S. aureus no 
fueron viables, es decir, mueren tras entrar en contacto con PHACOS. Sin embargo, tan solo un 
17 % de las células no son viables tras entrar en contacto con polímero control. El número total 
de bacterias (viables y no viables) adheridas a discos recubiertos de PHACOS comparadas con 
las bacterias presentes en los discos controles recubiertos con PHO fue similar, lo que 
demuestra que la adhesión bacteriana no está disminuida, pero sí que se afecta la 
supervivencia de las bacterias. 
Por otro lado, se estudió la biocompatibilidad y actividad antimicrobiana de PHO y 
PHACOS in vivo en ratones BALB c mediante el uso de una sonda fluorescente (H-ICG). Este 
trabajo se realizó en colaboración con el grupo del Dr. Andrés García (Georgia Institute of 
Technology, Atlanta, USA). Se demostró tanto la biocompatibilidad de PHO y PHACOS como la 
actividad antimicrobiana de PHACOS in vivo. Por lo tanto, se concluyó que el PHACOS es un 
material con capacidad antibacteriana intrínseca, tal cual se obtiene de la fermentación 
bacteriana, sin tener que modificarlo químicamente.  
En general, se pueden distinguir tres tipos de polímeros antimicrobianos: biocidas 
poliméricos, polímeros biocidas y polímeros liberadores de biocidas. Los biocidas poliméricos 
son polímeros que constan de unidades de repetición bioactivas, es decir, los polímeros son 
múltiples biocidas interconectados, que actúan de manera similar a los monómeros. No 
siempre, la polimerización de monómeros biocidas conduce a polímeros antimicrobianos 
activos, ya sea, debido a que los polímeros son insolubles en agua o las funciones biocidas no 
llegan a su destino. Los polímeros biocidas son usualmente macromoléculas cargadas 
positivamente que interactúan con las células microbianas que generalmente llevan una carga 
negativa neta en la superficie debido a sus proteínas de membrana, a los ácidos teicoicos en 
las bacterias Gram-positivas, y a los fosfolípidos cargados negativamente en la membrana 
externa de las bacterias Gram-negativas. Los últimos experimentos que forman parte de esta 
Tesis doctoral demuestran la actividad microbiana de los monómeros que componen el 
polímero PHACOS, por lo que se propone que PHACOS es un biocida polimérico.  
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Abbreviations 
 
3HA (R)-3-hydroxyalkanoate 
3HD (R)-3-hydroxydecanoate 
3HDD (R)-3-hydroxydodecanoate 
3HHx (R)-3-hydroxyhexanoate 
3HO (R)-3-hydroxyoctanoate 
3MB 3-mercaptobutyrate  
3MP 3-mercaptopropionate  
6-ATH 6-acetylthiohexanoic acid  
mcl-OHAs medium-chain-length oligo(3-hydroxyalkanoates)  
OH-4ATB 3-hydroxy-4-acetylthiobutanoate  
OH-6ATH 3-hydroxy-6-acetylthiohexanoate 
OHAs oligo(hydroxyalkanoates)  
OHB oligo(3-hydroxybutyrate) 
OHB-co-4HB oligo(3-hydroxybutyrate-co-4-hydroxybutyrate) 
OHB-co-HHx oligo(3-hydroxybutyrate-co-3-hydroxyhexanoate)   
OH-C6 3-(R)-hydroxyhexanoate  
OH-C8 3-(R)-hydroxyoctanoate  
OH-C10 3-(R)-hydroxydecanoate 
P4HB poly(4-hydroxybutyrate)  
PBS phosphate buffer saline 
PEG polyethylene glycol 
PHA polyhydroxyalkanoate 
PHACOS poly((R)-3-hydroxyacilthioalkanoate-co-3- hydroxyalkanoate) 
PHB poly((R)-3-hydroxybutyrate)  
PHB-co-HHx poly((R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate) 
PHB-co-HV poly((R)-3-hydroxybutyrate-co-(R)-3-hydroxyvalerate) 
PHD poly(3-hydroxydecanoate) 
PHO poly((R)-3-hydroxyoctanoate) 
PHO-co-HHx poly(3-hydroxyoctanoate-co-3-hydroxyhexanoate) 
PHO-co-HU poly(3-hydroxyoctanoate-co-3-hydroxyundecenoate) 
PLA poly-lactic acid 
RHAs (R)-hydroxyalkanoic acids  
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1. Polyhydroxyalkanoates (PHA) historical outline 
 
Bacterial polyhydroxyalkanoates (PHA) constitute a family of biopolyesters 
composed of range of different polymers, mainly discovered during the past 20 years 
(Steinbüchel, 1991). The exception is the simplest member of the class, poly((R)-3-
hydroxybutyrate) (PHB), that was first identified in 1926 in Bacillus megaterium 
(Lemoigne, 1926) and is the most well-known PHA polymer.  
During the 1980´s, many companies have tried to produce various PHA at pilot or 
industrial scales. The British company, Imperial Chemical Industries (ICI), developed a 
commercial process to produce PHB, and the copolymer poly((R)-3-hydroxybutyrate-
co-(R)-3-hydroxyvalerate) (PHB-co-HV) (Chen, 2009). Over the past years, PHA as 
polymeric materials have been designed for biomedical application, as drug delivery 
carriers, nutritional supplements, drugs, fine chemicals and others (Chen and Wu, 
2005). More recent interest in the medical application as implants has arisen, primarily 
in response to the emerging needs of the field of tissue engineering. In fact, in the past 
two years PHA has become one of the leading classes of biomaterials under 
investigation for the development of tissue-engineered cardiovascular products, due 
to their properties not available in existing synthetic absorbable polymers. Although 
most products containing these materials have yet to be approved for in vivo medical 
use, some companies are currently engaged in the development of diverse tissue-
engineered products based on PHA polymers (e.g. Tepha, Inc., USA). PHA draw 
particular interest since they were shown to be biodegradable and biocompatible 
(Brandl et al., 1995; Brandl et al., 1990). The best approach for achievement of those 
properties is by production in bacteria, thus, guaranteeing complete stereospecificity 
(all chiral carbon atoms in the back-bone are in the R configuration), which is essential 
for their biodegradability and biocompatibility. Both, the type of bacterium and growth 
conditions determine the chemical composition of PHA as well as the molecular 
weight, which typically ranges from 2 x 105 to 3 x 106 Da (Byrom, 1987; Lee, 1996).  
Apart from immense potential for medical applications, due to the biodegradable 
properties and natural origin, PHA is being also considered as bioplastics, an 
alternative to the plastic materials derived from petrochemicals. Since bacteria utilize 
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renewable sources for the production of PHA, dependency on fossil resources can be 
reduced (Chen, 2009; Chen and Patel, 2011). Currently the production costs of 
bioplastics synthesis is 5–10 times higher compared to the cost of synthesis of plastics 
derived from petrochemicals, which is up to date a major hindrance for the successful 
commercialization of bioplastics (Rehm, 2010).  
This work will focus on design and application of added value PHA using different 
approaches for polymer functionalization. The strategy is founded on seizing the 
advantages of intrinsic polymer features and adding modifications that confer new 
properties to the biomaterial for medical applications. The work is based on the 
processes developed in bacterial model strain Pseudomonas putida KT2440 and 
therefore in many aspects will be centered on PHA produced by this strain.  
2. Occurrence of PHA 
 
PHA are synthesized by many bacteria as carbon and energy storage in response 
to the excess of carbon source, when growth is limited due to starvation of other 
nutrients as for instance nitrogen and phosphorus (Madison and Huisman, 1999; Preito 
et al., 2007; Escapa et al, 2012). PHA is accumulated in a form of intracellular inclusions 
with an amorphous, hydrophobic PHA core mainly enveloped by proteins involved in 
PHA metabolism (see section 3; Potter and Steinbüchel, 2005) (Figure 1).  
 
Figure 1. Transmission electron microscopy (TEM) image of mcl-PHA producing P. putida 
KT2442 cells. PHA reserve granules are located intracellularly. The number and the size of 
granules is specie dependent ranging from 100-500nm and 2-8 granules per cell.  
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This accumulation is subject to extensive regulation (i) at enzymatic level, by 
cofactor inhibition and availability of metabolites (Escapa et al., 2012; de Eugenio et 
al., 2010a), (ii) at transcriptional level by specific and global transcriptional regulatory 
factors (De Eugenio et al., 2010a and 2010b) and (iii) at translational level driven by 
global post-transcriptional regulators (Olearly 2012; de Eugenio PhD-thesis). Moreover, 
new investigations of PHB granules revealed that granules isolated in native form can 
perform their function autonomously of the rest of the cell content since they harbour 
all proteins required for PHA metabolism (Jendrossek, 2009). Therefore, they are 
considered as subcellular organelles, named carbonosomes, performing at least tree 
functions (PHA synthesis, storage and mobilization).  
PHA have been classified according to various criteria: i) their monomer size as 
short-chain-length PHA (scl-PHA), with C4-C5 monomers and medium-chain-length 
PHA(mcl-PHA) with C6-C14 monomers, (Anderson et al., 1990) ii) their functional 
substituents found in the radical chain (such as double bonds or aromatic groups), or 
iii) the structure of the polymer (formed by homogenous, random or block 
copolymers) (Olivera et al. 2010a) (Figure 2). 
 
 
 
Figure 2. Classification of PHA according to different criteria. 
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Scl-PHA such as PHB and its copolymers PHB-co-HV are being produced on a 
commercial scale, and they have been extensively applied for packaging, molding, 
fibers and other commodities (Chen, 2009). Mcl-PHA mainly produced by bacteria 
belonging to genera Pseudomonas, are currently considered promising candidates for 
bioplastic applications owing the properties derived from their longer side-chains and 
altered crystalline structure, such as elasticity, hydrophobicity, low oxygen 
permeability, water resistance and biodegradability. They can be molded and 
processed into compostable packaging and resorbable materials for medical 
applications and have also been used as food coatings, pressure-sensitive adhesives, 
paint binders and biodegradable rubbers (Zinn et al., 2001, Elbahloul and Steinbüchel, 
2009).  
Furthermore, unconventional mcl-PHA bearing different functional moieties in 
their side chains can be produced through different biotechnological strategies that 
will be revised in detail in the following section. These reactive groups allow tuning of 
physical and chemical properties of the polymer, and represent potential targets for 
post-biosynthetic modifications (Escapa et al., 2011).  
 
3. Granule associated proteins (GAPs): The PhaF Phasin 
 
As previously mentioned, PHA constrain the hydrophobic core of intracellular 
inclusions surrounded by proteins involved in PHA metabolism (Potter and 
Steinbüchel, 2005). These granule associated proteins (GAPs), have been designated 
into following classes, namely, PHA synthases, depolymerases, regulatory proteins, 
acyl synthetase (ACS1) and phasins (Figure 3). Pseudomonas strains genes encoding 
GAPs proteins are organized in the pha cluster (Prieto et al., 2007). The organization of 
the pha gene cluster for the synthesis of mcl-PHA was partially reported in 1991 in the 
strain Pseudomonas putida GPo1 (Huisman et al., 1991) and completed in 1999 with 
the discovery of the genes encoding the phasins (Prieto et al., 1999) (Figure 4).  
Introduction 
 
7 
 
 
Figure 3. TEM image of P. putida KT2442 PHA granule (A) and a model of PHA granule 
structure (B). B, The PHA granule is composed of PHA core coated with phospholipid 
monolayer where granule-associated proteins GAPs (phasins, synthases, depolymerase, ACS1) 
are embedded or attached. Among GAPs phasins are the most aboundant proteins. 
 
Phasins, the major GAPs, were described as amphiphilic proteins which generate 
an interphase between the cytoplasm and the hydrophobic core of PHA granules 
(Steinbüchel et al., 1995). They also play a role in controlling the size and the number 
of the granules per cell (Pieper-Furst et al., 1995; Wieczorek et al., 1995; Grage et al., 
2009). Other functions proposed for phasins are prevention of protein misfolding on 
the granule surface (Steinbüchel et al., 1995) and a storage source of nitrogen (McCool 
and Cannon, 1999).  
 
Figure 4. Genetic organization of pha cluster in P. putida KT2442. Arrows indicate different 
genes involved in PHA metabolism, their relative size and transcriptional direction. Promoter 
regions are indicated as curved white arrows. The pha is composed of two synthase coding 
genes, phaC1 and phaC2 (grey), interspersed by depolymerase coding gene phaZ (yellow), 
phaD gene coding for transcriptional regulator not classified as GAP (pink) and two genes 
coding for the phasins, phaF (dark blue) and phaI (light blue) transcribed divergently to the 
other pha genes. 
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They are widespread among bacteria, sharing similar functions but differing in 
their primary structures (Grage et al., 2009). It is generally accepted that phasins are 
composed of a hydrophobic domain associated to the PHA granules surface and a 
hydrophilic domain exposed to the cytoplasm. The amphiphilic layer stabilizes the PHA 
granules and prevents them from coalescing (Wieczorek et al., 1995).  
P. putida strains contain two phasins PhaI (15 kDa) and PhaF (26 kDa) (Prieto et al., 
1999). The PhaF is a nucleoid-associated protein involved in the transcriptional 
regulation of genes linked to PHA metabolism (Prieto et al., 1999; Galan et al., 2011). 
According to the structural three-dimensional model prediction, PhaF is an elongated 
protein, composed of long, amphipathic N-terminal helix with PHA binding capacity, 
followed by a short leucine zipper proposed as protein oligomerization linker, and a 
superhelical C-terminal domain wrapped around the chromosomal DNA (Maestro et 
al., 2013)(Figure 5). C-terminal half contains AAKP-like tandem repeats characteristic of 
the histone H1-family (Prieto et al., 1999). 
 
Figure 5. A structural model of PhaF phasin and a model of the interaction between PHA 
granules, phasins and chromosomal DNA in P. putida KT2440. A, Joint model structure of 
monomeric PhaF complex with DNA. The leucine zipper is shown in blue; B, PhaF tetramer is 
depicted interacting with the PHA granule while also attached to a fragment of nucleoid DNA. 
The hydrophobic residues in N-terminal domain are shown in orange, while the polar ones are 
colored blue. The leucine zipper is colored green and the DNA in cyan (Maestro et al., 2013). 
 
Several evidences support the structural and functional independence of the 
domains. First, the PhaI phasin, which shares considerable sequence similarity with the 
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N-terminal region of PhaF (57% similarity, 38% identity) (Prieto et al., 1999) is capable 
of acquiring a folded, stable and functional structure by itself (Moldes et al., 2004). 
Also, the N-terminal domain is conserved in other PHA-binding phasins with a different 
C-terminal part (Moldes et al., 2004; Maestro et al., 2013). Moreover, very diverse 
fusion proteins containing the N-terminal moiety of PhaF (the BioF affinity tag, see 
below) can be adsorbed on PHA granules without compromising their function 
(Moldes et al., 2004; Moldes et al., 2006).  
 
4. Peptide functionalized PHA using GAPs  
 
PHA granules are becoming increasingly recognized as potential functionalized 
beads for biotechnological and medical applications. Recently, granules formed inside 
recombinant bacterial cells were used as tailor-made functionalized micro- or nano-
beads where specific proteins attached to the PHA core have been engineered to 
display various functions. The application performance of engineered PHA beads in 
high-affinity bioseparation (Lewis and Rehm, 2009), enzyme immobilization (Moldes et 
al., 2004; Peters and Rehm, 2006), protein delivery to natural environments (Moldes et 
al., 2006), diagnostics (Baeckstroem et al., 2007) and as an antigen delivery system 
(Parlane et al., 2009) has been demonstrated. To that end, different strategies using 
GAP proteins located on the surface of PHA granules, as for instance synthase, 
depolymerase and phasins were employed (see below).  
Moreover, the approach using GAPs can be applied in vitro or in vivo. Namely, for 
in vitro technology PHA extraction is followed by in vitro bead production and using 
the advantage of GAPs-bead strong hydrophobic interaction, fusion proteins are in 
vitro purified/immobilized (Yao et al., 2008). The in vivo approach consists of GAP 
fusion immobilization onto the PHA granule surface while the granules are being 
formed inside the PHA producer cell (Moldes et al., 2004). 
Among GAPs, PHA granule binding proteins phasins are very attractive due to their 
diversity compared to the other GAPs. Thus, phasins were utilized as affinity tags to 
design recombinant protein purification system based on in vitro approach. This 
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method allowed low cost production and purification of high value added proteins in a 
continuous way (Wang et al., 2008). Significant improvements in bio-separation 
technology were made by upgrading the system interconnecting phasins and target 
proteins via self-cleaving intein (Banki et al., 2005). This approach allowed in vivo 
immobilization onto the granule and the release of purified recombinant proteins once 
the native PHB particles are recovered which in turn pushed bio-separation technology 
several steps forward in the direction towards convenience and cheapness. A receptor 
mediated drug delivery system was developed based on PhaP phasin. The system 
consists of in vitro synthesized PHA nanoparticles, PhaP and polypeptide or protein 
ligands (e.g. mannosylated human α1-acid glycoprotein (hAGP) and human epidermal 
growth factor (hEGF)) (Yao et al., 2008). Moreover, in vivo immobilized correctly folded 
eukaryotic proteins on the surface of PHA granules via phasin protein were used for 
fluorescence activated cell sorting (FACS) based diagnostics which is a powerful 
technique for the qualitative and quantitative detection of biomolecules used widely in 
both basic research and clinical diagnostic applications. Beads displaying a specific 
antigen are used to bind antibodies which are then fluorescently labeled using 
secondary antibodies (Backstrom et al., 2007). 
Similarly, applying in vitro approach the substrate binding domain of PHA 
depolymerase has been used to anchor fusion proteins to PHA microbeads (Lee et al., 
2005). Another example of successful GAPs application is for enzyme immobilization 
on the in vivo PHA granule surface using N-terminus of PHA synthase from 
Pseudomonas aeruginosa as a tag (Peters and Rehm, 2006).  
The convenience of in vitro technology is best spotted in medical applications such 
as drug targeting where is preferable the use of endotoxin free PHA for coating with 
GAPs fusions (see below). However, other applications as for instance protein delivery 
to natural environments do not necessary acquire extremely pure PHA and can 
beneficiate from in vivo approach. Thus, a system for protein 
immobilization/purification was designed, based on the use of PHA granules and the 
N-terminal domain of the protein PhaF (BioF tag) (Moldes et al., 2004). BioF system 
constitutes specific biotechnological tool for producing mcl-PHA beads (Figure 6). 
Once, the fermentation under optimal mcl-PHA production conditions is accomplished 
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in P. putida, the granules carrying the BioF-proteins fusions can be isolated from the 
crude cell lysate by a simple centrifugation process and directly used for further 
applications. This approach was used for in vivo immobilization of Cry1Ab derived 
insect-specific toxin protein into mcl-PHA granules. Generating BioF insect-specific 
toxin immobilized to bioplastics, suggested that the BioF tag could be exploited as a 
new tool for spreading active polypeptides to the environment (Moldes et al., 2006) 
(Figure 6). 
 
 
Figure 6. In vivo immobilization of fusion proteins to bioplastics by BioF tag. The procedure 
consists of the fermentation under optimal PHA production conditions in P. putida, isolation of 
the granules carrying the BioF-proteins fusions from the crude cell lysate by a simple 
centrifugation step and release of fusion proteins via detergent treatment (modified from 
Moldes et al., 2004). 
 
5. PHA metabolic network and polyester functionalization 
 
In most bacteria, such as the paradigmatic Ralstonia eutropha H16 strain, PHB is 
synthesized in three-step reaction starting with acetyl-CoA (Peoples and Sinskey, 1989) 
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(Figure 7). In the first step two acetyl-CoA molecules are condensed in a reaction 
catalysed by a 3-ketothiolase. Then, generated acetoacetyl-CoA is stereoselectively 
reduced to (R)-3-hydroxybutyryl-CoA by a NADPH-dependent acetoacetyl-CoA 
reductase. Finally, the (R)-3-hydroxybutyryl-CoA monomers are polymerized by a PHB 
synthase, releasing PHB and free CoA as end-products. 
 
 
Figure 7. Metabolic pathways involved in PHA biosynthesis. Intermediates for PHA synthesis 
are derived from pathways connected with central carbon metabolism (β-oxidation and de 
novo fatty acid synthesis). Acetyl-CoA is the key intermediate in the PHA synthesis, as the 
connection between catabolic and anabolic pathways involved in this system. PHA cycle is 
continuous process of synthesis (PhaC1) and degradation (PhaZ) of the polymer in which acyl-
CoA synthetase (ACS1) is encarged for transformation of the depolymerization products. 
Resulting products of ACS1 activity, (R)-3-hydroxyacyl-CoA, are potencial substrates for 
polymerase or enzyms of fatty acid metabolism. PHB is syntesized from acetyl-CoA in 3 
succesive steps invoplving the activity of β-ketoacil-CoA tiolase (PhbA), acetoacetyl-CoA 
dehydrogenase (PhbB) and PHB polymerase (PhbC) (Escapa et al., 2013). 
 
Pseudomonas species rely on β-oxidation pathway and de novo fatty acid synthesis 
to convert fatty acid or carbohydrate intermediates, respectively, into different (R)-3-
hydroxyacyl-CoAs. These metabolites are used as substrates by PHA synthases which 
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catalyze the committed step of mcl-PHA biosynthesis and finally end up in PHA 
polymer (Prieto et al., 2007).  
The β-oxidation pathway involves the participation of a transport system coupled 
to an acyl-CoA synthetase (FadD) which catalyses the activation of n-alkanoic acid to 
their acyl-CoA derivates. Later, an acyl-CoA dehydrogenase (FadF), which requires the 
participation of an electron-transferring protein (FadE), catalyses the formation of a 
double bond in the β-position. Finally, a protein complex (FadBA) with five enzymatic 
activities (enol-CoA-hydratase, 3-OH-acyl-CoA dehidrogenase, cis-Δ3-trans- Δ2-enoyl-
CoA isomerase, 3-OH-acyl-CoA epimerase and 3-ketoacyl-CoA thiolase) catalyses the 
removal of two carbon units of the acyl-chain being processed (Olivera et al., 2001) 
(Figure 7). Concerning the fatty acids β-oxidation protein complex (FadAB), two set of 
fadAB genes have been described in the strain P. putida KT2442, fadB and fadA 
(PP_2136 and PP_2137) and fadBx and fadAx (PP_2214 and PP_2215). Apparently, the 
first set plays a more important role in fatty acid degradation, since fadB and fadA 
deletion mutants did not show completely blocked β-oxidation, but production of PHA 
with higher content of longer chain monomers, possibly due to their defective β-
oxidation pathway (Escapa et al., 2011; Ouyang et al., 2007; Chung et al, 2009). 
Non-fatty acid precursors can be oxidized to acetyl-CoA and channeled into PHA 
by de novo synthesis pathway, via (R)-3-hydroxyacyl-acyl carrier protein (ACP) 
intermediates. In this process, malonyl-CoA and its precursor, acetyl-CoA, are activated 
by transacylation to acyl-carrier protein (ACP). Malonyl and acyl-ACP derivatives are 
condensed by ketoacyl-ACP synthetase, reduced losing a ketone group, dehydrated 
and saturated to the corresponding (R)-3-hydroxyacyl-ACP chain that may be further 
elongated in two-carbon growing chains.  Acyl-ACP intermediates can be then re-
transformed in (R)-3-hydroxyacyl-CoAs by a specific transacylase, PhaG, present in 
most Pseudomonads (Fiedler et al., 2000) (Figure 7). Interestingly, unsaturated 
monomers such as 3-hydroxy-5-dodecenoate and 3-hydroxy-7-tetradecenoate are also 
generated by fatty acid de novo synthesis (Huijberts et al., 1992).  
Due to the broad substrate specificity of PHA synthase (PhaC), many organic 
molecules containing a carboxyl and a hydroxyl group in the position 3, can be 
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converted to the respective CoA thioester and can, in principle, be incorporated into a 
high-molecular-mass PHA. The biosynthesis pathways of the activated PHA precursor, 
(R)-3-hydroxyacyl-CoA, have been extensively studied and exploited through metabolic 
engineering, leading to the production of modified PHA that is a range of 
heteropolymers and homopolymers containing (R)-3-hydroxy fatty acids (Rehm and 
Steinbüchel, 1999). 
 
5.1. Functionalized PHA through metabolic engineering strategies 
 
Over the past decade, a better understanding of the molecular mechanisms and 
regulatory processes underlying the synthesis of biopolymers has emerged. Genome 
sequencing, functional genomics and System Biology studies, cloning and 
characterization of biosynthesis genes have all had a substantial impact on 
understanding of biosynthesis pathways in organisms that produce commercially 
relevant polymers and also lead to the discovery of new biopolymer-producing 
bacteria (Pohlmann et al., 2006; Kalia et al., 2003; Lee, 2006; Escapa et al., 2012; 
Follonier; Pobletes etc). This knowledge provided a powerful tool to engineer bacteria 
that are capable of, not only efficient biopolymer production, but also the production 
of modified and even unnatural polymers exhibiting unique material properties for 
specific high-value applications. Since the discovery that some bacteria can incorporate 
(R)-3-hydroxyalkanoates (3HA) bearing functional groups from related substrates (Lenz 
et al., 1992), research has led to structural diversification of PHA by biosynthesis and 
post-biosynthesis chemical modifications (Hazer and Steinbüchel, 2007; Scholz, 2010). 
Structural and functional diversity is readily addressed in bacterial polyesters, as they 
are produced by modulated fermentation processes.   
This concept has been exploited to produce a plethora of tailor-designed mcl-PHA, 
with highly diverse structures that include acetylthioester, acetoxy, alkoxy, amino, 
cyano, cyclohexyl, epoxy, halogenated, hydroxy or propylthiol groups (Table 1) (Kim et 
al., 2007; Scholz, 2010). A larger variety of PHA compositions with varying molar 
amounts of functional groups can be generated in most of the cases, by altering the 
ratio of co-substrates. Functional groups prone to chemical modifications have been 
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introduced, mainly in P. oleovorans and P. putida, such as thiol, bromine, chlorine and 
fluorine radicals, cyano and epoxy groups. The introduction of such groups also 
modifies the thermal properties, and thus the processing requirements of the resulting 
polymers, enabling higher melting and lower glass-transition temperatures, or 
modified biological activities (see below).  
 
Figure 8. Schematic representation of medium chain lenght PHAs (mcl-PHAs) chemical 
structure. A, PHO-co-HHx composed of non-functionalized monomers OH-Alk (3-(R)-
hydroxyoctanoate (OH-C8) and 3-(R)-hydroxyhexanoate (OH-C6)); B, PHACOS composed of 
functionalized monomers (3-hydroxy-6-acetylthiohexanoate (OH-6ATH) and 3-hydroxy-4-
acetylthiobutanoate (OH-4ATB) ) and of non-functionalized monomers OH-Alk ((OH-C8), 3-(R)-
hydroxydecanoate (OH-C10), and traces (OH-C6)). 
 
Recently in our laboratory we produced poly((R)-3-hydroxyacilthioalkanoate-co-3- 
hydroxyalkanoate) (PHACOS) (Figure 8), a new second generation family of polymers 
containing thioester groups in the side chain. PHACOS is composed of 6-acetylthio-3-
hydroxyhexanoic acid (OH-6ATH) and the shorter derivative 4-acetylthio-3-
hydroxybutanoic acid. Previous studies described the biosynthesis of PHA containing 
sulphur groups in side chains, comprising either thiophenoxy functional groups (Takagi 
et al., 1999) or thioether groups (Ewering et al., 2002). Moreover, biopolymers with 
thioester linkages in the polymer backbone were isolated from PHA-accumulating 
bacterium R. eutropha, containing 3-metrcaptopropionate (3MP) or 3-
mercaptobutyrate (3MB) as constituents (Lütke-Eversloh et al., 2002; Lütke-Eversloh 
and Steinbüchel, 2004).   
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PHACOS were obtained applying 6-acetylthiohexanoic acid (6-ATH) as precursor in 
a co-feeding strategy with decanoic acid as co-substrate. P. putida KT2442 and its fadB 
mutant were used for PHACOS synthesis. The necessity of adding mcl-fatty acids to the 
medium for promoting PHA synthesis in the presence of 6-ATH was clearly 
demonstrated. Decanoic acid was confirmed to be a good PHA precursor in cultures 
containing 6-ATH. However, results showed that PHACOS cannot be efficiently 
produced in mutant strain under conventional one-stage culture process as a 
consequence of KT42FadB strain inability to use 6-ATH and incorporate thioester 
groups in the side chain of polymer. Two-stage culture process was optimal for 
efficient production of PHACOS in both strains. The procedure consists of two 
consecutive cultivation stages. In first stage cells were grown in LB medium for 
biomass production. In the second stage, cells were incubated in minimal medium in 
the presence of 6-ATH as precursor in a co-feeding strategy with decanoic acid as co-
substrate. When the derived strain KT42FadB, mutated in the fadB gene from the β-
oxidation pathway, is used, the polymer is overproduced and contains mainly OH-6ATH 
units (Escapa et al., 2011).  
Although most of functionalized mcl-PHA intermediates are obtained through β-
oxidation of  fatty-acids, non-related carbon sources such as acetate, ethanol, fructose, 
glucose, gluconate or glycerol are channeled to PHA by the de novo fatty acid pathway, 
yielding a fraction of unsaturated monomers (3-hydroxy-5-dodecenoate and 3-
hydroxy-7-tetradecenoate, see above and Figure 7). The molar fraction of unsaturated 
monomers usually ranges from 5 to 10 mol% depending on the strain (Sanchez et al., 
2003; Silva-Queiroz et al., 2009) and can be increased by diminishing the culture 
temperature (Huijberts et al., 1992). The use of carbohydrate-related sources is 
advantageous in terms of substrate cost and diversity of monomer composition. 
However, PHA yields are generally lower in comparison to yields obtained when using 
fatty acids as substrates. Besides carbohydrates, glycerol has also been considered as 
an attractive raw material for PHA production due to its availability as by-product of 
biodiesel industry (Gómez et al, 2012). In Pseudomonas strains, glycerol is converted to 
glycerol-3-phosphate and then to dihydroxyacetone phosphate, which is further on 
catabolized by a branch of Entner–Doudoroff (ED) pathway (Schweizer et al., 1997; 
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Cuskey et al., 1985). Glycerol use is hindered by a prolonged lag phase, caused by the 
transcriptional repressor GlpR. GlpR knock-out mutants resulted in faster consumption 
of glycerol, together with improved PHA accumulation, possibly as a consequence of 
the larger availability of intermediates generated by de novo fatty acid synthesis 
(Escapa et al., 2013).  
 
Table 1. Precursors used in the literature to produce functionalized mcl-PHA (branched alkyl, 
cyclohexyl, halogenated, acetoxy, ester, alkoxy, epoxy, thio, cyano, nitro, aromatics) (Modified 
from Tortajada et al., 2013) 
Precursor 
%Mol functional  
groups 
Strain Ref. 
Branched alkyl 
Citronellol >99.0 P. citronellolis ATCC 13674 Choi et al., (1994) 
Alkylhydroxyoctanoates  5.0 P. oleovorans ATCC 29347 Scholz et al.,(1994) 
Methyloctanoates  3.0-96.4 P. oleovorans ATCC 29347 
Fritzsche et al., (1990)c, 
Lenz et al., (1992) 
 Cyclohexyl 
Cyclohexylbutyric acid >99.0 P. cichorii YN2 Honma et al., (2004) 
Cyclohexylvaleric/ 
butytic acid  
13.2-100.0 P. oleovorans ATCC 29347 
Andújar et al., (1997), 
Kim et al., (2001) 
Unsaturated 
Alkenes (C7-C9) 45.0-55.0 P. oleovorans ATCC 29347 Lageveen et al., (1988) 
Undecenoic acid  27.1-100.0 P. putida KCTC 2407 Kim et al., (2000) 
Undecenoic  5.0-99.0 P. oleovorans ATCC 29347 
Kim et al., (1995b), 
Park et al., (1998),  
Sparks et al., (2008) 
Hydroxyoctenoic acids  63.5-81.6 P. oleovorans ATCC 29347 Fritzsche et al., (1990)b 
Dicarboxylic acids  
(C4-C10) 
4.7-11.7 P. citronellolis ATCC 13674 Choi et al., (1994) 
Undecynoic acid  32.0-100.0 P. oleovorans ATCC 29347 Kim et al., (1998) 
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Undecynoic acid  22.0-100.0 P. putida KCTC 2407 Kim et al., (1998) 
Halogens 
Bromoalkanoic acids  
(C6-C11)  
3.7-38.0 P. oleovorans ATCC 29347 
Kim et al., (1992),  
Lenz et al., (1992) 
Chlorooctane  69.0 P. oleovorans ATCC 29347  Doi et al., (1990) 
Fluorohexanoic/ 
nonanoic acids  
1.9-8.8 P. oleovorans ATCC 29347 Kim et al., (1996)a 
Fluorohexanoic/ 
nonanoic acids  
1.0-17.3 P. putida KT2440 Kim et al., (1996)a 
Fluorophenoxyundecan
oic acid 
>99.0 P. putida 27N01 Takagi et al., (2004) 
Acetoxy 
Octanone , octylacetate  3.3-10.3 P. oleovorans ATCC 29347 Jung et al., (2000) 
Ester, Alkoxy, Epoxy 
Alkylheptanoate  2.5-60.0 P. oleovorans ATCC 29347 Scholz et al.,(1994) 
Alkxyhexanoic/octanoic/ 
undecanoic acids  
31-100.0 P. oleovorans ATCC 29347 Kim et al., (2003) 
10-epoxyundecanoic acid  25.0-75.0 P. oleovorans ATCC 29347 Bear et al., (1997) 
C7-C12 alkenes 4.2-20.0 P. cichorii YN2 Imamura et al., (2001) 
Soybean oil  63.0 P. stutzeri 1317 He et al., (1998) 
Thio, sulfanyl 
Acetylthiohexanoic acid  16.5-78.5 P. putida KT2442, KT24FadB Escapa et al., (2011) 
Propylthiohexanoic acid 14.5-17.5 R. eutropha DSM541  Ewering et al., (2002) 
Propylthioundecanoic acid  6.02% w/w S P. putida KT2440 Ewering et al., (2002) 
Methylsulfanylphenoxyvaleric 
acid  
12.2-35.6 P. cichorii H45, YN2 Kenmoku et al., (2002) 
Methylsulfanylphenoxyvaleric 
acid  
18.4 P. jessenii P161 Kenmoku et al., (2002) 
Thiophenoxyundecanoic acid >99.0 P. putida 27N01 Takagi et al., (1999) 
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Cyano, nitro 
Cyanoundecanoic acid  17.0-32.0 P. oleovorans ATCC 29347 Lenz et al., (1992) 
Cyanophenoxyhexanoi acid 0-2.2 P. oleovorans ATCC 29347 Kim et al., (1996)a 
Cyanophenoxyhexanoi acid 0.0-34.0 P. putida KT2440 
Gross et al., (1996),  
Kim et al., (1995)a 
Nitrophenoxyhexanoc acid 4.2-5.1 P. oleovorans ATCC 29347 Kim et al., (1996)a 
Nitrophenoxyhexanoic acid  1.0-4.8 P. putida KT2440 Kim et al., (1996)a 
Dinitrophenylvaleric acid  1.2-6.9 P. oleovorans ATCC 29347 Aróstegui et al., (1999) 
Aromatics (benzoyl, methylphenoxy, phenoxy, phenyl) 
Benzoylalkanoic acids  
(C4-C8)  
8.3-79.8 P. cichorii YN2 Honma et al., (2004) 
Methylphenoxyalkanoic 
 acids (C6, C8)  
40-65 P. putida KCTC 2407 Kim et al., (2000) 
Methylphenoxyalkanoic  
acids (C6, C8) (PVA, NA) 
68-100 P. oleovorans ATCC 29347 Kim et al., (1999) 
Methylphenoxyalkanoic  
acids (C6, C8)  
24-100 P. putida KCTC 2407 Kim et al., (1999) 
Phenoxyundecanoic  
Acid 
>99 P. oleovorans ATCC 29347 Ritter et al., (1994) 
Phenoxyalkanoic 
 acids (C6,C8,C11) 
100 P. oleovorans ATCC 29347 Kim et al., (1996)b 
Phenoxyundecanoic acid  12-100 P. putida BM01 Song et al., (1996) 
Phenylvaleric acid 13.7-19.5 P. putida BM01 Song et al., (2001) 
Phenylvaleric acid  >99 P. oleovorans ATCC 29347 Curley et al.,(1996)b 
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Phenyl, tolylvaleric/ 
octanoic acids  
3-64 P. oleovorans ATCC 29347 Curley et al., (1996)a 
Phenylalkanoic acids (C4-
C8) 
>95 P. jessenii C8 Tobin et al., (2005) 
Phenylalkanoic acids (C4-
C8) 
>95 P. putida S12, CA-1, H4, F6, D5 Tobin et al., (2005) 
Phenylalkanoic acids (C6-
C11)  
>99 
P. putida U fadA-, ΔFadBA-
PhaZ 
Abraham et al., (2001), 
García et al., (1999), 
Olivera et al., (2001) 
Phenylvaleric acid  >99 P. oleovorans ATCC 29347 Fritzsche et al., (1990)a 
Phenylvaleric acid  12.6-40.6 P. oleovorans ATCC 29347 Kim et al., (1991) 
 
 
5.2. Properties of PHA carrying functionalized groups  
 
The physical and material properties of PHA are significantly influenced by their 
monomer composition and chemical structure (Chen, 2009). On one hand, scl-PHA 
may be too rigid and brittle and lack the superior mechanical properties required for 
biomedical and packaging film applications. Poly-(R)-3-hydroxybutyrate-co-(R)-3-
hydroxyhexanoate (PHB-co-HHx) copolymers with low 3-hydroxyhexanoate (OH-C6) 
fraction are most commonly used PHA because of its appropriate mechanical 
properties for use as flexible films, compared with PHB (Noda, 1996). On the other 
hand, mcl-PHA may be elastomeric but at the same time characterized by very low 
mechanical strength. Therefore, for packaging materials, tissue engineering and other 
specific applications, the physical and mechanical properties of microbial polyesters 
need to be diversified and improved (Hazer et al., 2012). To date, more than 100 
different monomers such as linear, branched, saturated, unsaturated and aromatic 
(Huijberts et al. 1992; Olivera et al. 2001b; Scholz 2010; Scholz et al. 1994) have been 
reported as PHA constituents (Steinbüchel and Valentin, 1995). The length of the side 
chain and its functional group considerably influence the properties of the polymer. Of 
special interest are functionalized groups in the side chain that allow further chemical 
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modification, e.g. halogens, carboxyl, hydroxyl, epoxy, phenoxy, cyanophenoxy, nitroin 
phenoxy, thiophenoxy, and methylester groups (Kim and Lenz, 2001).  
 
Table 2. PHA monomer composition (%mol) of the polymers obtained from P. putida KT2442 
and P. putida KT42FadB 24 h cultures 
Carbon 
source 
Strain 
Culture 
procedure 
Monomer composition (mol%) 
 
  
OH-C6 OH-C8 OH-C10 Σ Alk. 
OH-
4ATB 
OH-
6ATH 
Σ 
Thio. 
15 mM SO KT2442 One-stage  8.5 91.5 - 100 - - - 
12 mM DA KT2442 One-stage  2 36.6 61.4 100 - - - 
2.4 mM  DA + 
12 mM 6ATH 
KT2442 One-stage  1.5 11.2 6.6 19.3 26.5 51 77 
2.4 mM  DA + 
12 mM 6ATH 
KT42FadB One-stage  0.9 19.6 60.9 81.4 2.5 14 16.5 
2.4 mM  DA + 
12 mM 6ATH 
KT2442 Two-stage  2.1 13.6 7.1 22.8 31.5 47 78.5 
2.4 mM  DA + 
12 mM 6ATH 
KT42FadB Two-stage  0.6 15.5 19.1 35.2 7.5 58 65 
 
OH-C6, OH-C8 and OH-C10 (percentages were estimated by GC-MS. OH-6ATH and OH-4ATB 
percentages were estimated by NMR. SO (Sodium octanoate), DA (Decanoic acid). 
 
PHACOS, the family of PHA carrying thioester group in the side chain, generally 
show an amorphous behavior due to the inability of the polymer backbone to fold 
tight enough and organize to form crystals. This property is caused by the presence of 
bulky side chains and functional groups that leads to stiffer and less mobile chains. 
Moreover, PHACOS show good thermal stability up to 200 °C. This could result in a 
good processing ability for these materials and potentially interesting mechanical 
properties. The molecular weights (Mn and Mw) of PHACOS are in the typical range 
observed for mcl-PHA (Witholt and Kessler, 1999). Regarding PHACOS elaboration, 
neither the culture procedure nor the bacteria strain (mutant or wild type) had 
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significant influence on the molecular weight. However, PHACOS have tunable thermal 
properties as a result of different glass transition temperatures derived from the 
different possibilities of monomer composition. The fadB mutant strain led to PHACOS 
with lower content in thioester-based monomers, but inserted monomers showed 
longer side chains (Table 2) that resulted in polymer having much lower glass transition 
temperature. This amorphus mcl-PHA with low values of glass transition (Tg) are 
expected to display relatively high softness and marked elasticity which are very 
interesting properties for materials dedicated to biomedical applications (Escapa et al., 
2011). 
Concerning mcl-PHA obtained from non-fatty acid precursors, it is observed that 
the higher the molar fraction of unsaturated constituents in the monomers, the lower 
the resulting melting and glass transition temperatures, very likely due to 
crystallization inhibition by unsaturated side chains (Ashby and Foglia, 1998). Double 
bonds are also easily attacked in chemical reactions, allowing even higher 
diversification of the polymer properties (Lageveen et al., 1988; Hazer and Steinbüchel, 
2007). A number of treatments have been described for crosslinking of unsaturated 
PHA, namely electron-beam irradiation, UV-irradiation or even autoxidation (De 
Koning et al., 1994; Bassas et al., 2008a; 2008b; Silva-Queiroz et al., 2009) and in some 
cases those PHA can be transformed into rubbers (De Koning et al., 1994). Moreover, 
chemical epoxidation of the pendant vinyl groups has been applied to decrease 
melting temperature and increase glass transition temperature (Park et al., 1998). In 
addition, new plastic properties can also be achieved by blending PHA with other 
polymers. 
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6. PHA as scaffold biomaterial in tissue engineering 
 
Any material, natural or man-made, biodegradable and biocompatible, that 
comprises the whole or part of a living structure or a biomedical device which 
performs, augments, or replaces a function that has been lost through disease or injury 
is known as a "biomaterial". They have played an important role in the treatment of 
disease and the improvement of health care (Langer and Tirrell, 2004). Among them, 
PHA polymers are promising materials for biomedical applications because they are 
natural, renewable, biodegradable and biocompatible thermoplastics (Hazer and 
Steinbüchel, 2007).  
Elastomeric mcl-PHA and its copolymers offer an extensive design space with a 
large range of properties that opened a new incites of polymer application and 
subsequently accelerated research in the past few years (Chen, 2009). However, the 
lack of availability of these polymers in large quantities still limits the investigation. 
Hence, most of the current research is concentrated on poly-(R)-3-hydroxyoctanoate 
(PHO) and PHB-co-HHx copolymer due to their large quantities production and 
improved mechanical and elastomeric properties compared to scl-PHA (Wiliams et al., 
2000; Chen et al., 2001). 
Many successful studies using various animal models have clearly demonstrated 
that PHA, represented by PHB, poly-4-hydroxybutyrate (P4HB), PHO and PHB-co-HV 
and PHB-co-HHx copolymers possesses the biodegradability, biocompatibility and 
thermoprocessibility for not only implant applications but also controlled drug release 
uses (Chen and Wu, 2005). The application performance of those PHA as different 
biomedical devices has been studied (e.g. sutures, repair devices, repair patches, 
slings, cardiovascular patches, orthopedic pins, adhesion barriers, stents, guided tissue 
repair/regeneration devices, articular cartilage repair devices, nerve guides, tendon 
repair devices, bone marrow scaffolds, artificial oesophagus and wound dressings) 
(revised in Chen and Wu, 2005) (Table 3). Among them, P4HB has been approved by 
FDA (The Food and Drug Administration agency of the United States Department of 
Health and Human Services) for suture application with a trade name TephaFLEX 
marketed by Tepha Inc., of Cambridge, Mass., USA. Tepha specializes in manufacturing 
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pericardial patches, artery augments, cardiological stents, vascular grafts, heart valves, 
implants and tablets, sutures, dressings, dusting powders and prodrugs (Figure 9). 
With successful approval of P4HB as an implant biomaterial, more PHA based 
biomaterials are expected to go into clinical trials soon. With the diversity of PHA 
materials, they are expected to become a family of bioimplant materials with rich 
applications (Chen, 2009). Herein the most outstanding possible applications of PHA in 
biomedical field will be revised. 
Potential use of PHA in the construction of the devices for cardiovascular 
applications has been intensively studied. One of the most advanced application of 
PHB has been the development of regenerative pericardial patch (Bowald and 
Johansson-Rudel, 1997) used to close pericardium after surgery without adhesion 
between heart and sternum. Following the in vivo study on animal models, clinical 
testing on human patients has been successfully performed (Duvernoy et al., 1995). In 
addition, PHB was successfully used for arterial septal defect repair (Malm et al, 1992) 
and construction of cardiovascular stents (Behrend et al., 1998). Furthermore, PHA 
were tested in vascular grafting studies for repair or replacement of malfunctioning 
blood vessels in the arterial or venous systems due to damage or disease. 
 
Table 3. PHA used in biomedical field 
Modified/unmodified PHA Medical application Reference 
PHB Subcutanous patches Baptist et al. (1965) 
PHB Peripheral nerve guide Hazari et al. (1992), 
Moshahebi et al. (2002) 
PHB Regenerative pericardial 
patch 
Bowald et al. (1997), 
Duvernoy et al. (1995) 
PHB Pulmonary artery 
regeneration 
Malm et al. (1994) 
PHB Arterial septal defect repair Malm et al. (1992) 
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PHB Cardiovascular stents Behrend et al. (1998) 
PHB Stomach wall patch  Löbler et al. (2002)  
PHB  Drug delivery, 
chemoembolization  
Kassab et al. (1999)  
PHB Spinal cord injury  
 
Navikov et al. (2002) 
PHB-co-HV  Guided tissue regeneration Leenstra et al. (1995) 
PHB-co-HV Bone regeneration Cool et al. (2008) 
tricalcium phosphate 
reinforced PHB,  PHB-co-HV  
Internal bone fixation Jones et al. (2000) 
PHB-co-HV Urethral reconstruction Bowald et al.(1990) 
PHB-co-HV Subcutanous patches Gogolewski et al. (1993)  
PHB-co-HV Myocardial patch  Kenar et al.  
PHB-co-HV  Bone regeneration Cool et al. (2008) 
PHB-co-HV Auricular implant for drug 
delivery 
Jones et al. (1994) 
PHB-co-HV Rods, drug delivery Hasirci et al. (1998), 
Korkusuz et al. (2001) 
PHB-co-HV Cartilage proliferation  Kose et al. (2005)  
PHB/PHB-co-HV  Suture  
 
Shishatskaya et al. 
(2004)  
PHBHHx Vessel stent 
 
Qu et al. (2006) 
PHBHHx Nerve conduit Chen et al. (2009) 
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PHBHHx  Bone regeneration  Wang et al. (2004) 
PHBHHx  Cartilage proliferation  
 
Wang et al.(2005)  
PHB/PHBHHx  Cartilage proliferation  Ye et al. (2009)  
PHB-co-HV,PHB-4HB Drug delivery  
 
Turesin et al. (2001)  
PHB-co-HV-PLGA  Nerve guide  
 
Yücel et al. (2010)  
 HA reinforced PHB Bone regeneration  Shishatskaya et al. 
(2006) 
HA reinforced PHB/VA  Bone regeneration  Luklinska et al. (2003)  
PHO  Pulmonary valve 
 
Stock et al. (2000)  
PHO  Pulmonary heart valve  
 
Sodian et al. (2000)  
PHO-co-HHx-PGA Abdominal aorta scaffold  Tim et al. (1999),  
Stock et al. (2000) 
PHO-Sy  Subcutaneous patches  
 
Hazer et al. (2009)  
PHOU-Au  Subcutaneous patches  Hazer et al. (2011)  
PHACOS  Antimicrobial polymer Dinjaski et al. (2013)  
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PHA monomers  (R3HB) therapeutic effects on 
Alzheimer’s and 
Parkinson’s diseases, 
osteoporosis and even 
memory improvement 
Massieu et al. (2003),  
Zou et al. (2009), 
Kashiwaya et al. (2000) 
PHA monomers and 
oligomers  
nutritional and energy 
supplements 
Ca2+ stimulation effect  
Qu et al. (2006), 
Cheng et al. (2005), 
Cheng et al. (2006) 
 
The elastomeric polymer PHO-co-HHx has been evaluated for a two components 
scaffold for abdominal aorta tissue engineering in a lamb model (Tim et al., 1999; Stock 
et al., 2000a). Perhaps the most remarkable results with PHA polymers have been 
obtained in the development of cell-seeded tissue-engineered heart valves. P4HB and 
PHO heart valve scaffolds were constructed and tested in vivo (see below; Sodian et al, 
2000a) (Figure 9).  
In dental and maxillofacial field PHB-co-HV was utilized for guided tissue 
regeneration, where polymer barrier membranes were constructed to encourage 
regeneration of new periodontal ligament by creating a space that excludes gingival 
tissue from healing wound. Their performance in vivo was found to be satisfying 
(Leenstra et al., 1995). Moreover, PHB-co-HV was used for guided bone regeneration 
(Cool et al., 2008). When used in orthopedic for internal bone fixation PHB and PHB-
co-HV polymers were usually reinforced with hydroxyapatite (HA), glass or tricalcium 
phosphate (Jones et al., 2000). Obtained results showed favorable overall tissue 
responses, some indication of osteogenic activity was noted as well and therefore it 
was concluded that they can serve as alternative to corticocancellous bone grafts.  
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Figure 9. Examples of possible applications of PHA in biomedical field. From left to right PHO 
heart valve scaffolds, PHB-co-HV suture and TephaFLEX® surgical mesh (used for soft tissue 
reinforcement in plastic and reconstructive surgery, for temporary wound support, 
reinforcement of soft tissues and hernia repair).  
 
Another possible application of PHB-co-HV copolymer was reported in urology for 
urethral reconstruction where the polymer scaffold was reported to support 
regeneration to fully functional urethra tissue (Bowald and Johansson, 1990). 
Moreover, wound management is one of the well studied areas where PHA found 
many applications. PHB and PHB-co-HV sutures were proven to feature necessary 
strength for the healing of muscle-fascial wounds not causing any acute vascular 
reaction at the site of implantation or any adverse events (Shishatskaya et al., 2004) 
(Figure 9). Finally, it has been verified that PHB shows a good polymer characteristics 
for soft tissue defect repair, especially for the closure of lesions in the gastrointestinal 
tract (Löbler et al., 2002).  
The use of PHB and PHB-co-HV for drug delivery was evaluated in numerous 
studies that included investigation of their performance as subcutaneous implants 
(Jones et al., 1994), compressed tablets for oral administration (Hasirci et al., 1998; 
Korkusuz et al., 2001) and microparticles for intravenous use (Kassab et al., 1999). The 
therapeutic potential of P4HB was investigated and it was found to have possible 
beneficial effects in narcolepsy treatment and others (Williams and Martin, 2001). 
Oligomeric forms of ketone body hydroxybutyrate (HB) were evaluated as an 
alternative to the sodium salt of the monomer that could provide controlled release 
systems for monomers and overcome the problem associated with administering large 
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amounts of sodium ion in vivo. This system could find application in seizure control, 
reduction of protein catabolism, appetite suppression, metabolic disease control, 
treatment of diabetes and insulin resistant states and others (Martin et al., 2000).  
Due to the elastomeric behavior and biodegradability of mcl-PHA they can be used 
as promising base polymers for developing biodegradable pressure synthetic adhesives 
(PSA). Such PSA can find applications in wound coverings and closures, surgical drapes, 
electrocardiograph electrode mounts and transdermal drug delivery (Babu et al. 1993). 
For the development of PSA, PHO, poly-(R)-3-hydroxydecanoate (PHD) and mixtures of 
poly-(R)-3-hydroxyoctanoate-co-(R)-3-hydroxyundecenoate (PHO-co-HU) were used 
(Babu et al., 1993). Moreover, mcl-PHA like PHO and copolymers as PHB-co-HHx have 
been used as biopolymer scaffolds for the regeneration of nerve axons (Chen et al., 
2010). Many other applications of PHA have been addressed with great potential for 
clinical use (Table 3). 
 
7. Factors affecting PHA application 
 
7.1. The pyrogen removal 
 
For medical use, most PHA as attractive biopolyesters, have been sterilized using 
ethylene oxide, without causing significant physicochemical properties of the 
polymers. However, inappropriate extraction of PHA from bacterial biomass results in 
contamination with lipopolysaccharides (LPS) that form an integral part of the gram-
negative bacteria outer membrane (Petsch and Anspach, 2000). Due to their high heat 
stability and insensitivity to pH changes they cannot be eliminated by simple 
sterilization step. Those cell-associated compounds, named endotoxins, are pyrogenic 
and cause fever and pathology when injected into animals. A special attention was 
paid to minimize the endotoxin contamination of PHA as a number of contaminants 
were reported in industrial samples of PHB-co-HV (Rouxhet et al., 1998; Garrido, 
1999).  
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Endotoxin levels are measured in endotoxin units (EU) because their molecular 
weight may vary a great deal (10 000 to 1 000 000 Da). One EU is approximately 
equivalent to 100 pg of Escherichia coli lipopolysaccharide—the amount present in 
around 105 bacteria. Humans can develop symptoms when exposed to as little as 5 
EU/kg body weight. These symptoms include, but are not limited to fever, low blood 
pressure, increased heart rate, low urine output. Even smaller doses of endotoxin in 
the blood stream are often fatal.  
A conventional industrial sample of PHB was found to contain more than 120 EU/g 
(Williams et al., 1999). Several methods have been reported for endotoxin removal, 
such as depyrogenation based on the use of peroxide (Williams et al., 1999) and 
sodium hydroxide (Lee et al., 1999). FDA permits concentration of less than 20 EU/g of 
PHA or per medical device. This can be successfully achieved by a heat driven PHA 
extraction with a solvent followed by non solvent precipitation. Another method is 
temperature-controlled recovery of PHO-co-HHx from P. putida GPo1. In contrast to 
other methods, precipitation of PHO was triggered by cooling the hot solution to a 
particular temperature. Applying this method a minimal endotoxicity of 2 EU/g PHO 
can be achieved and a purity of close to 100% (w/w) (Furrera et al., 2007).  
 
7.2. Biocompatibility 
 
There were many attempts to define biocompatibility related to the behavior of 
biomaterials in various contexts. The term refers to the ability of a material to perform 
its desired function generating an appropriate host response in a specific situation 
(Black, 2006). The ambiguity of the term reflects the ongoing development of insights 
into how biomaterials interact with the human body and eventually how those 
interactions determine the clinical success of a medical device. Indeed, the main 
objective when using biomaterials is to generate the most appropriate beneficial 
cellular or tissue response without eliciting any undesirable local or systemic effects in 
the recipient or beneficiary of the therapy. However, since the immune response and 
repair functions in the body are so complicated the biocompatibility of a material 
should not be describe in relation to a single cell type or tissue. Nevertheless, 
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considering in vitro cellular behavior is essential for a comprehensive biocompatibility 
evaluation of further on implanted polymers. 
A high biocompatibility is essential for the acceptance of any incorporated object 
by humans and mammals. Several factors are shown to influence implant 
biocompatibility such as shape, surface porosity, surface hydrophilicity, surface energy, 
chemistry of the material, the environment (tissue) where it is incorporated and its 
degradation products (Zinn et al., 2001). PHA have the potential to become an 
important compound for medical applications. For instance, tests have shown PHB 
biocompatibility, which is not surprising when considering the fact that R-3-
hydroxybutyric acid is a normal constituent of blood at concentrations between 0.3 
and 1.3 mM  (Wiggam et al., 1997) and is also found in the cell envelope of eukaryotes 
(Reusch, 2000).  
 
7.2.1. In vitro effect of PHA on mammalian cells  
 
In vitro investigations have been shown to be suitable for elucidating several 
aspects of cell interactions with biomaterials. They preclude the numerous events that 
might occur after implantation of a foreign material in an animal model and provide a 
simple environment to study cellular responses. As upon implantation of polymers, the 
local tissue reaction consists of an inflammatory response, which initiates tissue repair, 
and regeneration processes, many different mammalian cell lines have been used in in 
vitro studies. Most commonly used are fibroblasts, macrophages, polymorphonuclear 
leukocytes (PMNs) and endothelial cells (Saad et al., 1999). 
Cytotoxicity and inflammation studies of PHA have been mainly focus on 
characterizing cell response to the extracts of the polymers, whereas few studies 
attempted to analyze cell response in direct contact with the polymer (Chaput et al., 
1995).  However, the results varied with the medium, surface-to-volume ratio, time 
and temperature.  
Tissue response was characterized by seeding the cells on the polymers surface 
and evaluating their initial attachment, growth and morphology. Thus, the effect of 
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surface morphology of PHA, as one of the factors influencing biocompatibility, was 
studied in vitro on mouse fibroblast (Kai et al., 2002). The study demonstrated that 
films with a fairly regular and smooth surface as PHB-co-HHx/PHB blends with low 
crystallization allowed improved cell attachment and growth of the seeded mouse cell 
line L929, thereby increasing its biocompatibility (Kai et al., 2002). Moreover, good 
endothelial cell and myofibroblasts attachment to PHO-co-HHx was reported (Sodian 
et al., 1999). Interactions between PHA as for instance PHB-co-HV and human 
keratinocytes (Ji et al., 2008), allogeneic chondrocytes (Wang et al., 2008), glial cells 
(Xiao et al., 2008), fibroblast and osteoblast (Wang et al., 2005), were studied and 
results proved the ability of mentioned cell lines to adhere and proliferate. 
In tissue engineering, apart from reaction to material itself, evaluation of the 
cellular behavior affected by the degradation products is very important and especially 
in the case of PHA that are considered to be biodegradable. To analyze the effect of 
PHA degradation products, oligo-hydroxyalkanoates (OHAs), studies were carried out 
on macrophages, Kupffer cells, fibroblasts, osteoblasts and others (Cardielli et al., 
1995; Sun et al., 2007; Saad et al., 1996 a,b,c). Those studies demonstrated that OHAs 
in low concentration (10-20 mg/L ) do not significantly affect cell viability, whereas 
higher concentrations (>40 mg/L) reduce cell viability with more cell apoptosis, more 
cell death, delayed cell cycle and reduced cell proliferation. Moreover, the cytotoxicity 
of OHA decreased with increasing OHA side chain length indicating that medium chain 
length OHAs and mcl-PHA are more biocompatible then scl-PHA (Sun et al., 2007).  
Attempts to increase the biocompatibility of polymer scaffolds have been made 
using different approaches. Current strategies for improving implant biocompatibility 
may be grouped into two areas: i) passive coatings and ii) active release. Passive 
strategies rely on modification of the implant surface through chemical and physical 
means. Alternatively, active release is based on the release of molecules that may 
modify the host´s foreign body response, direct the wound healing process and favor 
tissue integration of the implant (Bridges and Garcia, 2008).  
Because the surface chemistry at the tissue-implant interface has a large influence 
on the immune system activation, the outer surface of implant is of great importance. 
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One of passive strategies includes increasing the hydrophilicity of the polymer to 
enable better adherence of the cells on the scaffolds. To that end, graft 
copolymerisation of acrylamide onto the PHO films was carried out and allowed better 
ovary cells attachment (Kim et al., 2002). Coating the surface of the polymer with a 
biocompatible compound is another approach to increase the biocompatibility of the 
polymer. With that aim, the surface of PHB-co-HHx matrices was coated with a 
biocompatible silk fibroin protein (Mei et al., 2006), PHA granule binding protein PhaP 
fused with cell adhesion motif Arg-Gly-Asp, RGD (Dong et al., 2010) and others. 
Moreover, approaches such as cell deposition can increase biocompatibility (Sodian et 
al., 2000).  
In another initiative, using active strategies different implant coatings that deliver 
active molecules (e.g. anti-inflammatory agents) and offer more interactive and direct 
approach to modulate cell behavior have been designed (Bridges and Garcia, 2008). 
Immunomodulatory agents can be immobilized onto the surface or delivered in soluble 
form. Possible strategies for the controlled release of agents include passive diffusion, 
bioerodible/degradable coatings, hydrolysable or enzyme-degradable linkages and 
many others.  
 
7.2.2. In vivo tissue response 
 
In spite the fact that investigation of in vivo response to implanted PHA has began 
in the mid 1960s (Baptis and Ziegler, 1965) it is still a controversial subject as multiple 
factors and wide range of tested PHA with different monomer composition influence in 
a specific way and produce distinctive tissue and inflammatory responses. In vicinity of 
some of implanted PHA presence of inflammatory cells has been reported (Gogolewski 
et al., 1993). However, care should be taken when interpreting these data, since some 
of the studies have been based on industrial and commercially available rather than 
medical grades of PHA polymers (Williams et al., 1999). Moreover, inflammation and 
other undesirable reactions of tested biomaterials can be related to polymer chemical 
composition, a particular implantation site, the shape of the implant, the degree of 
chemical purity of the material and others. The biocompatibility of the implants is 
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evaluated applying various criteria. Histological approach is based on determination of 
the degree of fibrotic reaction surrounding the samples and the presence of 
inflammatory or malign cells. Biochemical assays are used to reveal cellular and 
extracellular matrix formation (e.g. presence of collagen by 4-hydroxyproline assay). 
Imunocytochemical analysis is based on the use of antibodies for inflammatory cell 
detection. Many other assays can be performed depending on the specificity of 
scaffold function (e.g. thrombus formation, echocardiography for investigation of 3-
leaflet heart valve proper functioning, scaffold vascularization, etc.).  
Up on implantation of foreign body (biomaterial) host reactions occurs. This host 
reaction includes: i) blood-material interactions, ii) acute inflammation, iii) chronic 
inflammation, iv) granulation tissue development, and v) fibrosis/fibrous capsule 
development (Figure 10). In the very early process of implantation, proteins and other 
biomolecules present in the blood plasma and biological fluids rapidly adsorb onto the 
surface of biomaterial completing the first stage of the process, blood/material 
interactions. Adsorbed molecules (fibrinogen, IgG and complement fragments) 
mediate leukocyte biomaterial interactions and subsequent inflammatory reactions. 
During acute phase neutrophils are stimulated and recruited to implantation site. The 
biological role of the acute inflammatory response is to phagocytose foreign material. 
The attempt by inflammatory cells to engulf and degrade the implant leads to reduced 
analyte diffusion. Further on, neutrophils are replaced by macrophages and chroinc 
inflammation begins. Additionally, consumption of oxygen and glucose produces 
superoxide and peroxide. Moreover, local pH may drop due to this oxidative process, 
resulting in enzyme degradation. Differentiated macrophages secrete a variety of 
inflammatory mediators and often fuse to form multinucleated foreign body giant cells 
(FBGC) that is the hallmark of chronic response. FBGC further enhances degradation of 
the underlying implant surface. The extent of the chronic inflammatory response is 
dependent on not only the physical and chemical properties of the implant but also on 
mechanical stresses (i.e., movement) at the implant site. Granulation tissue is formed 
following resolution of the chronic inflammatory response due to the persistence of 
macrophages and infiltration of fibroblasts to the wound site. During the final step in 
the immune sequence, fibroblasts infiltrate to the site and generate a fibrous capsule 
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around the implant (Bridges and Garcia, 2008) (Figure 10). The severity and extent of 
the biological response to an implanted biomaterial or device influences the 
probability for its successful integration with surrounding tissue, as well as overall 
device performance. Initial phases of foreign body reaction are dictated largely by the 
extent of injury and surgical technique, implantation site, implant shape, size and local 
and systemic health of the recipient (Anderson, 2001). Significant research efforts have 
focused on modifying material properties to generate more biocompatible implants. 
A small amount of information on PHO, PHO-co-HHX and P4HB is available, 
whereas most of current information relates to PHB and PHB-co-HB (reviewed in 
Hasiric, 2000) as previously discussed. One of the earliest in vivo studies on mcl-PHA 
was carried out on the copolymer PHO-co-HHx through subcutaneous polymer 
implantation in mice (Williams et al., 1999). No evidence of macrophages was found in 
the implant sites and the tissue response continued to be very mild even 40 weeks 
post-implantation. Histological analysis revealed that the implants were encapsulated 
by a thin layer of fibroblasts surrounded by collagen and the polymer proved to be 
particularly inert, and could be readily removed with little tissue adherent to the 
implants (Williams et al., 1999).  
 
Figure 10. Events of host foreign body response to implanted materials. 1-3, 
Polymorphonuclear leukocytes (PMF) and monocytes (MC) recruited by stimulatory cues 
emigrate from blood vessels (BV) and adhere to the layer of adsorbed proteins on the implant; 
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4-6, Differentiated macrophages (MΦ) become activated, secreting a variety of inflammatory 
mediators, and often fuse into foreign body giant cell (FBGC); 7, Fibroblasts (FB) infiltrate to 
the site and generate a collagenous fibrous capsule around the implant.  
 
One of the strategies to improve biocompatibility and implant integration is by 
their in vitro seeding with autologous cells. Thus, after the proper functioning of 
constructed PHO trileaflet heart valve scaffold tested in pulsatile bioreactor was 
confirmed by synchronous opening and closing (Sodian et al., 2002), scaffold was 
seeded with vascular cells harvested from vascular arteries (Sodian et al., 2000). This 
study demonstrated that tissue-engineered heart valve scaffolds fabricated from PHO 
can be used for implantation in the pulmonary position with an appropriate function 
for 120 days in lambs (Sodian et al., 2000). In another study the feasibility of creating 
PHO trileaflet pulmonary conducts seeded with autologus cells was evaluated (Stock et 
al., 2000). Based on obtained results, it was concluded that engineered scaffold can 
properly function in pulmonary circulation. 
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7.3. In vitro and in vivo biodegradation 
 
PHA polymers are known as biodegradable, whose degradation might be triggered 
by different mechanisms. One of the well studied processes is enzymatic hydrolysis by 
microbial depolymerases. Many microorganisms can catabolize PHA through 
extracellular or intracellular degradation under aerobic or anaerobic conditions 
(Jendrossek and Handrick, 2002). Up to date, both extracellular scl-PHA (Jendrossek 
and Handrick, 2002) and intracellular mcl-PHA depolymerases have been characterized 
(de Eugenio et al., 2007). The interest in the study of the PHA hydrolysis lies not only in 
their potential use as bioplastics or biomaterials but also in the production of 
intermediates (3HA), as they can be used as chiral starting materials in fine chemical, 
pharmaceutical, and medical industries (Luengo et al., 2003; Ren et al., 2005). In 
addition, biodegradable materials have numerous applications in medicine and 
surgery. Those materials are designed to degrade in vivo in a controlled manner over a 
predetermined implantation period, such that degradation achieves or helps to 
achieve a particular function. The rates of PHA polymer degradation vary considerably 
and depend primarily upon chemical composition. It was demonstrated that PHA 
biodegradation is influenced by the presence of functional groups in the polymer 
chain, as well as by hydrophilicity/hydrophobicity balance (Mochizuki and Hirami, 
1997; Tokiwa and Calabia, 2004). Moreover, stereoregularity, molecular mass, 
morphological properties and crystallinity affect the biodegradability of PHA 
(Mochizuki and Hirami, 1997; Tokiwa and Calabia, 2004). Other factors influencing in 
vivo degradation such as location, surface area, physical shape and form can be very 
important. Thus, in vitro studies are not always good indicators of in vivo polymer 
behavior. The specific material requirements will differ according to the nature of the 
application.  
Studies on PHA polymers enzymatic hydrolysis in animal tissue are primarily based 
on in vitro investigation. With that aim, influence of different additives as for instance 
polysaccharides, polycaprolactone (PCL), lipases, PHA depolymerases and several 
extract on PHA degradation was examined. 
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PHA depolymerases are profoundly studied enzymes involved polymer 
degradation. However, even they are abundant in the environment, their PHA 
degradation activity is linked to soil and there are no evidences of their presence in 
animal tissue (Williams and Martin, 2002). However, characterization of PHA 
depolymerases gave some hints on the properties that other α/β hydrolases from 
animal tissue might harbor (Winkler et al., 1990; Jendrossek et al., 1996). Thus, to 
examine the involvement of lipases in degradation process, 16 different lipases were 
tested on 5 PHA polymers. It was demonstrated that lipases can hydrolyze PHA 
polymers decreasing in following order poly-3-hydroxypropionate (PHP)>P4HB > poly-
5-hydroxyvaleriate (P5HV)>poly-6-hydroxyhexanoate (P6HH), whereas none of the 
lipases hydrolyzed PHB (Mukai et al., 1993). Moreover, some of the earliest studies 
suggest that microbial lipases neither degrade PHB (Tokiwa et al., 1986). However, two 
lipases have been detected in tissue adjacent to PHB implant raising the possibility of 
their involvement in PHB degradation (Lobler et al., 1999).  
Moreover, possible participation of the gastrointestinal tract enzymes in the 
degradation process was studied in vitro. To that end, PHB was subjected to porcine 
pancreatin that contains a mixture of enzymes (lipase, amylase, α-chymotrypsin, 
trypsin and protease) and obtained results indicated a participation of enzymes in PHB 
hydrolysis (Freiera et al., 2002). 
Effect of different extracts on PHB-co-HV degradation was tested in vitro. It was 
demonstrated that percentage of weight loss decreased in following order newborn 
calf serum > pancreatin > synthetic gastric juice > Hank´s buffer (Atkins and Peacock, 
1996). Moreover, digestability of PHB-co-HV in vivo was demonstrated and it increased 
when polymer was treated with sodium hydroxide (Forni et al., 1999) 
Studies have demonstrated that macrophages are able to phagocytize PHB in vitro 
(Saad et al., 1999) and free radicals, acidic products or enzymes produced by these 
cells may also accelerate the degradation (Tracy et al., 1999). Moreover, it was 
demonstrated that when biodegradable polymer is implanted in vivo, macrophages 
and foreign body giant cells phagocytize and resorb the polymer (Marios and Zang, 
1999; Shishatskaya et al., 2008). However, unique mechanism and enzymes involved in 
Introduction 
 
39 
 
degradation process in vivo have not been identified, as they are shown to differ 
depending of the PHA polymer. 
Another proposed mechanism of PHA degradation is based on non-enzymatic 
chemical hydrolysis. This type of degradation was studied on PHO in water and 
phosphate buffer saline, PBS in vitro (Marois et al., 1999). It was found that the 
hydrolytic degradation is characterized by water absorption that induces increase of 
porosity and crystallinity, which subsequently leads to polymer hydrolysis (Marois et 
al., 1999). In addition, physical appearance of polymer changes, surface gloss is lost 
and rugosity develops (Chaput et al., 1995).  
Water uptake and chemical hydrolysis that lead to polymer swelling are the 
mechanisms proposed to initiate the degradation process of in vivo implanted PHA 
(Hazer and Hazer, 2011). In the studies carried out in vivo it was found that PHO-co-
HHx degrades slowly. The subcutaneous implants of PHO-co-HHx in mice decreased in 
Mw from 137,000 at implantation to around 65,000 over 40 weeks, and there was no 
significant differences between the molecular weights of samples taken from the 
surfaces and interior of the implants. The latter finding suggests that slow, 
homogenous hydrolytic breakdown of the polymer occurs (Williams et al., 1999). For, 
PHB it was reported that hydrolysis starts from random chain scission as this kind of 
hydrolysis is followed by decrease in molecular weights with unimodal distribution and 
relatively narrow polydispersity (Williams and Martin, 2001). However, PHB-co-HHx 
increased its polydispersity accompanied by an increase of crystallinity followed by a 
drop over the period of 6 months. These phenomena are attributed to the difference 
in the degradation rate of crystalline and amorphous regions in the polymers. The fact 
that amorphous regions are more accessible to aqueous liquid usually leads in increase 
in crystallinity. When the chain scission occurs in crystallinity regions, reduction of 
overall crystalinity manifests. Possible reason of the difference in PHB and PHB-co-HHX 
degradation could be coexistence of two different degradation mechanisms: enzymatic 
and non-enzymatic catalyzed (Qu et al., 2006). 
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It is worth nothing that in vivo as most PHA polymers break down they release 
hydroxyl acids that are significantly less acidic and less inflammatory than many 
currently used synthetic absorbable polymers (Taylor et al., 1994).  
Different approaches have been used to increase PHA degradability as for instance 
increasing hydrophilicity, polymer surface, crystallinity reduction and others.  Thus, 
PHO-co-HHx was blended with gelatin and the degradation was accelerated (Wang et 
al., 2004). Blending of gelatin created a more porous polymer surface and 
subsequently more surface area of the polymer was exposed for hydrolysis attack 
(Wang et al., 2004). Studies have been carried out to increase the hydrophilicity of the 
polymer, either by incorporating more hydrophilic groups in the polymer chain or by 
grafting more hydrophilic molecules onto the polymer chain. Such modifications 
enable improved water uptake and swelling of the polymer matrix, thus leading to 
better hydrolysis (degradation) of the polymer. In one such study, efficient 
improvement of degradation was achieved by PLA and polyethylene glycol (PEG) 
grafting onto the backbone of PHO-co-HU (Renard et al., 2012). 
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As it was previously mentioned, functionalization of PHA confers new properties 
to the polymer and subsequently open wide range of possibilities for industrial and 
biomedical application. Depending on the needs of designated application different 
strategies for polymer modification can be used. Moreover, due to the high 
hydrophobicity of the PHA and the presence of endotoxins, polymer modification 
processes need to be studied in detail and refined for specific application. Therefore, 
the main gol of this PhD Thesis was to study the components of PHA machinery that 
control granule formation and localization within the bacterial cell, as well as to 
address the key factors that drive phasin tag immobilization to the granule. Moreover, 
the new properties of functionalized PHA applying metabolic engineering approach 
were investigated. Therefore, this PhD Thesis was organized in following objectives: 
• Design of natural PHA nano-beads engineered to display fusion proteins of 
interest by strategy for tailor-made functionalizing of PHA granules. 
• Testing new properties of second generation bacterial polyesters carrying 
chemically modifiable functionalized side chain that confers new properties to 
the polymer. 
• In vivo investigation of second generation mcl-PHA antibacterial properties and 
biocompatibility. 
• Development of a noninvasive method for in vivo real-time monitoring of mcl-
PHA implant associated infection and inflammation.  
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1. Bacterial strains, plasmids, media and growth conditions 
 
The bacterial strains used throughout this study are listed in Table 4. Unless 
otherwise stated Escherichia coli and Pseudomonas putida strains were grown in Luria-
Bertani (LB) medium (Stambrook and Russell, 2001) with aeration at 37°C and 30°C 
respectively. The appropriate selection antibiotics, kanamycin (50 µg/mL), gentamycin 
(5 µg/mL), rifampicin (50 µg/mL) or ampicillin (100 µg/mL) were added when needed. 
The P. putida strain KT2442, a derivative strain of the parental strain KT2440 whose 
complete nucleotide sequence of the genome is accessible in the data bank (Nelson et 
al., 2002), was used throughout this study. Escherichia coli DH10B (Invitrogen) and E. 
coli BL21 (DE3) (harboring the T7 RNA polymerase gene under control of the lacUV5 
promoter) were used as hosts for gene cloning and overexpression, respectively.  
 
Table 4. Bacterial strains, plasmids and oligonucleotide primers 
Strains   
P. putida   
KT2442 KT2440 derivative strain  Nelson et al. (2002) 
KT42F KT2442 derivative strain, phaF deletional mutant Galan et al. (2011) 
KT42I 
KT42C1 
KT42C1ZC2 
KT42C1ZC2F 
KT42C1ZC2F-BG 
KT42-BG 
KT42F-BG 
KT42I-BG 
KT2442 derivative strain, phaI deletional mutant 
KT2442 derivative strain, phaC1 deletional mutant 
KT2442 derivative, phaC1, phaZ, phaC2 deletional mutant 
KT42C1ZC2 derivative strain, phaF deletional mutant 
KT42C1ZC2F derivative strain containing BioF-GFP 
KT2442 derivative strain containing BioF-GFP  
KT42F derivative strain containing BioF-GFP  
KT42I derivative strain containing BioF-GFP  
This work 
Eugenio et al. (2010) 
This work 
This work 
This work 
This work 
This work 
This work 
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KT42I-F 
KT42I-BGF 
KT42I derivative strain containing phaF  
KT42I-BG derivative strain containing phaF 
This work 
This work 
KT42I-GC KT42I derivative strain containing GFP::C-PhaF Galan et al. (2011) 
KT42F-GC KT42F derivative strain containing GFP::C-PhaF Galan et al. (2011) 
KT42-GC KT2442 derivative strain containing GFP::C-PhaF Galan et al. (2011) 
Escherichia coli   
DH10B Host for E. coli plasmids Invitrogen 
CC118λpir Host for pVLT35 plasmids Herrero et al. (1990) 
SM10λpir Host for pPF61 plasmids Prieto et al. (1999) 
SM10λpir 
(pKNGFdel) 
Host for pKNGFdel plasmids Galan et al. (2011) 
Plasmids   
pMAB20-GFP-
LYTAG 
pMAB20 derivate harboring BioF-GFP-LYTAG  Biomedal S.L. 
pKI18mobsacB pK18mobsacB derivate containing fragments upstream 
and downstream phaI gene 
This work 
pCNB5 
pCNB5-BioF-GFP-
LYTAG 
pUTminiTn5, lacIq::Ptrc, Kmr, Apr 
pCNB5 derivate containing BioF-GFP-LYTAG 
 
Lorenzo et al. (1993) 
This work 
pCNB5-GFP-Cterm pCNB5 derivate containing GFP-C-term This work 
pGEM-T 
pPF61 
pKNGFdel 
 
Apr, cloning vector 
pJMT6, lacIq::Ptrc::phaF 
pKNG101 derivate containing fragments upstream and 
downstream phaF gene 
Invitrogen 
Prieto et al. (1999) 
Galan et al. (2011) 
 
pGreenTIR plasmid harbouring GFP cassette  Miller et al. (1997) 
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pUC18NotGFP pUC18Not derivate containing GFP casstet This work 
pUC18NotGFP-
Cterm  
pUC18Not derivate containing GFP-C-term This work 
Oligonucleotide primers 
F5mutI GCGGATCCCCGGTCAGCTTCTCGATCTG (BamHI) 
F3mutI CGGAATTGGAGAGCAGGATGGCTGGC (EcoRI) 
X5mutI CGGAATTCATGGAGGCTGGGCTTGAG (EcoRI) 
X3mutI TCCCCCGGGAGATCACCTGTGCTGGCC (SmaI) 
D5mutF CGGGATCCCAACGAACTCGGCATCAGC (BamHI) 
I3mutF TCCCCCGGGCTGGACACGCTTGGCGAGG (SmaI) 
D3MutF  CGGAATTCCAACACTACATCTCCAGCAG (EcoRI) 
I5mutF  CGGAATTCGCCAGCCATCCTGCTCTCC (EcoRI) 
 I3mutF  TCCCCCGGGCTGGACACGCTTGGCGAGG (SmaI) 
GFP-F GGGAATTCTGATTAACTTTATAAGGAGGAAAAACAT (EcoRI)  
GFP-RBamHI CGGGATCCTTTGTATAGTTCATCCATGCCAT (BamHI)  
C-termF (GFP) CGGGATCCTCGCGCGCTGCAGCAAC (BamHI)  
C-termR (GFP) GCCAAGCTTCAGATCAGGGTACCGGTGCC (HindIII) 
FR1-C1ZC2-5′  GCTCTAGAGATCCAGATCCAGATCGACGCGGC (XbaI) 
FR1-C1ZC2-3′ CGGGATCCCATCTACGACGCTCCGTTGTCC (BamHI) 
 
For optimal PHA production, a preculture of the P. putida strains was cultivated 
overnight in LB medium, washed and inoculated at 0.3 OD600 in 0.1 N M63, a nitrogen-
limited minimal medium (13.6 g of KH2PO4/l, 0.2 g of (NH4)2SO4/l, 0.5 mg of 
FeSO4·7H2O/l, adjusted to pH 7.0 with KOH) at 30°C and 250 rpm as previously 
described (Moldes et al., 2004). This medium was supplemented with 1 mM MgSO4 
and a solution of trace elements (composition 1,000× 2.78 g of FeSO4·7H2O/l, 1.98 g of 
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MnCl2·4H2O/l, 2.81 g of CoSO4·7H2O/l, 1.47 g of CaCl2·2H2O/l, 0.17 g of CuCl2·2H2O/l, 
0.29 g of ZnSO4·7H2O/l). Sodium octanoate 15 mM was used as carbon source. Growth 
was monitored with a Shimadzu UV-260 spectrophotometer at 600 nm.  
For analyzing: i) biofilm formation, ii) bacterial adhesion properties on PHACOS 
and PHO, iii) antibacterial activity of PHACOS and PHO and iv) minimal inhibitory 
concentration (MIC) of their fatty acid precursors, pre-culture of all bacterial strains, 
bacteria were transferred from a stock frozen at -80 °C with 15% of glycerol, to a 
screw-capped test tubes with Nutrient Agar slant culture medium (Nutrient Broth 
DifcoTM (ref 234000, Becton, Dickinson and Company, France) supplemented with 
1.5% agar) and incubated at 37 °C for 16-24 h. Afterwards, bacteria were transferred 
onto fresh slant culture medium and incubate at 37 °C for 16 h-20 h. 
Bacterial test inoculum for adhesion experiments and antibacterial activity testing 
were prepared by resuspending bacteria pre-cultured on slant medium in 2 mL of 
1/500 Nutrient Broth, to serve as cell suspension according to the protocol described 
in ISO 22196:2007(E). Bacterial concentration was estimated via colony forming units 
counting (CFU) in the suspension by plating 10-fold serial dilutions in phosphate-
buffered physiological saline (PBS 10mM, pH 7.2) on LB agar plates (Sambrook and 
Rusell, 2001). CFU were counted after 24h incubation at 37°C. 
For the assays corresponding to bacterial capacity to form biofilms on polymer 
surfaces, cells pre-cultured on slant medium were transferred and grown with aeration 
in trypticase soy broth (TSB) supplemented with 0.3% glucose and 0.4% yeast extract 
for 20h at 37°C. Bacterial concentration was estimated spectrophotometrically at 600 
nm.  
For MIC determination, test inoculums were prepared by resuspending bacteria 
pre-cultured on slant medium in 2 mL of Muller-Hinton broth (MHB, Becton Dickinson). 
Bacterial concentration was estimated spectrophotometrically at 600 nm. 
The bacterial strains used for in vivo real-time monitoring implant infection were 
Staphylococcus aureus subsp. aureus ATCC 12600, its two derivate luminescent strains 
S. aureus pAmiBlaz and S. aureus pAmiSPA2. All bacterial strains were pre-cultured in 
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TSA plates and incubated at 37°C for 24 h. The appropriate selection antibiotics, 
chloramphenicol (10 µg/mL) or kanamycin (200 µg/mL) were added when needed. 
Trypticase soy broth (TSB, Difco ref) was used as the growth medium to culture the 
bacterial pathogens.  
 
2. Molecular biology techniques 
 
Standard molecular biology techniques were performed as previously described 
(Sambrook and Russell, 2001). PCR products were purified with the High Pure plasmid 
isolation kit (Roche Applied Science). DNA fragments were purified with Gene-Clean 
Turbo (Q-BIO-gene). Genomic DNA from P. putida KT2442 was isolated with the 
Genomic Prep Cells and Tissue DNA Isolation kit (Amersham Biosciences). All cloned 
inserts and DNA fragments were confirmed by DNA sequencing with fluorescently 
labeled dideoxynucleotide terminators and AmpliTaq FS DNA polymerase (Applied 
Biosystems Inc.) in an ABI Prism 377 automated DNA sequencer (Applied Biosystems 
Inc.). Transformation of E. coli cells was carried out using the RbCl method (Sambrook 
and Rusell, 2001). All oligonucleotides used for PCR amplification are listed in Table 4. 
3. Construction of different genetically manipulated P. putida KT2442 
and S. aureus CECT 86 strains 
 
3.1. Construction of PhaF null mutant and PhaI null mutant of P. putida 
KT2442  
 
The phaF gene was inactivated by marker exchange as described previously using 
the mobilizable suicide plasmid pKNG101 (Kaniga et al., 1991). The deletion of phaF 
gene was engineered with the DNA fragments DmutF and ImutF of 575 bp and 402 bp 
respectively, generated by PCR using the primer pairs D5mutF and D3MutF for DmutF, 
and I5mutF and I3mutF for ImutF. These two fragments were digested with the 
appropriate restriction enzymes and ligated using T4 ligase resulting in a single 977 pb 
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fragment carrying a deletion of the phaF gene which was cloned into the unique 
BamHI and SmaI sites of pKNG101 to yield pKNGFdel. Plasmid pKNGFdel was used to 
deliver the phaF mutation to the host chromosome via homologous recombination. 
Biparental mating was performed following protocols described by de Lorenzo and 
Timmis (1994), using E. coli SM10pir (pKNGFdel) as donor strain and P. putida KT2442 
as recipient strain. For conjugation, 100 µl of overnight cultures of donor and recipient 
strains were mixed in 5 mL of 10 mM MgSO4 and collected on a Millipore filter which 
was subsequently placed on an LB agar plate and incubated overnight at 30°C. After 
incubation, the cells were resuspended in 5 mL of 10 mM MgSO4 and plated on M63 
selective plates supplemented with 5% sucrose as described previously (Kaniga et al., 
1991). Transconjugants (SucR, SmS) were isolated. The second crossover event was 
confirmed by PCR using primers D5MutF and I3MutF. The resultant mutant strain was 
denoted KT42F. 
P. putida KT42I, phaI gene deleted strain, was constructed by disruption of phaI 
gene using plasmid pK18mobsacB (Schäfer et al., 1994). DNA manipulations and other 
molecular biology techniques were performed according to Stambrook and Russel 
(2001). The 481bp and 339bp fragments upstream and downstream phaI gene were 
PCR-amplified with F5mutI and F3mutI or X5mutI and X3mutI primers respectively. 
Total DNA of P. putida KT2442 strain was used as template. DNA fragments were 
purified by standard procedures using Gene Clean (BIO 101, Inc.). The resulting 
fragments were digested with the appropriate restriction enzymes and ligated using T4 
ligase resulting in a single 820bp fragment carrying a deletion of the phaI gene which 
was cloned into the unique BamHI and SmaI sites of pK18mobsacB to yield 
pKI18mobsacB. Plasmid pKI18mobsacB was used to deliver the phaI mutation to the 
host chromosome via homologous recombination. Similarly, P. putida KT42C1ZC2 
strain was constructed using FR1-C1ZC2-5′ and FR1-C1ZC2-3′ and FR2-C1ZC2-5′ and 
FR2-C1ZC2-3′ set of oligonucleotides. Triparental mating was performed following 
protocols described by Herrero et al. (1990), using E.coli DH10B (pKI18mobsacB) as 
donor strain and P. putida KT2442 as recipient strain. Successful gene disrupted strains 
were selected in M63 0.1N plates supplemented with 0.1% citrate, 5% sucrose and 
kanamycin and confirmed by PCR analysis, DNA sequencing and SDS-PAGE analysis. 
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The second crossover was confirmed by PCR amplification using F5mutI and X3mutI 
primer. 
 
3.2. PhaF null mutant strains construction of P. putida KT42C1ZC2 
 
To construct P. putida KT42C1ZC2F strain, the phaF gene was inactivated by 
marker exchange using the mobilizable suicide plasmid pKNGFdel as previously 
described (Galan et al., 2011). Briefly, biparental filter-mating technique was 
performed (de Lorenzo and Timmis, 1994) using E. coli SM10λpir (pKNGFdel) as donor 
strain and P. putida KT42C1ZC2 as recipient strain. Transconjugants (SucR, SmS) were 
isolated. The second crossover event was confirmed by PCR using primers D5MutF and 
I3MutF. 
 
3.3. Complementation of P. putida KT42F, P. putida KT42I and P. putida 
KT42I-GN strains 
 
Plasmid pPF61, harbouring the phaF gene from P. putida GPo1 under the control 
of the Ptrc promoter (Prieto et al., 1999) was introduced into P. putida KT42F, P. putida 
KT42I and P. putida KT42I-GN chromosome by triparental mating. The resulting strains 
called KT42F-F, KT42I-F and KT42I-GNF, respectively were cultivated in PHA production 
medium in the presence of 5 mM (isopropyl-1-thio- -D-galactopyranoside) IPTG as 
described (Prieto et al., 1999). 
 
3.4. Construction of P. putida strains expressing a cassette consisting in a 
fusion gene GFP and C- terminal domain of PhaF 
 
The GFP::C-PhaF fusion was obtained by amplification of two DNA fragments. GFP 
cassette was amplified from plasmid pGreenTIR (Miller and Lindow, 1997) with GFP-F 
and GFP-RBamHI. After digestion with the corresponding restriction endonucleases, 
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the GFP cassette was cloned into pUC18Not plasmid yelding pUC18NotGFP. phaF C-
terminal domain was PCR amplified using C-termF (GFP) and C-termR (GFP) 
oligonucleotides from genomic DNA of P. putida KT2442. Obtained PCR product was 
digested and cloned into pGEM-T plasmid. The fragment obtained after digestion with 
HindIII and BamHI was cloned into pUC18NotGFP plasmid. The resulting hybrid plasmid 
pUC18NotGFP-Cterm was transformed into E.coli strain DH10B. Construction was 
confirmed by sequencing using an ABI Prism 3730 DNA Sequencer. The GFP::C-PhaF 
fusion was cloned from pUC18NotGFP-Cterm plasmid into pCNB5 vector as NotI 
fragment. Constructed plasmid pCNB5-GFP-Cterm was introduced into the P. putida 
KT2442 and P. putida KT42F chromosomes by triparental mating yielding KT42-GC and 
KT42F-GC, respectively. Conjugates were isolated after plating on M63 0.1N selective 
plates supplemented with 0.2% citrate and kanamycin. Afterwards colonies were 
picked in LB plates and LB plates with IPTG and selected with a fluorescent magnifying 
lamp. 
 
3.5. Insertion of GFP and BioF (N-terminal of PhaF protein) fusion as a 
monocopy into the chromosome of P. putida strains 
 
To study localization of BioF in vivo, the mobile cassette carrrying the BioF-GFP 
fusions were inserted as a monocopy into the chromosome of different P. putida 
strains via mini-Tn5 transposons. A 1730-bp DNA NotI/NotI fragment containing 
Ptac::BioF-GFP-LYTAG was obtained after digestion from pMAB20-GFP-LYTAG plasmid 
kindly provided by Biomedal S.L. Plasmid pCNB5 was used as cloning vector where 
BioF-GFP was inserted as NotI fragment to yield pCNB5-BioF-GFP allowing to drive the 
expression of the fusion under the control of lacIq-Ptrc regulatory system. E. coli 
CC118λpir cells were transformed and positive clones were selected in LB plates 
supplemented with kanamycin. Resulting construction (pCNB5- BioF-GFP) was 
transferred into P. putida KT2442, P. putida KT42F, P. putida KT42I, P. putida 
KT42C1ZC2 and P. putida KT42C1ZC2F by triparental mating technique to give rise to P. 
putida KT42-BG, P. putida KT42F-BG, P. putida KT42I-BG, P. putida KT42C1ZC2-BG and 
P. putida KT42C1ZC2F-BG respectively (Figure 17A). Transconjugants were selected on 
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0.1N M63 plates supplemented with 0.2% citrate, kanamycin, 0.1mM IPTG (isopropyl-
1-thio- -D-galactopyranoside) and confirmed by SDS-PAGE and Western Blot analysis as 
previously described (Moldes et al., 2004). Western blot analysis was performed with 
the ECL Western Blotting Detection Kit (Amersham Biosciences) according to the 
protocol described by the manufacturer. Rabbit polyclonal antiserum against PhaI and 
BioF was generated as previously described (Moldes et al., 2004). Colonies were picked 
to LB plate with and without IPTG. Selection of fluorescent green colonies was done 
from LB plate supplemented with IPTG by fluorescent magnifying lamp. 
 
3.6. Construction of S. aureus luminescent strains 
 
Bioluminescent S. aureus strains were generated by transforming CECT 86 strain 
with a modified Photorhabdus luminescens luxCDABE (lux) gene cluster using the 
pAmiBlaz or pAmiSPA2 plasmids. To construct the vectors, blaz (β-lactamase) with 
selected mutation and spa2 (protein A) promoters were inserted into promoterless-lux 
cloning vector, pAmilux (Mesak et al., 2009) to yield pAmiBlaz or pAmiSPA2 plasmid, 
respectively. Vectors were introduced into the cells by electroporation as previously 
described (ref). Transformants were selected on trypticase soy agar (TSA) plates 
containing chloramphenicol (10 µg/ mL). Successful transformation was confirmed by 
bioluminescent colonies screening using an IVIS Lumina bioimaging system (Xenogen). 
 
4. Flow cytometry 
 
Cells were harvested and washed twice with distilled water and resuspended in 
water to a final OD600 of 0.2 for staining with Nile Red. A Nile Red stock solution was 
made by dissolving the dye to a concentration of 1 mg/mL in dimethyl sulfoxide 
(DMSO). Three microliters stock solution was added to 1 mL of cell suspension. The 
mixture was incubated in the dark for 15 min and analyzed by Flow citometry (flow 
cytometer Coulter EPICS XL). P. putida KT42C1 minus strain (a phaC1 mutant which 
produces <1% CDW PHA) (de Eugenio et al., 2010a) was used as negative control. A 
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calibration curve for the quantification of the PHA content using flow cytometry was 
made comparing the fluorescence intensity and PHA content analyzed by gas 
chromatography throughout the growth curve in P. putida KT2442 (data not shown). 
The relation between both parameters was fitted to the equation y= 30.874 Ln(x) + 
38.11 with a R2=0.9984. This equation has been used to translate the cytometry 
fluorescence intensity data into PHA values. 
 
5. Transmission electron microscopy 
 
Cells were harvested, washed twice in PBS, and fixed in 5% (w/v) glutaraldehyde in 
the same solution. Afterwards, cells were suspended in 2.5% (w/v) OsO4 for 1 h, 
gradually dehydrated in ethanol [30, 50, 70, 90, and 100% (v/v); 30 min each] and 
propylene oxide (1 h), embedded in Epon 812 resin. Ultrathin sections (thickness 70 
nm) were cut with a microtome using a Diatome diamond knife. The sections were 
picked up with 400 mesh cupper grids coated with a layer of carbon and subsequently 
observed in a Jeol-1230 electron microscope (JeolLtd., Akishima, Japan). 
To determine the size of PHA granules from the micrographs, 50 cells of the wild 
type and of the mutant were selected, in which the PHA granule diameter was 
measured. We analyzed 100 granules of the wild type and 100 of the mutant. Only 
granules with sharp boundaries were selected. The number of PHA granules per cell 
was determined only from cells which were fully visible in the electron micrographs. 
 
6. In vivo localization of the C- and N-terminal domain of PhaF by 
fluorescence microscopy 
 
P. putida KT42-GC and KT42F-GC strains were cultivated overnight in LB medium. 
Then, cells were washed and inoculated at 0.3 OD600 in 0.1 N M63. Cultures were 
induced with 2 mM IPTG in the exponential phase of growth to induce the production 
of the GFP::C-PhaF fusion protein. Staining for nucleoids (Nucleoids staining) was 
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performed by incubation with 2 µg/mL (DAPI) for 15 min while the PHA granules were 
(stained) visualized after staining with 1 µg/mL Nile Red for 15 min. Then cells were 
fixed with 4% paraformaldehyde at room temperature for 1 h, washed tree times with 
PBS and visualised by confocal microscopy Laser Confocal espectral (CLSM) Leica TCS 
SP2-AOBS. 
P. putida KT42-BG, P. putida KT42F-BG, P. putida KT42I-BG, P. putida KT42I-BGF, P. 
putida KT42C1ZC2-BG and P. putida KT42C1ZC2F-BG living cells expressing BioF-GFP 
fusion protein were visualized with a Zeiss Axioplan Universal epifluorescence 
microscope operated for incident-light fluorescence and contrasting techniques of 
bright field and phase contrast. Cells cultivated in LB medium or in PHA producing 
conditions were induced with 2 mM IPTG in the exponential phase of growth for the 
production of the BioF-GFP fusion protein and observed after 8h of incubation. 
Micrographs were recorded with digital camera Leica DFC350FX.  
To examine in detail co-localization of BioF-GFP fusion protein, nucleoid and 
granules P. putida KT42I-BGF strain was cultivated overnight in LB medium. Once 
washed, cells were inoculated at 0.3 OD600 in 0.1 N M63. Cultures were induced with 
2 mM IPTG in the exponential phase of growth for the production of the BioF-GFP 
fusion protein. Nucleoids staining was performed by incubation with 2 µg/mL (DAPI) 
for 15 min while the PHA granules were stained with 1 µg/mL Nile Red for 15 min. 
Afterwards, cells were fixed with 4% paraformaldehyde at room temperature for 1 h, 
washed tree times with PBS and visualised by confocal microscopy Laser Confocal 
espectral (CLSM) Leica TCS SP2-AOBS. 
 
7. PHA quantification 
 
Polyhydroxyalkanoate monomer composition and cellular PHA content were 
determined by gas chromatography-mass spectrometry (GC-MS) following previously 
described protocol (de Eugenio et al., 2010). Briefly, samples were subjected to 
methanolysis in the presence of 15% (w/v) sulfuric acid, and resulting methyl esters of 
monomers were analyzed by injecting 1 μl of sample into Perkin Elmer AutoSystem gas 
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chromatograph equipped with SPB1 Supelco capillary column (25 m x 0.25 mm inner 
diameter x 0.22 μm) and ionization detector. Biomass was calculated as previously 
described (de Eugenio et al., 2010). 
An additional, quantification of the PHA content was performed by Flow citometry 
(flow cytometer Coulter EPICS XL). Analysis was done as described before (Galan et al., 
2011). Briefly, PHA was stained adding 3 μl of Nile Red stock solution (1 mg/mL in 
dimethyl sulfoxide) to 1 mL of harvested and washed cells, previously diluted to OD600 
of 0.2. The mixture was incubated in the dark for 15 min and analyzed. P. putida 
KT42C1 minus strain (a phaC1 mutant which produces <1% CDW PHA) (de Eugenio et 
al., 2010) was used as negative control. The quantification of the PHA content using 
flow cytometry was made comparing the fluorescence intensity and PHA content 
analyzed by gas chromatography as previously described (Galan et al., 2011).  
 
8. Protein quantification 
 
Content of BioF-GFP fusion protein was quantified by flow cytometry, fluorometry 
and software package QuantityOne protein for protein quantification in SDS-PAGE 
protein gels. 
For BioF-GFP fluorescence quantification by flow cytometry, 1 mL of cells grown in 
PHA producing conditions was harvested after 8h of incubation, washed twice with 
distilled water and resuspended in water to a final OD600 of 0.2. P. putida KT42C1 
minus strain (a phaC1 mutant which produces <1% CDW PHA) (de Eugenio et al., 2010) 
was used as negative control. 
Furthermore, an additional quantification of BioF-GFP fluorescence was 
performed by fluorometry, allowing the comparison of fluorescence of GFP in whole 
cells and isolated granules carrying GFP. P. putida strains were cultivated in PHA 
producing conditions. When A600 reached 0.6 the culture was induced with 0.1 mM 
ITPG. After 8 h of incubation, 1 mL of cultures were harvested, washed twice with 
distilled water and resuspended in water to a final OD600 of 0.2 for fluorometry 
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analysis of whole cells. The rest of the culture was used for granule isolation. After 
harvesting, cells were resuspended in 15mM Tris-HCl pH 8, and disrupted by passing 
through a French pressure cell twice. The extracts were centrifuged 30 min at 
10,000×g, and the pellet fraction was dissolved in 5 mL of 15mM Tris-HCl pH 8. Granule 
isolation was done by centrifugation (12,000xg for 30 min) onto 55% glycerol (Merrick 
and Doudoroff, 1964) of total crude extract kept at 4°C during the entire process. After 
extraction granules containing PHA-immobilized GFP protein were resuspended in 
15mM Tris-HCl pH 8 to a final OD600 of 0.2 and analyzed by Fluorimetry 
(excitation/emission). 
For BioF-GFP quantification by QuantityOne, isolated granules proteins were 
separated in 12.5% SDS-polyacrylamide gels and stained with Coomassie brilliant blue 
G-250 following previously described protocol (Stambrook and Russell, 2001). Protein 
content calculation in examined P. putida strains was carried out by densitometric 
scanning using Gel Doc XR and analyzed using Quantity One software (version 4.6 
basic) (Bio-Rad, Hercules, CA) and calibrating with broad-range molecular mass 
markers from Bio-Rad. 
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9. PET disk coating with PHACOS and PHO  
 
All medium-chain-length polyhydroxyalkanoates (mcl-PHA) applied in this study 
were prepared as previously reported (Escapa et al., 2011) and kindly provided by 
Bioplolis S.L. To determine PHA monomer composition, gas chromatography-mass 
spectrometry (GC-MS) and nuclear magnetic resonance (NMR) analysis were carried 
out as previously described (Escapa et al., 2011). The monomer content of PHACOS 
was 29.7% of non-functionalized monomers OH-Alk (17.5% of 3-hydroxyoctanoate 
(OH-C8), 10.3% of 3-hydroxydecanoate (OH-C10), and 1.9% of 3-hydroxyhexanoate 
(OH-C6) monomers) and 70.3% of functionalized monomers (46.4% of 3-hydroxy-6-
acetylthiohexanoate (OH-6ATH) and 23.9% of 3-hydroxy-4-acetylthiobutanoate (OH-
4ATB) monomers). The PHO (poly 3-hydroxyoctanoate-co-hydroxyhexanoate) 
consisted of 8.5% OH-C6 and 91.5% OH-C8.  An optimized downstream processing was 
applied to eliminate endotoxins as previously described (Furrer et al., 2007). Briefly, 1 
g of PHA was dissolved in 100 mL of chloroform at 40˚C under intense stirring, 
subsequently the suspension was pressure filtrated (Vacuubrand MZ2C diaphragm 
vacuum pump) and the polymer was precipitated by addition of non-solvent methanol. 
Finally, the polymer was dried under vacuum at 40˚C for 48h. The procedure was 
repeated two times to obtain mcl-PHA with endotoxin units (EU) as low as 20 EU/g, in 
compliance with endotoxin requirements of the FDA for biomedical applications. The 
endotoxicity was measured using a Limulus amebocyte lysate (LAL)-test (Pyrogent Plus 
Single Test Kit, 0.125 EU/mL, Lonza) according to the protocol described elsewhere 
(Furrera et al., 2007). Each analysis was carried out at least twice. Using this method, 
values of PHACOS and PHO endotoxicity were determined being less than 12 EU/g and 
15 EU/g, respectively.  
For disk fabrication, the PET disks were coated with PHACOS or PHO by solvent-
casting method; polymeric materials dissolved in chloroform (2% w/v) were applied 
over sterile, endotoxin-free PET disks (6 mm diameter) kindly supplied by ACCIONA 
(Barcelona, Spain) in a dust-free atmosphere and the coatings were allowed to dry for 
72 h at room temperature. The resulting PHACOS-coated disks (PHACOS disks), PHO-
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coated disks (PHO disks) and control PET disks were sterilized overnight with ethylene 
oxide (EtO) at 40˚C. 
 
10. Mcl-PHA microparticles preparation 
 
The preparation of microparticles was carried out by the emulsion technique 
previously described (Freitas et al., 2005) and modified as follows: 1 mL water was first 
emulsified during the addition of 10 mL of PHA polymer solution in dioxane (1%w/v). 
The resulting emulsion was thereafter mixed by sonication for 1 min with a 2% PVA 
aqueous solution (40mL), involving the inversion of emulsion. After evaporation of 
ethyl acetate under reduced pressure, the microparticles were isolated by 
centrifugation (12 000 rpm for 20 min at 25 °C). Three washing cycles with deionized 
water followed by centrifugation were applied to remove the PVA. The morphology 
and the size of microparticles was analyzed by scanning electron microscopy (SEM) 
using a Philips XL 30 ESEM apparatus at an accelerating voltage of 15 keV. It was 
equipped with a field emission Hitachi SU800 apparatus. The samples were prepared 
by deposition of the corresponding microparticle suspension (0.01 mg mL1) over glass 
disks (13 mm diameter and 1 mm thickness), and the solvent (H2O) was evaporated at 
room temperature for 24 h. All the samples were coated with chrome prior to 
examination by SEM. 
 
11. Biofilm formation on mcl-PHA 
 
By means of this assay we studied the capacity of PHACOS disks to prevent 
bacterial biofilm formation on its surface in comparison to the other materials. S. 
aureus CECT 86 and P. aeruginosa CECT 4122 were used as model strains able to form 
biofilm on different materials. The ability of bacteria to form biofilm in vitro on 
PHACOS, PHO and PET disks was examined by environmental scanning electron 
microscopy (ESEM), crystal violet assay and CFU counting.  
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The same optimal conditions as previously described for pneumococcal biofilm 
formation (Moscoso et al., 2006) were used to induce the production of biofilms by all 
examined strains. Briefly, previously prepared endotoxin-free sterile PET disks or PET 
disks coated with PHACOS or PHO were placed in 24-flat bottom well plates 
(ref.353947 Falcon, Becton Dickinson) and each well was inoculated with 1 mL of 1:100 
diluted in fresh TSB cultures previously grown in TSB supplemented with glucose and 
yeast extract. Biofilm formation on each tested disk (PHACOS, PHO or PET) was carried 
out in triplicate. Plates were incubated in static condition for 16h at 37°C, and bacterial 
growth was determined by measuring the A595 using a plate reader (microplate 
absorbance reader 2020; Anthos Labtec Instruments GmbH). 
For ESEM examination, following the incubation samples were washed three times 
with PBS 10mM, pH 7.2 and fixed with 2.5% glutaraldehyde for 2h at room 
temperature. The dried samples were mounted on aluminum stumps and sputter-
coated with gold before examination under an environmental scanning electron 
microscopy (ESEM) apparatus (Philips XL 30) at an accelerating voltage of 15 KeV. 
Formed biofilm was quantified by crystal violet assay according to previously 
described protocol (Moscoso et al., 2006). Briefly, after the staining with 0.5% crystal 
violet and rinsing to remove non adherent bacteria, biofilm was mechanically removed 
from the disks, solubilized in 95% ethanol (200 μL per well) and the absorbance was 
determined at 595 nm using an Anthos 2020 microplate absorbance reader (Anthos 
Labtec Instruments). 
For CFU counting of bacteria present in the biofilm, pre-incubated disks were 
washed with distilled water to remove non adhered bacteria. Biofilm, in this case 
without staining, was mechanically removed from the disk using disposable steril 
micropipette tip, subsequently 10-fold dilutions were made in 10mM PBS, pH 7.2 and 
plated on LB plates. Bacteria were enumerated after 24h incubation at 37°C. 
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12. Bacterial adhesion to PHACOS and PHO 
 
The number of viable bacterial cells adhered to the surface of biopolymers was 
determined by fluorescence microscopy using Bacterial Viability test LIVE/DEAD 
BacLightTM (Invitrogen L13152). The reference strains of S. aureus (CECT 86) and P. 
aeruginosa (CECT 4122) were used for in vitro adherence test. The same protocol was 
followed as indicated for measuring the antibacterial activity on plastic surfaces 
according to ISO 22196:2007 (E) (see below). As test inoculum bacterial suspensions in 
1/500 NB (1-2 × 108 cells/mL) were placed on PHACOS, PHO and PET disks. After the 
incubation, bacteria were washed out from the disks and the solution was dyed 
following the manufacturer’s instructions (Invitrogen L13152). Samples were visualized 
by Zeiss Axioplan Universal epifluorescence microscope operated for incident-light 
fluorescence and contrasting techniques of bright field and phase contrast. 
Micrographs were recorded with a digital camera Leica DFC350FX.  
An additional test for confirmation of bacterial cells adherence on PHACOS, PHO 
and PET disks was performed by ESEM. PHACOS, PHO and PET disks were incubated 
with bacterial suspensions in 1/500 NB (1-2 × 108 cells/mL) for 24h at 37 37˚C. 
Afterwards, disks were washed to remove unattached bacteria and samples were 
processed in the same way as stated for biofilm examination. 
 
12.1. Radioactive cell labelling  
 
For enumeration of cells attached to microparticles bacterial were radioactively 
labelled. Following over night precultivation in LB medium, cell were washed with PBS 
15mM, pH 7.2 and inoculated in Muller Hinton Broth II to optical density A600 0.1. For 
radioactive labelling, previously overnight air dried C14-6-glucose 20µCi for ethanol 
evaporation, was added to the cell culture and incubated for 24h at 37ºC. As a control, 
culture with non labelled glucose was used. Following the incubation, cells were 
peleted and cpm of supernatant was measured. Cell concentration was determined 
spectrophotometricaly. 
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For attachment assay, 1mL of previously prepared microparticles was mixed with 
108 CFU/mL and incubated 1h at 37°C with shaking. Cpm was measured before and 
after 1h of incubation. For enumeration of bacteria attached to the microparticles, 
suspension was left 10min to sediment. Cpm of unattached and attached bacteria was 
determined. 
 
13. Antimicrobial activity of mcl-PHA 
 
Antibacterial activity was determined according to ISO 22196:2007(E) 
Measurement of Antibacterial Activity on Plastics Surfaces, with certain modifications. 
The bacterial strains used in this study are listed in Table 5. PHACOS, PHO and PET 
disks were used as test materials. Each disk was placed into a separate sterile Petri dish 
with the test surface uppermost and wet filter paper beneath to maintain relative 
humidity not less than 90%. Test inoculums prepared in 1/500 NB (6.2-25 × 103 
cells/cm2) were placed onto the analyzed surfaces without cover film as stated in ISO 
22196:2007(E) and incubated for 24h at 37˚C. Each material was tested in triplicate. 
Two set of controls were used; 1) non coated PET disks for determination of bacterial 
viability 2) PET disks coated with PHO, to analyze the effect of non functionalized PHA 
on bacterial viability.  The controls and the disks coated with PHACOS were analyzed 
according to ISO 22196:2007(E) at 0h and 24h. Following the incubation with bacterial 
suspension, disks were washed with 1 mL of 10mM PBS, pH 7.2. The number of 
colonies recovered from PET disks at 0h is the value that was later on used to 
determine the recovery rate of the bacteria from the disks under investigation.   
Viable bacteria were enumerated by performing 10-fold serial dilutions in 10mM 
PBS, pH 7.2 from 1 mL bacterial solution washed out from the disks. 1mL of each 
dilution was placed into separate sterile Petri dishes. Afterwards, 15 mL of LB agar 38 
°C was poured into each Petri dish and swirled gently to disperse the bacteria. All 
plating was performed in duplicate. Inverted Petri dishes were incubated at 37°C for 
40h to 48h. The number of colonies in the Petri dishes was counted, considering plates 
that contained 30 to 300 colonies as valid. Antibacterial activity was calculated as R 
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value according to the equation stated in ISO 22196:2007(E). R value of "0" means that 
the logarithm of number of viable cells in the sample disk after 24h is the same to that 
of control disk after 24h, whereas R=1 means 10-fold less viable cells recovered from 
sample disk after 24h when compared to that of control disk. 
An additional test was performed to determine the activity of PHACOS against 
higher cell density conditions up to 1 × 1010 cells/cm2. Bacterial viability was 
determined on PHACOS and PHO disks according to ISO 22196:2007(E) following the 
protocol stated before. Each disk was inoculated with correspondent S. aureus (CECT 
86) suspension in 1/500 NB, starting with suspensions of 1 × 104 cells/cm2 to 1 × 1010 
cells/cm2. Following the incubation, disks were washed with 1 mL of 10mM PBS, pH 
7.2. 10-fold serial dilutions were made and plated on LB plates. Viable bacteria were 
enumerated after 24h incubation on 37 °C. 
 
Table 5. Bacterial strains used for antibacterial activity assay 
Bacteria Strains 
Staphylococcus aureus subsp. aureus   CECT 86 
Mycobacterium smegmatis mc2 CECT 3020 
Escherichia coli  CECT 516 
Pseudomonas aeruginosa PAO1 CECT 4122 
Staphylococcus epidermidis CECT 232 
Bacillus subtilis subsp. subtilis ATCC 6051 
Streptococcus dysgalactiae subsp. equisimilis   CECT 926 
Streptococcus pyogenes  CECT 59T 
Staphylococcus aureus 61115 MRSA 201232560  
Staphylococcus aureus 61286    MRSA 201237858   
Staphylococcus aureus 61314   MRSA 201238814/12  
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14. Determination of Minimal inhibitory concentration (MIC)  
 
The minimal inhibitory concentration (MIC) of polymer precursors 6-
acetythiohexanoic acid (545554, Sigma-Aldrich), octanoic acid (C5038, Sigma-Aldrich) 
and hexanoic acid (P9767, Sigma-Aldrich) was calculated by microdilution assay 
according to CLSI (Clinical and Laboratory Standards Institute) standard procedure. 
Moreover, to determine the antibacterial activity of PHACOS hidrolizate, two reaction 
mix containing 3.4 mg/ml of e PHACOS latex in 0.2 M Tris-HCl (pH 8), and a control 
containing 3.0 mg/ml of PHO latex in 0.2 M Tris-HCl (pH 8) were separately subjected 
to enzimatic hydrolysis with mcl-PHA extracellular depolymerase PhaZGK13, from 
Pseudomonas fluorescens GK13 (0.2 mg per assay). Following 1h incubation at 37°C, 
supernatants of each reaction mix were centrifuged and filtrated (filter de 0.2 µm). The 
degradation products were identificated and quantificated by HPLC mass spectrometry 
(HPLC-MS). It was determined that PHACOS hydrolizate was composed of 63% of 
trimer (tree monomeros of 3OH-acetyltiohexanoate fused) and 30% of trimeros 
containing mix of 3-hydroxioctanoic and 3-hydroxy-acetyltiohexanoic monomeros. The 
rest (7%) was a mix of all monomers and dimers. The PHO hydrolizate contained 66% 
of dimer (two 3-hydroxioctanoic monomers fused) and 26% of trimer (tree 3-
hydroxioctanoico monomers fused) and the rest was a mix of all 3-hydroxioctanoic and 
3-hydroxihexanoic monomers and dimers. 
Stock solution of each compound was prepared in 10mM PBS, pH 7.2 with an 
initial concentration of 60 mM. Afterwards, serial dilutions were made in Muller-
Hinton broth (MHB, Becton Dickinson) to determine MIC values. Briefly, the sterile 96-
well round bottom clear polystyrene plates (Cultek S.L.U., Spain) were prepared by 
dispensing 100 µL of appropriate dilution of tested compound in culture broth per 
well. The S. aureus (CECT 86) inoculum in MHB was added to each well, providing a 
final concentration of 5 x 105 CFU/ml. A positive control (containing inoculum without 
tested compound) and negative control (containing tested compound without 
inoculum) were included in each microplate. The minimum inhibitory concentration 
(MIC) was defined as the lowest concentration of tested substance that inhibited 
visible growth of test bacteria. 
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15. In vitro biocompatibility 
 
15.1. Cell cultures 
 
The effect of toxicity of the analyzed systems was evaluated using two type of 
cells, mouse monocyte macrophages RAW 264.7 (ECACC, Sigma P11) and mouse 
fibroblasts BALB 3T3 (ATCC, CCL-163, P12), while anti-inflammatory activity and effect 
on cell proliferation was monitored on RAW 264.7. The cells were cultured in 
Dulbecco´s modified Eagle´s medium (DMEM) enriched with HEPES for BALB 3T3 cells 
and 110 mg/L of sodium pyruvate for RAW 264.7 cells and supplemented with 10% 
FBS, 100 units/mL penicillin, 100 µg/mL streptomycin and 200 mM L-glutamine 
(complete medium). A humidified atmosphere at 37 °C with 5% CO2 and 95% of air 
was used for maintenance of cell culture. 
 
15.2. MTT assay 
 
The in vitro effect of products possibly liberated from polymers, while being in 
contact with culture media, on cellular viability was assessed by the 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) MTT assay (Mosmann et al., 
1983).  Previously prepared PHO, PHACOS and control PET disks were immersed in 5 
mL of FBS-free DMEM each and placed on a roller mixer at 37 °C. The medium was 
removed at different time points (1, 2 and 7 days) and replaced with fresh medium. All 
the extracts were obtained under sterile conditions. RAW 264.7 cells were seeded at a 
density of 2 x 105 cells/mL in complete medium, while BALB 3T3 cells at a density of 1 
x 105 cells/mL, plated in a sterile 96-well culture plate and incubated to confluence. 
Medium was replaced with the corresponding extract and incubated at 37 °C in 
humidified air with 5% CO2 for 24h. After incubation cell viability was determined by 
adding MTT (0.5 mg/mL in PBS pH 7.2) and incubated for 4h at 37 °C. Excess medium 
Materials and methods 
 
69 
 
and MTT was removed and DMSO was added to each well in order to achieve 
solubilization of formazan crystal formed in viable cells. The absorbance was measured 
at 570 nm (test wavelength) and 630 nm (reference wavelength) using a microplate 
reader (Biotek SYNERGY-HT). The cell viability (CV) was calculated from equation: 
CV (%)=100 x (ODS – ODB)/ODC  
where ODS, ODB and ODC are the optical density of formazan production for the 
sample, blank (DMEM without without cells) and control respectively. 
 
15.3. Griess assay 
 
The inflammatory activity of polymers was investigated using nitric oxide 
inhibitory assay performed according to the method of Wang et al. Briefly, RAW 264.7 
cells were seeded in 96-well plates at a density of 2 x 105 cells/mL and incubated at 37 
°C for 24h. After incubation corresponding extracts were added. To the control wells 1 
mg/mL of lipopolysaccharide (LPS) was added and the cells were incubated for 24 h. 
The nitrite concentration was determined applying Griess reaction (Schmidt and Kelm, 
1996). Aliquots of 100 µl of the supernatant from RAW 264.7 cells were reacted with 
100 µl of Griess reagent (1:1 mixture of 0.1% N-(1-naphthyl) ethylenediamine in water 
and 1% sulphanilamide in 5% phosphoric acid) in a 96 well plate. The absorbance was 
recorded using a Biotek SYNERGY-HT reader at 548 nm. The nitrite concentration was 
calculated from a calibration curve previously obtained using known NaNO2 
concentrations. Data were expressed as percentage of NO production. 
 
15.4. Cell proliferation assay 
 
Alamar Blue assay (AB) was performed to follow cell adhesion and proliferation. 
Mouse fibroblasts BALB 3T3 were seeded at a density of 8 x 104 cell/mL over the disks 
placed in 24-well culture. After 24h incubation, 1 mL of Alamar Blue dye (10% Alamar 
Blue solution in phenol red free DMEM medium) was added to each specimen and 
incubated for 4h. Then, 100µL of culture medium from each test sample was 
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transferred to a 96-well plate, and the absorbance was measured at 530 nm 
emission/590 excitation on a Biotek SYNERGY-HT spectrometer. The disks were 
washed with 10mM PBS, pH 7.2 twice to remove rest of the reagent, and 1 mL of 
culture medium was added in order to monitor the cell growth over the time. This step 
was repeated at defined time points (5 and 10 days). Adhesion and proliferation of 
cells was also followed by direct analysis of the seeded disks by environmental 
scanning electron microscopy (ESEM). 
 
15.5. Cell adhesion and cell growth  
 
For determination of cell adhesion and growth, PHO, PHACOS and control PET 
disks were placed in a 24-well tissue-culture plate. BALB 3T3 cell suspension was added 
at a density of 8 x 104 cells/mL per well in 1 mL of respective culture medium and 
allowed to attach at 37 °C. Cell morphology and growth was monitored by scanning 
electron microscopy (SEM). For examination under ESEM microscope samples were 
collected at different time points (1, 2 and 7 days), washed  with 10mM PBS, pH 7.2 to 
remove unattached cells and immobilized with 2.5% glutaraldehyde in distilled water  
for 1h at room temperature. The dried samples were mounted on aluminum stumps 
and sputter-coated with gold before examination under an environmental scanning 
electron microscopy (ESEM) apparatus (Philips XL 30) at an accelerating voltage of 15 
KeV. 
 
16. In vivo biocompatibility 
 
16.1. Preparation of hydro-indocyanine green (H-ICG)  
 
Hydro-indocyanine green (H-ICG) was synthesized from ICG (Acros Organics) by 
reduction with sodium borohydride as described previously (Kundu et al., 2009). 
Briefly, 2 mg of dye was dissolved in 4 mL of methanol and reduced with 2-3 mg of 
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sodium borohydride (Aldrich). Solvent was removed by stirring reaction mix for 5 min 
under reduced pressure.  The dye was nitrogen capped and stored overnight at -20 °C. 
For bioimaging, the resulting solid was dissolved in sterile water to final concentration 
of 1 mg/mL and further filtered to remove solid precipitates. 
 
16.2. Implant preparation for in vivo antimicrobial assay 
 
Biomaterial disks were incubated for 30 min at 37 °C with S. aureus suspension in 
1/500 NB (1 × 104 cells/cm2) under static conditions. After incubation disks were 
placed in sterile containers. 
 
16.3. Disk implantation and ROS bioimaging 
 
National Institutes of Health guidelines for the care and use of laboratory animals 
(NIH Publication #85-23 Rev. 1985) were observed. All surgical procedures were 
approved by the Institutional Animal Care and Use Committee at the Georgia Institute 
of Technology.  Sterile, endotoxin-free disks (6 mm diameter) were implanted 
subcutaneously in the back of 6-8 weeks old male BALB/c mice (Jackson Laboratories) 
anesthetized by isofluorane. A single 1-cm incision was made on the dorsum proximal 
to the spine, and a subcutaneous pocket laterally spanning the dorsum was created. 
Sterile disks (two per subject on either side of the spine) were implanted, and the 
incision was closed using sterile wound clips. Mice undergoing the same surgical 
procedure but receiving no biomaterial implants were used as sham controls to 
account for surgery-associated trauma/inflammation. The same procedure was 
followed for implants incubated with bacteria. 
For bioimaging, 30 µL of hydro-indocyanine green (H-ICG) at a concentration of 1 
mg/mL in sterile water was injected near the vicinity of the implant. Thirty minutes 
after dye injection, the animal was anesthetized and the whole body of the animal was 
scanned in an IVIS Lumina® bioimaging system (Xenogen). Biofluorescence was 
integrated using Living Image®software Version 3.1 (Xenogen). ROS bioimaging was 
Materials and methods 
 
72 
 
performed 30 min after dye injections immediately following surgery/implantation and 
1, 4, 7 and 14 days post-surgery/implantation. 
 
16.4. Implant analysis 
 
Mice were sacrificed at specific time points (7 and 14 days post-implantation) and 
the disks were carefully explanted with the surrounding tissue intact to avoid 
disrupting the cell-material interface. For immunohistochemical staining, explants 
were embedded in optimal cutting temperature compound (Tissue-Tek) and 
cryosectioned at 10 µm. Fresh-frozen cryostat sections were incubated in 100 mM 
hydro- Cy5 (H-Cy5) for 45 min at 37 °C to stain for intracellular ROS. Following 
incubations in H-Cy5, sections were fixed with 4% paraformaldehyde and were stained 
with primary rat monoclonal antibodies (Abcam) against the macrophage marker 
(CD68) or neutrophil marker (NIMP-R14). AlexaFluor 488-conjugated goat anti-mouse 
specific antibody (Invitrogen) was used as a secondary antibody. The sections were 
mounted with antifade mounting media containing 4´,6-diamidino-2-phenylindole 
(DAPI, Vector Labs) and imaged under a Nikon C1 imaging system. Five-six fields per 
sample were acquired and ImageJ software was used to count the fluorescent-labeled 
cells. For CFU counting, each explant was placed in glass tube containing 1 mL of 
10mM PBS, pH7.2 and sonicated for 10min in ultrasonic bath (REFF) to remove 
adhered bacteria. Afterwards, two more sonicating cycles were applied (5min and 
30sec) interspersed with 30sec vortex treatment. Bacterial solution was plated on LB 
agar plates and CFU were counted after 24h incubation at 37°C.   
 
17. Gravimetry assay 
 
The kinetics of weight loss of polymers was studied by immersing disks (6 mm 
diameter and 1 mm thickness) in 10mM PBS, pH 7.2 at 37 °C. The weight of the 
damped disks was monitored after different intervals of immersion time (1, 7, 14, 30 
and 60 days). Disks were dried and weight on balance (Sartorius). The percent of 
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weight loss was calculated from the initial dry mass of the disks and the mass of the 
damped disks after certain immersion time. 
 
18. Implant preparation for in vitro and in vivo assays with S. aureus 
luminescent strains 
 
Both parental strains and their bioluminescent derivatives were tested in vitro and 
in vivo. Bacterial strains were cultivated overnight in TSB with aeration at 37 °C. The 
cultures were diluted with fresh TSB to reach absorbance A595 0.1 and incubated for 
3-4h to A595 0.7. Afterwards, bacterial test inoculum for were prepared in 2mL of 
1/500 Nutrient Broth DifcoTM (ref 234000, Becton, Dickinson and Company, France), 
to serve as cell suspension. Bacterial concentration was estimated 
spectrophotometrically at 595nm using (spectrophot ref).  
Bacterial suspensions (1 × 104 to 1 × 1010 cells/cm2) were placed on previously 
prepared sterile endotoxin-free PHO and PET disks. Set of disks was prepared for 
bioluminescence screening, and the other for CFU counting. Each tested concentration 
was examined in triplicate. 
To correlate luminescence signal intensity and colony forming units counts (CFU), 
each disk was placed into a separate sterile Petri dish with a wet filter paper beneath 
to maintain relative humidity not less than 90% and incubated for 24h at 37 °C under 
static conditions. Two set of controls were used; 1) non coated PET disks for 
determination of bacterial viability 2) PET disks coated with PHO, to analyze the effect 
of non functionalized PHA on bacterial viability. Both set of controls were incubated for 
1h at 37 °C under static conditions. 
For in vivo assay, following 30min incubation under static conditions at 37 °C disks 
were placed in sterile containers. 
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19. In vitro assay with S. aureus luminescent strains 
 
Bacteria incubated on PHO and PET disks were scanned in an IVIS Lumina® 
bioimaging system (Xenogen). Bioluminiscence was integrated using Living Image® 
software Version 3.1 (Xenogen). Luminiscence after 1h of incubation was compared to 
that after 24h of incubation. For estimating bacterial concentration via colony forming 
units counting (CFU), disks were washed with phosphate-buffered physiological saline 
(PBS 10mM, pH 7.2), 10-fold serial dilutions of suspension were made and plated on 
TSA plates (ref). CFU were counted after 24h incubation at 37°C. Number of recovered 
bacteria after 1h of incubation and 24h of incubation were compared. 
 
20. In vivo real time monitoring of bacterial infection 
 
For the measurement of bioluminescence of subcutaneously implanted disks 
precolonized with bioluminescent S. aureus strains, mice were anesthetized with 
isofluorane and imaged with a CCD camera (IVIS Lumina® bioimaging system, Xenogen) 
directly following implantation  and 1, 4, 7 days post implantation. Total counts from 
the metabolically active S. aureus were collected during a 2-min exposure using the 
IVIS Imaging System and Living Image software (Xenogen Corporation). Bioluminescent 
images were displayed using a pseudocolor scale (blue representing the least-intense 
light and red representing the most-intense light) that was overlaid on a gray-scale 
image to generate a two-dimensional picture of the distribution of bioluminescent 
bacteria in the animal. To account for the background luminescence, one uninfected 
mouse was imaged along with the infected animals. The total counts from a region 
were quantified using the Living Image software package (Xenogen Corporation), and 
the data are presented as total counts contained within each region. 
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21. Disk implantation and ROS bioimaging 
 
Previously prepared sterile, endotoxin-free disks (6 mm diameter) were implanted 
subcutaneously following IACUC-approved procedures in 6-8 weeks old male BALB/c 
mice (Jackson Laboratories) anesthetized by isofluorane. A single 1-cm incision was 
made on the dorsum proximal to the spine, and a subcutaneous pocket laterally 
spanning the dorsum was created. Sterile disks (two per subject on either side of the 
spine) were implanted, and the incision was closed using sterile wound clips. Mice 
undergoing the same surgical procedure but receiving no biomaterial implants were 
used as sham controls to account for surgery-associated trauma/inflammation. The 
same procedure was followed for implants incubated with bacteria. 
For bioimaging, 30 µl of hydro-indocyanine green (H-ICG) at a concentration of 1 
mg/mL in sterile water was injected near the vicinity of the implant. Thirty minutes 
after dye injection, the animal was anesthetized and the whole body of the animal was 
scanned in an IVIS Lumina® bioimaging system (Xenogen). Biofluorescence was 
integrated using Living Image®software Version 3.1 (Xenogen). ROS bioimaging was 
performed 30 min after dye injections 7 days post-surgery/implantation. 
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Herein we describe two different strategies for polymer functionalization to obtain 
added value PHA for industrial and biomedical applications. The first strategy consists 
in in vivo bacterial production of tailor-made functionalized nano-beads where 
proteins attached to the natural PHA granule have been engineered to display fusion 
proteins of interest. The second strategy relays on the functionalization of polymer 
itself using metabolic engineering approach to design bacterial strains able to produce 
new non-natural polyesters carrying functionalized groups at the side chain. In the 
previous work, a strain of Pseudomonas putida able to accumulate poly-acetylthio-
hydroxyalkanoate (PHACOS) was constructed (Escapa et al., 2011). This functional 
group at the side chain of PHACOS confers new biological properties to the 
biomaterial. Thus, we analyzed novel properties of PHACOS both in vitro and in vivo. 
 
1. Bacterial production of tailor made functionalized nano-beads 
 
PHA granules represent a useful tool for recombinant protein immobilization due 
to their unique structure (Figure 3). Using the advantage of the presence of natural 
proteins (GAPs) on the granule surface we designed functionalized PHA nano-beads. 
Phasins are one of the most abundant proteins attached to the PHA granule. 
Therefore, they were chose as tags for anchoring recombinant proteins to bacterial 
PHA granules. Moreover, we investigated their physiological function trying to describe 
the key factors involved in the in vivo immobilization of proteins to PHA granules. To 
that end, P. putida phasin PhaF was used as a peptide tag to anchor the protein to 
bacterial PHA granules. This system provides a useful tool for in vivo immobilization of 
active proteins to a biodegradable support for protein delivery to environments, 
diagnosis, antigen delivery and many others.   
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2. The role of PhaF in the PHA machinery  
 
In the previous work of our group phasins have been used for protein 
immobilization, however their physiological role in mcl-PHA machinery is not 
completely understood. To improve existing model and maximize recombinant protein 
yield we investigate phasin involvement in cell physiological processes. Therefore, by 
swapping different phasin domains we intent to optimize the in vivo attachment of 
proteins to mcl-PHA granules and achieve the most favorable conditions for 
recombinant protein immobilization.    
 
2.1. PhaF affects heterogeneity of the cell population concerning the 
PHA production   
 
Previous results from our laboratory showed that the total PHA content of a PhaF 
mutant strain of P. putida GPo1 was reduced considerably in comparison to that of 
wild type strain, when the PHA content was studied in cell dividing continuous culture 
(Prieto et al., 1999). Based on this observation, we focus our interest in studying the 
PHA production not only at stationary phase but throughout the growth curve to 
analyze PhaF dependent variation in terms of PHA content in all fermentation stages. 
With this aim, the phaF gene of the prototype PHA producer strain P. putida KT2442 
was deleted by using a suicide vector (see Experimental Procedures section). The PHA 
production abilities of the resulting strain P. putida KT42F was compared to that of the 
wild type bacterium when cultured in optimal PHA production conditions. To monitor 
the PHA content at every stage of the growth curve, a fast and accurate method for 
analysis of PHA content by flow cytometry was adapted for Pseudomonas strains. 
Fluorescence intensity of Nile red stained granules obtained by flow cytometry was 
correlated with data of PHA content analyzed by gas chromatography. Relation 
between those parameters was further on used to translate the cytometry 
fluorescence intensity data into PHA values.    
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Figure 11. Study of cell population heterogeneity in terms of PHA production by flow 
cytometer. A, Quantification of PHA content (bars) and OD600 (circles) of P. putida KT2442 
(black bars and black circles) and KT42F (gray bars and gray circles) strains throughout the 
growth curve; B, Example of a flow cytometer histogram of the P. putida KT2442 (black plot) 
and the P. putida KT42F (grey plot) strains grown in PHA production medium during 7 h (see 
Experimental Procedures for details); C, Percentage of PHA positive cells KT2442 (black 
column) and KT42F (gray column).  
 
Cells from P. putida KT2442 and its phaF disrupted mutant strain KT42F were 
harvested from the culture at different growth times. Figure 11A shows that at the 
early exponential phase of growth (2 h and 4 h), wild type and mutant strains showed 
similar PHA content, around 10% and 20% of cell dry weight (CDW), respectively. After 
6 h of growth the total PHA content detected in the wild type strain KT2442 was 
slightly higher than that of the mutant strain KT42F. This difference increased over the 
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growth curve, being maximal (1.5-fold) after 24 h of growing (Figure 11A). This result 
demonstrates that PhaF is not essential for the synthesis of PHA in P. putida KT2442 
but contributes to optimize the yield of PHA synthesis and accumulation.  
Besides, these flow cytometry analyses allowed us to relate the total PHA content 
of the cell population versus the PHA content of individual cells (heterogeneity of the 
population). Figure 11B shows an example of a histogram of KT42F and wild type cells 
after 7 h of growing. A major overlay corresponding to positive fluorescent cells was 
detected in the wild type cells (Figure 11B), demonstrating a homogeneous population 
regarding the PHA granules content. Interestingly, two main overlays showing different 
fluorescence intensities (Figure 11B), were detected in the KT42F sample. In this case, 
only 55% of cell population displayed positive PHA content while the rest of the cells 
were negative, suggesting that they did not contain PHA granules (Figure 11C). These 
results demonstrated the presence of at least two different cell populations in terms of 
PHA content in the KT42F cultures suggesting a role of PhaF in PHA granules partition 
during cell division.  
 
2.2. Impact of PhaF mutation on granule location and segregation during 
cell division 
 
To monitor the presence of the PHA granules during cell division at early growth 
phase and the influence of the presence or absence of PhaF protein on the PHA 
content, samples from wild type and KT42F mutant strains were taken at different 
growth times for TEM analysis (Figure 12 and 13).  
Interestingly, cells at time zero, that means LB grown cells used to inoculate the 
cultures contain a few and small granules of PHA which constitute less than 1% of the 
CDW (Figure 12 and 13). In perfect correlation with the PHA content (Figure 11A), the 
size and number of the PHA granules in the wild type cells increased progressively 
during the growth curve being maximal at 24 h of growing (Figure 14). Most of the cells 
contained 5-6 granules of about 500 nm of diameter (Figure 14). The number and 
average size of the granules in the KT42F mutant decrease when compared to those of 
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the wild type strain (Figure 14). These results confirmed those obtained by flow 
cytometry, which showed a remarkable heterogeneity on the total population in the 
KT42F culture in terms of PHA content and the presence of PHA empty cells when PhaF 
protein is not produced. 
 
 
Figure 12. TEM images of P. putida KT2442 growth curve in PHA production medium. A-E, 
Samples were taken 0, 2, 4, 6 and 24 h after the inoculum (Panels A, B, C, D and E, respectively) 
and processed as described in Experimental Procedures; F, Detail of the granule distribution of 
a single cell from a 4 h culture in PHA production medium. 
 
TEM studies also provided additional information about granule distribution in the 
cell, and we observed that after 2 h and 4 h of growing, granules were detected in the 
wild type at the center of the cross section of the majority of the cells, i.e., located 
running lengthwise the cell, forming a characteristic needle array (Figure 12B, 12C and 
12F). This distribution was less evident when the accumulation of PHA was close to the 
50% CDW after 6 h of growing (Figure 12D and 12E). In contrast, the granules in the 
KT42F mutant strain were agglomerated in one of the cell poles (Figure 13B, 13C and 
13F) at the early growth stages (2 h and 4 h).  
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In agreement with the results observed by flow cytometry (Figure 11), the PHA 
content of the mutant was similar to that of the wild type strain at the earliest stages 
of growth (Figure 13B, 13C and 13F).  
 
 
Figure 13. TEM images of P. putida KT42F growth curve in PHA production medium. A-E, 
Samples were taken 0, 2, 4, 6 and 24 h after the inoculum (Panels A, B, C, D and E, respectively) 
and processed as described in Experimental Procedures; F, Detail of the granule distribution of 
a single cell from a 4 h culture in PHA production medium. 
 
Moreover, at 24 h of growing 34% of mutant cells did not contain PHA granules 
generating two markedly different cell populations in the culture, i.e., with and 
without PHA (Figure 11B and 13E). While wild type strain distributed the previously 
formed PHA granules among the daughter cells keeping the needle array structure, the 
PHA granules in the PhaF mutant strain remained agglomerated in one of the daughter 
cells (Figure 15). It is worth noting that granules did not coalesce in a single big 
granule, as reported for other microorganism lacking phasins (Wieczorek et al., 1995), 
very likely due to the presence of the other phasin PhaI (see below). 
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Figure 14. Determination of granule size and number in KT2442 and KT42F strains of P. 
putida. A-B, The granule number (A) and granule size distributions (B) in KT2442 (black bars) 
and KT42F (gray bars) were determined by TEM images analysis.  
 
On the other hand, P. putida KT42F cells were complemented by in trans 
production of PhaF from P. putida GPo1 giving rise to P. putida KT42F-F strain (see 
Experimental Procedures for details) (Figure 15). These results demonstrated that the 
presence of PhaF ensures the segregation of the PHA granules during the cell division. 
In addition, these results explain the reduction of the total PHA content at 24 h in the 
mutant strain (Figure 11) by a dilution effect due to the presence of PHA empty cells. 
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Figure 15. Analysis of the P. putida KT42F complementation and PHA segregation by TEM. A-
C, Samples were taken after 4 h growth in PHA production medium. Detail of the PHA granule 
distribution of KT2442 (A), KT42F (B) and the complemented strain KT42F-F (C); D-F, 
Segregation of PHA granules during cell division in KT2442 (D), KT42F (E) and KT42F-F (F). 
 
2.3. DNA binding abilities of PhaF protein  
 
The involvement of PhaF in the pha transcriptional regulatory system was first 
demonstrated in P. putida GPo1 (Prieto et al., 1999). Disruption of the phaF gene led in 
this strain to an increased expression rate of phaC1 gene, suggesting that PhaF acted 
as a negative regulator of the pha cluster in this strain. This function was ascribed to its 
C-terminal half due to the similarity observed to histone-like proteins, but there was 
no evidence pointing to direct binding of PhaF to the pha promoter regions so far. It 
was demonstrated that the binding of PhaF protein to DNA is not specific, i.e., it is 
independent of the recognition of a specific operator DNA sequence. Moreover, it was 
shown by spectroscopical techniques that PhaF binds DNA in vitro through its C-
terminal domain in a non-specific manner (Galan et al., 2011, Maestro et al., 2013).  
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Figure 16. In vivo localization of GFP::C-PhaF fusion protein in KT42-GC (A,B,E-G) and KT42F-
GC (C,D,H-J) P. putida strains by confocal microscopy. A, localization of GFP::C-PhaF fusion 
protein (in green) in KT42-GC  strain cultured in LB medium (non PHA producing conditions); B, 
localization of nucleoid(in blue) in KT42-GC  strain cultured in LB medium; C, localization of 
GFP::C-PhaF fusion protein (in green) in KT42F-GC  strain cultured in LB medium; D, localization 
of nucleoid(in blue) in KT42F-GC  strain cultured in LB medium; Localization of GFP::C-PhaF 
fusion protein (in green) E, nucleoid(in blue) F and PHA granules (in red) G in KT42-GC  strain 
cultured in PHA producing conditions; Localization of GFP::C-PhaF fusion protein (in green) H, 
nucleoid(in blue) I and PHA granules (in red) J in KT42F-GC  strain cultured in PHA producing 
conditions.  
 
To confirm these findings in vivo, we have constructed a fusion protein between 
the reporter green fluorescent protein (GFP) and the DNA binding domain of the 
protein PhaF (C-PhaF). This GFP::C-PhaF fusion protein was introduced into the P. 
putida KT2442 and P. putida KT42F chromosomes giving rise to KT42-GC and KT42F-
GC, respectively. The strains KT42-GC and KT42F-GC producing GFP::C-PhaF fusion 
protein, have been used to analyse the in vivo localization of the GFP::C-PhaF fusion 
protein by confocal microscopy (Figure 16). By staining the cells with two different 
dyes, we have analysed localization of i) the PHA granules (Nile Red-stained), ii) the 
nucleoid (DAPI-stained) and iii) the protein GFP::C-PhaF. Our results confirm the co-
localization of the fusion protein GFP::C-PhaF and nucleoid in wild type and PhaF 
minus cells, independently of the presence or absence of the PHA granules. 
Furthermore, PHA granules produced in the wild type cells, which contain native PhaF 
protein, co-localised with the nucleoid and GFP reporter. However, PHA granules 
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produced in the KT42F mutant strain localised independently of the nucleoid and GFP 
reporter system. These results provide support to the role of PhaF as nucleoid-binding 
protein and its role in the intracellular localization of the PHA granule. 
 
3. The function of PhaI in the PHA metabolism 
 
As it was previously mentioned in Introduction section, P. putida KT2442 has two 
phasins, PhaF and PhaI. Those phasins belong to the same operon (Figure 4) and share 
considerable sequence similarity (Prieto et al., 1999). Since we spotted the key role of 
PhaF, we analyzed the physiological role of other P. putida phasin protein PhaI.  The 
effect of its absence and possible coordinated work with PhaF was tested. 
 
3.1. The outcome of PhaI phasin deficiency considering PHA granule 
accumulation/formation 
 
Previously we showed that lack of PhaF phasin, involved in PHA granules 
localization and balanced distribution during cell division induce considerable 
reduction of total PHA content due to the defect in granule segregation, and 
consequently, population heterogeneity. Those findings demonstrated a new role for 
phasins within the PHA apparatus that could be critical for cell survival under stress 
conditions. Based on this observation, we focus our interest in studying the influence 
of phasins on PHA accumulation, comparing the PHA production abilities of different 
phasin mutant strains to that of the wild type bacterium. With this aim, P. putida 
KT2442 strain was genetically manipulated to generate disruption mutations of the 
respective phasin genes designing P. putida KT42F that lacks PhaF phasin, P. putida 
KT42I-F that lacks PhaI phasin and P. putida KT42I that lacks both PhaF and PhaI 
phasins (Figure 17A). By western blot analysis we demonstrate that wild type and phaF 
mutant strain produce PhaI, while strains KT42I-F and KT42I do not produce PhaI 
(Figure 17B). Furthermore, we show that wild type strain produce higher quantity (7.5 
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fold) of PhaF when compared to KT42I-F strain, whereas KT42F and KT42I do not 
produce PhaF, last due very likely to a polar mutation in the operon phaIF (Figure 17B). 
 
 
Figure 17. Comparative representation of pha gene cluster organization of different P. putida 
strains and Western blot analysis. A, Scheme of constructed P. putida KT2442 mutant strains. 
Arrows indicate different genes involved in PHA metabolism, their relative size and 
transcriptional direction. P. putida KT2442 pha cluster is composed of phaC1 (white) and 
phaC2 (light grey) genes that encode two synthases, phaZ gene (black) that encodes an 
intracellular depolymerase, phaD gene (dark grey) that encodes a transcripitonal regulator and 
phaF (dark blue) and phaI (cyan) genes that code for phasins. Different mutant strains were 
constructed KT42F, KT42I-F, KT42I, KT42C1ZC2F lacking phaF, phaI, both phaF and phaI and 
phaC1, phaZ, phaC2, phaF respectively. bioF was fused with gfp (bi-colour arrow, blue and 
green) and randomly (marked with two parallel lines)  inserted in the chromosome of each 
strain, wild type and mutant strains on pha cluster giving rise to KT42-BG, KT42F-BG, KT42I-
BGF, KT42I-BG and KT42C1ZC2F-BG; B, Western blot analysis of phasin expression in different 
P. putida strains applying antibody against PhaI (left) and BioF tag (right). Lines 1, 5:  KT2442; 
lines 2, 6: KT42F; lines 3, 7: KT42I-F; lines 4, 8: KT42I.  
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For PHA content, analysis by GC-MS cells were cultured in optimal PHA production 
conditions and harvested after 24h of growth. Wild type strain showed PHA content of 
63% of cell dry weight (CDW), while mutant strain lacking phasin PhaF, PhaI and both 
phasins produced less amount of PHA, 33%, 21% and 7% respectively (Table 6). These 
results demonstrate that when P. putida strain lacks both phasins, PHA production 
dramatically decreases, suggesting that PhaF and PhaI phasins work in harmony and 
are essential for the optimal PHA synthesis and accumulation. 
 
Table 6. Quantification of PHA content by GC-MS and protein quantification by QuantityOne 
analysis 
P. putida 
strain PHA % Biomass (g/l) 
Protein 
mg/g biomass 
Protein  
mg/l culture 
Protein 
mg/g PHA 
KT2442 63.27±1.42 1.40±0.11 _ _ _ 
KT42F 33.36±1.19 0.65±0.18 _ _ _ 
KT42I-F 20.75±1.35 0.62±0.22 _ _ _ 
KT42I 7.44±0.39 0.58±0.17 _ _ _ 
KT42-BG 53.51±3.22 1.14±0.10 1.46±0.36 1.49±0.37 2.92±0.53 
KT42F-BG 33.85±1.88 0.80±0.06 4.06±0.66 3.53±0.57 11.38±0.65 
KT42I-BG 19.62±1.02 0.69±0.07 4.16±0.35 2.62±0.47 20.17±0.73 
KT42I-BGF 42.10±1.28 1.00±0.23 9.73±0.42 10.31±0.49 22.42±0.85 
 
 
3.2. BioF tag or its fusion derivatives can replace PhaI role in P. putida in 
terms of PHA production 
 
Since PhaI and N-terminal domain of PhaF (BioF) show high structural similarity 
and their 3D models predict a possible interaction between proteins through the 
oligomerization linker (Maestro et al., 2013), we investigated the possibility of PhaI 
functional replacement by BioF. To monitor the influence of BioF on PHA content, 
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BioF-GFP was stably integrated into the chromosome of P. putida phasin mutant 
strains. P. putida KT2442-BG, KT42F-BG, KT42I-BGF and KT42I-BG cells (Table 4; Figure 
17A) were cultured in optimal PHA producing conditions for 24h and their PHA content 
was analyzed by GC-MS. Interestingly, P. putida KT42I-BGF and KT42I-BG showed an 
increase in PHA content being, 42% and 20% of CDW respectively, when compared to 
their correspondent strains that did not contain BioF-GFP (Table 6). However, we did 
not observe significant difference in PHA accumulation in KT42F-BG strain when 
compared to KT42F strain, showing PHA content of 34% and 33% of CDW respectively. 
These results were confirmed by flow cytometry analysis, where fluorescence of nile 
red stained PHA granules was recorded for the determination of PHA cell content. In 
perfect correlation with GC-MS results, no significant difference was observed 
between KT2442 and KT42-BG. Similarly, the result obtained for PhaF phasin mutant 
(KT42F) and KT42F-BG strain showed no difference between these two strains in PHA 
content (data not shown). However, PhaI mutant harboring BioF::GFP fusion protein 
recovered PHA production to the level of PhaF mutant and KT42I-BGF strain showed 
PHA content similar to that of wild type. Taking into account the results presented 
above we definitively conclude that BioF tag or its fusion derivatives can replace the 
role of PhaI phasin in P. putida strain in terms of PHA content. 
   
3.3. The effect of PhaI absence on population homogeneity  
 
Since, a deletion of the PhaF phasin resulted in a defect in granule segregation and 
population heterogeneity in terms of PHA granules content (see section 2.2.), we 
interrogated the required imposition of phasin domains to reconstruct a uniform 
granule distribution and optimal PHA production.  
By flow cytometry analyses, we were able not only to determine the PHA content 
but to relate this parameter to the cell population, this is, the PHA content of 
individual cells (heterogeneity of the population). Figure 18A and C show a major 
overlay corresponding to positive fluorescent cells in the wild type cells indicating a 
homogeneous population regarding the PHA granules content. Two main overlays 
showing different fluorescence intensities were detected in the KT42I, KT42I-BG and 
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KT42F samples (Figure 18A). In the case of KT42I, KT42I-BG and KT42F strains, only 
24%, 51% and 45% of cell population displayed positive PHA content while the rest of 
the cells were negative, suggesting that they did not contain PHA granules (Figure 
18A). These results indicate the presence of at least two different cell populations in 
terms of PHA content, confirming the role of C-terminal of PhaF in granule distribution. 
Interestingly, strain KT42I-BGF did not show population heterogeneity (80% positive 
cells) as shown in Figure 18B and C, suggesting that PhaI phasin can be replaced by 
BioF domain, and that the presence of PhaF at low dosage (Figure 17B) is sufficient to 
control granules segregation during cell division.  
 
 
Figure 18. Study of cell population heterogeneity in terms of PHA production by flow 
cytometer. A, Percentage of PHA positive cells KT2442 (black bar), KT42F (dark grey bar), KT42I 
white bar, KT42I-BG light grey bar and KT42I-BGF (blue bar); B, Example of a flow cytometer 
histogram of the P. putida KT42I and P. putida KT42I-BGF strains grown in PHA producing 
conditions; C, Example of a flow cytometer histogram of the P. putida KT2442 and P. putida 
KT42I-BGF strains grown in PHA producing conditions.  
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Flow cytometry assay confirmed that lack of wild type phasins affects PHA 
production and influence granule segregation, and that BioF can replace those roles of 
PhaI. To analyze in vivo granule segregation and BioF fusion localization, we monitored 
the reporter, green fluorescent protein (GFP) fused to BioF (see Materials and methods 
section). The strains KT42-BG, KT42F-BG, KT42I-BGF, KT42I-BG (Table 6; Figure 17A) 
producing BioF-GFP have been used to analyse the in vivo localization of the BioF-GFP 
fusion protein by epifluorescent microscopy. These experiments were performed as 
well with the strain KT42C1ZC2F-BG, unable to accumulate PHA since it lacks both 
synthase genes, phaC1 and phaC2. As reported for the wild type strain (see section 
2.2.; Figure 15), KT42-BG strain contained more than one granule located running 
lengthwise the cell, forming a characteristic needle array and during cell division 
equally distributed between daughter cells. PhaF and double PhaF and PhaI phasins 
mutant strains expressing BioF-GFP fusion (KT42F-BG, KT42I-BG) contained usually one 
or agglomerated pool of granules in one of the cell poles (Figure 19B,C).  
However, PhaI phasin mutant strain complemented with phaF and expressing 
biof::gfp fusion (KT42I-BGF) showed similar phenotype to that of wild type strain in 
terms of granule segregation and number (Figure 19D,H). Additionally, diverse 
functions of BioF and the C-terminal module of PhaF were confirmed by comparative 
in vivo monitoring of GFP-BioF and GFP::C-PhaF (Figure 19); BioF-GFP fusion protein 
co-localize with PHA granules in wild type and phasin minus in PHA producing 
conditions, whereas the PhaF C-terminal domain interacts with nucleoid independently 
on the strain and growth conditions (Figure 19G). By monitoring BioF-GFP fusion 
protein in KT42C1ZC2F-BG strain, not capable of producing PHA, we investigated the 
localization of BioF module in the absence of PHA granules (Figure 19E,F). In fact, in 
the absence of PHA granules, BioF domains interact, likely through leucine-zipper 
motif, forming small cytoplasmatic inclusions that are accumulated mainly in the 
vicinity of the membrane at the cell poles. 
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Figure 19. In vivo localization of BioF::GFP (A-F; H) and GFP::C-PhaF (G) fusion protein in P. 
putida. Epifluorescence analysis of A, KT42-BG; B, KT42F-BG; C, KT42I-BG; D, KT42I-BGF and E, 
KT42C1ZC2F-BG in PHA producing condition; F, Shows KT42C1ZC2F-BG  strain cultured in LB 
medium (non PHA producing conditions); G, Shows in vivo localization of GFP::C-PhaF fusion 
protein in KT42I-GC in PHA producing conditions; H, Represents detailed confocal microscopy 
analysis of BioF::GFP protein localization within KT42I-BGF cells demonstrating granules (in 
red), nucleoid (in blue) and BioF::GFP protein (in green).  
 
To analyse in detail the recovery of wild type phenotype of KT42I-BGF strain and 
the localization of the granules, the cells were stained with two different dyes and 
visualized by confocal microscopy (Figure 19H). With this aim, we monitored in vivo 
localization of i) the PHA granules (Nile Red-stained), ii) the nucleoid (DAPI-stained) 
and iii) the protein GFP::BioF. Obtained results confirm the co-localization of the fusion 
protein BioF-GFP and PHA granules in KT42I-BGF cells. Furthermore, we confirm that 
the presence of PhaF ensures the segregation of the PHA granules during the cell 
division. Moreover, when whole protein PhaF is expressed together with BioF tag the 
strain recovers wild type phenotype accumulating more than one granule and showing 
granule distribution similar to that of wild type strain. 
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3.4. The influence of phasins on BioF protein recruitment on the surface 
of PHA granule  
 
Based on the results presented above and to optimize the best BioF fusion protein 
yield achievement, we focused our interest in encountering most favourable host for 
the BioF system concerning expression or not of the natural phaF and phaI phasins. To 
establish the optimal conditions for in vivo immobilization of BioF fusion proteins, we 
monitored the biomass and PHA production, as well as the concentration of fusion 
protein attached to the granules in the absence or the presence of phasins in the P. 
putida strains.  
The results obtained according to the SDS-PAGE analysis suggested that the 
amount of BioF-GFP protein is higher in phasin mutant strains (Figure 20). Additionally, 
in all tested conditions BioF-GFP fusion protein was mainly associated with the 
granules (Figure 19 and 21). To quantify the difference in fusion protein content in the 
presence and the absence of phasins, Gel Doc Quantity One analysis were conducted 
on the base of SDS-PAGE acrylamide gels. Relative content of BioF-GFP fusion protein 
in phasin mutant strains was 4-folds higher than the concentration of fusion protein 
accumulated by wild type strain. The best immobilized protein yield was obtained 
when PhaF phasin and BioF tag were expressed together, giving BioF-GFP 
concentration of 9.73 mg per gram of biomass in the strain P. putida KT42I-BGF. 
Furthermore, BioF-GFP concentration obtained in wild type strain was 6.6-fold lower 
when compared to KT42I-BGF strain as shown in Table 6. 
The influence of different pattern of phasin expression on BioF-GFP concentration 
was monitored by flow cytometry. In perfect correlation with the results obtained by 
Quantity One the lowest BioF-GFP concentration was observed in KT42-BG strain. 
KT42F-BG and KT42I-BG showed similar levels of BioF-GFP protein, that were about 4-
fold higher when compared to that of KT42-BG strain. The best protein yield was also 
obtained in KT42I-BGF strain (Figure 22).  
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Figure 20. Comparative SDS-PAGE analysis of BioF::GFP fusion protein production and 
granule association depending on phasin presence/absence in P. putida strains. Line 1, P. 
putida KT42-BG granules; Line 2, P. putida KT42F-BG granules; Line 3, P. putida KT42I-BG 
granules; M, Molecular weight markers (BioRad, Prestained SDS-PAGE Broad Range Standard). 
BioF::GFP fusion protein, PhaF and PhaI are marked with the arrows.  
 
 
 
Figure 21. Fluorymetry comparative analysis of green fluorescence level of P. putida cells and 
PHA granules.  From left to right KT42-BG, KT42F-BG, KT42I-BG and KT42I-BGF cells harbouring 
BioF::GFP fusion protein (grey bars) and isolated PHA granules (white bars) of correspondent 
strains carrying BioF::GFP fusion anchored to the granule surface. RFU (relative fluorescence 
unit). 
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To compare the quantity of BioF-GFP in the cells with the quantity of BioF-GFP 
immobilised to the granules fluorometry analysis were performed. According to 
obtained results, similar concentration of fusion protein was found in the cells and in 
the isolated granules. Those results are in perfect correlation with the data obtained 
by SDS-PAGE analysis that showed that majority of the BioF-GFP protein was 
immobilised on the surface of PHA granules (Figure 20). In addition, fluorometry 
results confirm the results of flow cytometry for BioF-GFP quantification in different P. 
putida strains. 
 
 
Figure 22. Relative quantification of fusion protein production in P. putida cells by flow 
cytometry. KT42-BG (black bar), KT42F-BG (grey bar), KT42I-BG (white bar) and KT42I-BGF 
(blue bar).  
 
4. Mcl-PHA side chain functionalization 
 
Many examples of mcl-PHA side chain functionalization have been reported, 
however there is no published data on thioester group incorporation in side chain of 
mcl-PHA. Previously, in our laboratory we established the optimal conditions for 
PHACOS production. Herein we investigate PHACOS antibacterial activity, as well as its 
advantages in terms of bacterial adhesion and biocompatibility over non functionalized 
PHO-co-HHx for biomedical application.  
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4.1. PHACOS prevents Staphylococcus aureus biofilm formation  
 
Previous results showed that the quality of bacterial biofilm on mcl-PHA, varies 
depending on both bacterial strain and material purity that supports biofilm formation 
(Mauclaire et al., 2010). Based on this observation, we focused our interest in studying 
the ability of S. aureus and P. aeruginosa (Table 5) to form biofilm on PHACOS and PHO 
surfaces. Biofilm formation was examined by environmental scanning electron 
microscopy (ESEM), crystal violet assay and CFU counting.  
 
 
Figure23. Study of PHACOS and PHO disks capacity to inhibit bacterial biofilm formation. A, 
Environmental Scanning Electron Microscopy (ESEM) of S. aureus and P. aeruginosa; B, Crystal 
violet staining assay to quantify formed biofilm where the value of capacity of biofim 
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formation on PET disks is considered 100%; C Colony Forming Units CFU counting of deatached 
cells that were forming biofilm. 
 
ESEM observation suggested less biofilm formed by S. aureus than P. aeruginosa 
on PHACOS, while the biofilms formed on PHO were similar. However, adhered cells 
were always observed in both polymers (Figure 23A). The differences between biofilm 
formation by S. aureus and P. aeruginosa on PHACOS, were quantified by crystal violet 
assay and CFU counting. S. aureus formed (3-fold) less biofilm than P. aeruginosa on 
PHACOS, whereas the biofilm formed on PHO was similar for both strains (Figure 23B). 
Moreover CFU counting confirmed these results, showing that the S. aureus biofilm on 
PHACOS was composed of 1 log less cells than that of P. aeruginosa (Figure 23C). 
 
4.2. S. aureus adheres equally to PHACOS and PHO 
 
The initial bacterial cell attachment to mcl-PHA was monitored to determine its 
possible influence on biofilm formation. Mcl-PHA microparticles were prepared by 
water-in-oil-in-water emulsion/solvent evaporation technique and used to evaluate S. 
aureus and P. aeruginosa surface adhesion. Commercially available polystyrene 5µm 
particles were used as positive control. Cells were radioactively labelled and the 
number of adhered bacteria was analyzed by cpm monitoring of labelled bacterial cells 
attached to microparticles. To radioactively label the cells, bacteria were cultured in 
MHBII medium supplemented with C14-6 glucose. The adhesion assay was performed 
by incubating the suspension of microparticles and bacterial cells. Advantages of this 
approach are the automation of the method that allows recording an immense 
number of interactions and the possibility to simultaneously record effects on both 
surface adhering and planktonic bacteria. Obtained results suggested lower adhesion 
of S. aureus when compared to P. aeruginosa to PHO microparticles. 4.1% of assayed S. 
aureus cells were attached to PHO microparticles, while in case of P. aeruginosa 13% 
of assayed cells were attached to particle surface, demonstrating 3-fold higher 
adhesion of P. aeruginosa. To monitor the stability of microparticles, we analyzed their 
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size and surface morphology by ESEM. Obtained results demonstrated PHO particle 
aggregation and subsequently size increment (Figure 24). Therefore, to confirm results 
obtained for bacterial adhesion and discard the possibility of particle aggregation 
influence on bacterial cell adhesion we used different approach. 
 
 
Figure 24. Microparticles stability examination by ESEM. A, Polystyrene microparticles; B, PHB 
microparticles; C, PHO microparticles. 
 
Table 7. Monitoring of bacterial adhesion to microparicles 
Bacterial strain 
% of attached cells to 
PHO microparticles 
% of attached cells to 
polystyrene microparticles 
Pseudomonas aeruginosa  13 1.6 
Staphylococcus epidermidis 4.2 3.1 
Salmonella typhimurium  3.6 35.7 
Staphylococcus aureus  4.1 32.6 
 
We monitored bacterial adhesion to mcl-PHA films by ESEM. To that end, PET 
(6mm) disks were coated with PHO and PHACOS by solvent-casting method. In these 
experiments cells were previously suspended in a 1/500 NB medium and deposited on 
the PHACOS and PHO surfaces during 24 h. The lack of nutrients in the diluted 
suspension avoided biofilm formation but allowed us to test the adhesion step in the 
biofilm formation.  The number of S. aureus cells was lower on both surfaces (PHO and 
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PHACOS) when compared with the number of P. aeruginosa cells. However, there was 
no difference in adhesion of S. aureus to PHO and PHACOS (Figure 25A,B). 
We next examined whether PHACOS impacted bacterial viability cell. To do so, 
adhered cells onto PHACOS and PHO were removed by washing out with saline 
solutions and tested by LIVE/DEAD BacLightTM kit (Figure 25C-D). Interestingly, the 
number of viable S. aureus cells incubated on PHACOS was much lower (20%) in 
comparison to those on PHO (83%). As shown in Figure 25C, most of S. aureus cells 
were not viable (red stained) after the contact with PHACOS, whereas bacteria were 
mostly viable (green stained) on PHO (Figure 25D). These results indicated a possible 
PHACOS antimicrobial activity against S. aureus. 
 
 
Figure 25. Measurement of antiadherent (A, B) and antibacterial activity (C, D) of PHACOS 
and PHO surfaces against S.aureus. A,B Environmental Scanning Electron Microscopy (ESEM) 
of PHACOS (A) and PHO (B); C,D Fluorescent Microscopy using Bacterial Viability test 
(LIVE/DEAD BacLightTM , Invitrogen) of  S. aureus that was in contact with PHACOS (C) and PHO 
(D). 
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4.3. PHACOS shows antibacterial activity against methicillin-resistant 
(MRSA) S. aureus strains  
 
We further analyzed the antibacterial activity of PHACOS by precisely measuring of 
antibacterial activity on the material surface. In these assays we compared the viability 
of ten Gram-positive and two Gram-negative pathogen strains (Table 5) after 
contacting to PHACOS surface (see Material and methods section for details). 
Susceptibility to PHACOS was found in S. aureus, while it was not detected among 
Gram-negative bacteria. Moreover, antimicrobial activity of PHACOS against S. aureus 
was higher than the one of other Gram-positive pathogens, showing R value of 1.03 
(Figure 26) concluding that PHACOS shows significant antimicrobial activity (one order 
of magnitude) exclusively in the case of S. aureus type strain and MRSA strains (less 
than 10% bacterial cell survival). 
 
 
Figure 26. Measurement of antibacterial activity of polymer (PHACOS and PHO) surfaces 
according to ISO 22196:2007 (E) standard protocol, where R=1 means 10-fold less viable cells 
recovered from sample disk after 24h when compared to that of control disk . 
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To calculate the maximal PHACOS antimicrobial activity in terms of cell/cm2, we 
analyzed the antibacterial effectiveness of PHACOS in the presence of a range of 
bacterial concentration (104 to 1010 cells/cm2). It was observed that PHACOS is not 
effective against high bacterial concentration, when inoculums exceed 106 cells/cm2. 
This result could suggest the PHACOS mode of action where all cells have to be in 
direct contact with the polymer. 
 
4.4. Antimicrobial activity of PHACOS lies on thioester group 
 
In order to check whether antimicrobial effect is due to the presence of thioester 
groups in the side chain of PHACOS, antimicrobial activity of some fatty acids with 
close structures to PHACOS monomers (octanoic, hexanoic and 6-acetylthiohexanoic 
acids) was studied against S. aureus (CECT 86). Values of MIC for 6-acetylthiohexanoic 
acid were 15-fold higher than that of hexanoic (40µM and 0.7mM respectively). These 
results clearly demonstrate inhibitory effect of thioester group on S. aureus growth. 
Moreover, S. aureus showed higher tolerance to octanoic acid (MIC 3mM) in 
comparison with hexanoic acid. 
Furthermore, we tested minimal inhibitory concentration of suspension containing 
hydroxycarboxylic acid dimers (7%) and trimers (63%). Obtained results show the same 
MIC for dimmers/trimers as for 6-acetylthiohexanoic acid.  
 
4.5. Examination of possible toxic effect of mcl-PHA on mammalian cells 
 
Mammalian cell viability and metabolic function was measured by MTT assay. This 
test is dependent on the intact activity of a mitochondrial enzyme, succinate 
dehydrogenase, which may be impaired after exposure of cells to toxic species. MTT 
results showed the absence of mitochondrial damage in any of the tested surfaces. 
Cellular viability (CV) of macrophages in presence of extracts from all tested polymers 
was around 100%, indicating the absence of cytotoxic effect (Figure 27A,B). Figure 27C 
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shows CV values of fibroblasts for PHO and PHACOS extracts. All tested polymers 
present cytocompatibility levels equivalent to the PET control.  
Nitric oxide (NO) inhibitory assay was applied to measure the inflammatory 
activity of tested polymers. NO is a mediator and regulator in many pathological 
reactions, especially in acute inflammatory responses (Wang et al., 2008). Pro-
inflammatory agents, such as LPS, can significantly increase NO production in 
macrophages through activation of inducible nitric oxide synthase (iNOS) (Kojima et al., 
2000). LPS-stimulated RAW 264.7 cells were used as a reference to evaluate the NO 
production of extracts coming from the polymeric samples. Figure 28A shows no 
inflammatory effects produced by the extracts of PHO and PHACOS. The extracts of 
PHO and PHACOS induced production of less than 10mM NO, being lower 
concentration when compared to that of negative control. 
 
 
Figure 27. In vitro determination of PHACOS and PHO cytotoxicity by MTT assay. A,B Viability 
test performed on mouse monocyte macrophages RAW 264.7 where for negative control 
extracts incubated with PET disks were used and as a positive control cells were treated with 
LPS to monitor the decrease in cell viability; C- MTT assay on mouse fibroblasts BALB 3T3 
where as a control extracts incubated with PET disks.  
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Alamar Blue assay was performed to monitor cell adhesion and proliferation. AB is 
a redox indicator that changes colour with the chemical reduction of the culture 
medium, occurring as the result of cells growth and proliferation. This reagent can be 
withdrawn and replaced with fresh medium, for monitoring cell proliferation. It is 
soluble, stable in culture media and nontoxic for cells (Nakayama et al., 1997). Results 
of the assay demonstrate similar cell metabolic activity between PHACOS and control 
(Figure 28B). However, lower metabolic activity was observed on PHO compared to 
PHACOS and control. Consequently, lower adhesion rate and proliferation were 
observed. Figure 28B demonstrates twofold higher adhesion of cells on PHACOS then 
on PHO during first 10 days. This behaviour can be explained based on the higher 
roughness of PHACOS. It is known that the cell behaviour depends on surface 
roughness and surface free energy (Wise et al., 1998).  
 
 
Figure 28. Determination of PHACOS and PHO in vitro immunocompatibility by Griess (A) and 
Alamar blue assays (B). A, Griess test for determination of PHACOS and PHO inflammatory 
effect on mouse monocyte macrophages RAW 264.7 as a measurement of NO production in 
cells treated with lipopolysacharide-positive control (white bars), extracts incubated with PET-
negative control (grey bars), extracts incubated with PHACOS (green bars) and extracts 
incubated with PHO (purple bars); B, Alamar blue assay for determination of mouse fibroblasts 
BALB 3T3 in vitro proliferation on PHACOS (green bars) and PHO surfaces (purple bars), where 
white bars represent PET control.  
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ESEM studies provided additional information about fibroblasts adhesion, 
morphology and growth when being in direct contact with materials. Obtained results 
show adequate adhesion and expansion of cells during 7 days (Figure 29). On PHACOS 
less quantity of adhered cells was observed when compared to control. Fibroblasts 
showed normal growth and no evidences of morphological changes. In contrast, poor 
cell adhesion was observed on PHO surfaces during first two days. However, after 7 
days growth process was recovered as well as cell morphology, being similar to that of 
control surface. 
 
 
Figure 29. Environmental Scanning Electron Microscopy study of mice fibroblasts BALB 3T3 
morphology and in vitro adhesion to PHACOS and PHO. A, Cell adhesion after 1 day 
incubation on PET, PHACOS and PHO disk (from top to bottom); B, Cell adhesion after 2 days 
incubation on PET, PHACOS and PHO disk (from top to bottom); C, Cell adhesion after 7 days 
incubation on PET, PHACOS and PHO disk (from top to bottom). 
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4.6. Inflammatory responses of mammalian cells to mcl-PHAs 
 
The use of hydro-indocyanine green (H-ICG) to measure reactive oxygen species 
(ROS) associated with implant-associated inflammation has recently established 
(Selvam et al., 2011). The H-ICG was synthesized from commercially available ICG dye 
via a one-step reduction with sodium borohydride. This dye possess excellent stability 
to auto-oxidation, tunable emission wavelengths, and importantly, high selectivity and 
speciﬁcity as well as nanomolar sensitivity to ROS. In addition, it is small a molecule 
that can diffuse from the injection site or vascular bed into the tissue and cells directly 
associated with the implanted device. These attributes render H-ICG ideal probe for 
detecting implant-associated inﬂammation.  Of note, ICG is a FDA-approved 
ﬂuorophore that has found wide use as a noninvasive imaging agent. PET is used in 
many biomedical devices including sutures, vascular grafts, sewing cuffs for heart 
valves, and components for percutaneous access devices.  Therefore, sterile, 
endotoxin-free disks (6 mm diameter) PET disks and PET disks coated with PHO and 
PHACOS were implanted subcutaneously in the back of 6-8 weeks old male BALB/c 
mice (Jackson Laboratories) anesthetized by isofluorane. A single 1-cm incision was 
made on the dorsum proximal to the spine, and a subcutaneous pocket laterally 
spanning the dorsum was created. Sterile disks (two per subject on either side of the 
spine) were implanted, and the incision was closed using sterile wound clips. Mice 
undergoing the same surgical procedure but receiving no biomaterial implants were 
used as sham controls to account for surgery-associated trauma/inflammation.  
To monitor extracellular ROS associated with inflammatory responses to 
implanted biomaterials a single local injection of H-ICG dye was applied near the 
vicinity of the surgery site/implant of anesthetized mice. After 30 min animals were 
imaged via an IVIS fluorescence imaging system. Mice undergoing the same surgical 
procedure, but receiving no PET implants were used as sham controls to account for 
surgery-associated trauma/inflammation. Mice receiving biomaterial implants 
exhibited increases in fluorescence signal over time (Figure 30,31). Importantly, no 
significant differences in fluorescence signal were observed among sterile PHACOS, 
PHO and PET implant groups or the sham control during 14 days. 
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Figure 30. In vivo biocompatibility ROS imaging of PHACOS and PHO implant associated 
inflammation after subcutaneous administration of H-ICG. Bioimaging data of animal scanned 
in an IVIS® imaging system.  
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4.7. In vivo study of PHACOS antibacterial properties against S. aureus  
 
We next examined whether PHACOS exhibits antimicrobial properties in vivo. With 
that aim, six animal groups were monitored: i) control group (shaved mice, no surgical 
procedure), ii) sham group (mice undergoing surgical procedure, but not receiving 
implant), iii) mice receiving sterile PHO disk, iv) mice receiving sterile PHACOS implant, 
v) mice receiving PHO implant precolonized with S.aureus and vi) mice receiving 
PHACOS implant precolonized with S. aureus. After a short incubation with S. aureus, 
biomaterial disks (PHACOS and PHO) were implanted subcutaneously as previously 
described for sterile implants. Implant associated inflammation was monitored for 14 
days.  
 
 
Figure 31. In vivo biocompatibility ROS imaging of PHACOS and PHO implant associated 
inflamation after subcutaneous administration of H-ICG. Quantification of ROS fluorescence 
data from mice with PHACOS and PHO implants incubated with S. aureus and sterile PHACOS 
and PHO implants. 
 
Significantly higher fluorescent signal was observed for PHO disks incubated with 
bacteria compared to sterile PHO disks (Figure 30,31). These increased levels reflect 
the increased inflammatory response associated with the infected implant. 
Remarkably, PHACOS disks incubated with bacteria exhibited significantly lower ROS 
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signal compared to bacteria-incubated PHO, and the ROS levels for bacteria-incubated 
PHACOS were not different from the levels for sterile PHACOS implants. Taken 
together, these results demonstrate that PHACOS effectively controls biomaterial-
associated infections in an in vivo model of device-related infection. 
Following imaging, mice were sacrificed and the disks were retrieved along with 
implant-associated tissues intact to avoid disrupting the cellematerial interface. 
Explants were embedded in optimal cutting temperature compound (Tissue-Tek), 
freezed and cryosectioned at 10µm. For immunohistochemical staining, fresh-frozen 
cryostat sections were incubated in hydroCy5 (H-Cy5) to stain for intracellular ROS. 
After ﬁxation,  by immunohistochemistry, we analyzed macrophage (CD68+) and 
neutrophil (NIMP-R14+) recruitment to the implant (Figure 32).  
 
 
Figure 32. Immunohistochemical staining for macrophages (A-D) and neutrophils (E-H) in 
implant-associated inflammation. A-D, Representative co-localization images of macrophages 
(CD68+,green) and nuclei (DAPI ,40,6-diamidino-2-phenylindole, blue) in 14-day sterile PHO 
(A), S. aureus precolonized PHO (B), sterile PHACOS (C), S. aureus precolonized  PHACOS 
implants (D); E-H, neutrophils (NIMP-R14+, green) with DAPI in 14-day sterile PHO (E), S. 
aureus precolonized PHO (F), sterile PHACOS (G), S. aureus precolonized  PHACOS implants (H).  
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In addition, we co-stained for ROS activity using hydro-Cy5 (H-Cy5) as previously 
described (Lin et al., 2009). We observed an influx of inflammatory cells (76% of all 
cells; 33% macrophages, 43% neutrophils) to the vicinity of the PHO implant and 
PHACOS implant (62% of all cells; 29% macrophages, 33% neutrophils) at day 14 of 
implantation (Figure 33). Moreover, when the implants were precolonized with S. 
aureus influx of inflammatory cells was higher (82% of all cells; 38% macrophages, 44% 
neutrophils) in the vicinity of the PHO implant and (69% of all cells; 31% macrophages, 
37% neutrophils) PHACOS implant. It is worth noting that there was statistically 
significant difference between macrophage recruitment to sterile and S. aureus 
precolonized PHO implant. However, there was no statistically significant difference in 
macrophage recruitment between S. aureus precolonized PHACOS and sterile PHACOS 
and PHO implants. Moreover, obtained results show significant difference in 
neutrophil recruitment to PHO and PHACOS sterile implants, as well as between S. 
aureus precolonized PHO and PHACOS implants.  Importantly, co-staining analysis for 
inflammatory cell markers and ROS activity demonstrated that neutrophils and 
macrophages are primarily responsible for the ROS activity associated with the implant 
(Figure 33). Neutrophils are mainly responsible for ROS activity, when the implants are 
precolonized with S. aureus.   
 
 
Figure 33. Immunohistochemical staining for macrophages and neutrophils in implant-
associated inflammation. A, Quantification of CD68+ and ROS+ cells that stained positive for 
CD68+; B, Quantification of NIMP-R14 (±s.e.m.) and ROS+ cells that stained positive for NIMP-
R14+ cells (±s.e.m.).  
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4.8. In vitro degradation of mcl-PHAs 
 
To monitor in vitro degradation of PHO and PHACOS, polymers were analyzed by 
gravimetry assay. In vitro degradation was monitored during 1 month incubation of 
polymers in PBS. According to the obtained results no significant weight change was 
observed (Table 8). Consequently, applying this method we could not detect any sign 
of polymer degradation.  
 
Table 8. In vitro PHACOS and PHO degradation monitoring 
Incubation period PHO (mg) PHACOS (mg) 
6 h 0.0281 0.0388 
24 h 0.0281 0.0383 
7 days 0.0283 0.0395 
15 days 0.0281 0.0391 
32 days 0.028 0.0385 
 
 
5. Real-time non invasive in vivo monitoring of mcl-PHA implant 
associated infection 
 
 
On time detection and appropriate treatment of implant associated infection is of 
great importance, taking into account that each year from 150 million implanted 
intravascular devices in the United States (Mermel, et al. 2009), 250,000 result in 
bloodstream infections (O’Grady, et al., 2011). S. aureus is one of the most common 
pathogens associated with these cases. Herein we describe a strategy for noninvasive 
real-time monitoring of bacterial mcl-PHA implant infection using bioluminescent S. 
aureus strains. Furthermore, we develop a new method for detecting early stages of 
bacterial infection and quantification of pathogen number correlating infection and 
induced inflammatory response. To that end, the sensitivity of imaging probes, H-ICG 
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was tested in correlation with increasing bacterial cell concentration and subsequently 
higher inflammation response.   
 
5.1. Correlation between bioluminescence measurement and viable 
bacteria counting over different growth stage 
 
To assess the feasibility of using bioluminescence as a quantitative indicator of 
bacterial number, in vitro studies were performed to compare bioluminescence to the 
number of viable cells on PHO and PET disks. During exponential phase of growth (1h 
of incubation), the luminescence output was proportional to the bacterial biomass, as 
determined by the number and bioluminescence of cells. Bioluminescence was found 
to closely correlate with viable-cell count, yielding correlation coefficients of 2.06 for S. 
aureus pAmiSPA2 (Figure 34).  However, once the cultures reached stationary phase 
(24h of incubation), the bioluminescence no longer correlated with the number of 
cells. While the number of bacteria was constant the bioluminescence signal drastically 
decreased, indicating that as metabolic activity of the population decrease, monitoring 
bioluminescence of cells no longer reflects the bacterial counts. Nevertheless, as it was 
previously demonstrated that reduced expression of bioluminescence can be restored 
by replacement of the culture medium with fresh medium together with removal of 
planktonic cells (Kadurugamuwa et al., 2003), we investigated the relationship 
between bioluminescence expression and CFU in mice model in vivo.   
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Figure 34. In vitro assay correlating S. aureus bioluminiscence and CFU counts during 
different growth stages. In pink demonstrated correlation between luminiscence and bacterial 
number after 1h incubation of S.aureus on PHO, while in green represented the correlation 
between luminiscence and bacterial number after 24h incubation of S.aureus on PHO. 
 
5.2. In vivo detection of bioluminescent S. aureus strains PHO implant 
colonization 
 
We next analyzed in vivo bioluminescence in mice model, for that, disks were 
precolonized with bioluminescent S. aureus pAmiSPA2 and S. aureus pAmiBlaz and 
implanted in the back of the mice. 7-day implant-based infection was real-time 
monitored. Moreover, we investigated if stable infection could be achieved and 
subsequently bacterial bioluminescence might be monitored. Both strains produced a 
bioluminescent signal in mice when the disks were precolonized with high bacterial 
inoculums (109 - 1010 CFU/disk). The total bioluminescent counts from the infected 
sites were quantified using Living Image software. Following implantation of 
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precolonized disks, the bioluminescence measurements decreased over 4 days post-
implantation, whereas by day 7, bioluminescence could not be detected (Figure 35).  
 
Figure 35. Non invasive monitoring of bacterial infection in mouse animal model using 
luminiscent S.aureus strains. Monitoring of luminiscent signal of S.aureus in PHO implants 
precolonized with different CFU counts.  
 
5.3. Precise monitoring of biomaterial-associated inflammation by 
fluorescence imaging  
 
Applying H-ICG, NIRF ROS sensor we monitored differences in inflammation levels 
associated with disks precolonized with different bacterial inoculums. Moreover, we 
examined the correlation between inflammation and density of S. aureus pAmiSPA2 
and S. aureus pAmiBlaz inoculum used to precolonize disks 7 days post implantation. 
We observed the link between fluorescent signal and density of bacterial inoculums.  It 
Results 
 
116 
 
is worth noting that the greater bacterial inoculum was used to precolonize implant 
the higher fluorescent signal was obtained, induced inflammation was higher (Figure 
36).  Therefore, we conclude that H-ICG sensor posses enough sensitivity to detect 
difference in inflammation induced by different bacterial inoculums.  
 
 
Figure 36. In vivo ROS imaging of implant associated inflammation using H-ICG NIFR sensor. 
Green line demonstrates inflammation provoked by PHO implant precolonized with different 
CFU of S.aureus pAmiBLAZ 7 day postimplantation, blue line line demonstrates inflammation 
provoked by PHO implant precolonized with different CFU of S.aureus pAmiSPA 7 day 
postimplantation, while in purple demonstrated inflammation provoked by steril PHO implant 
7 day postimplantation.  
 
Following imaging, mice were sacrificed and the disks were retrieved along with 
implant-associated tissues. The number of CFU recovered from disks was counted 
following the 7-day imaging. We observed that independent on the starting density of 
bacterial inoculums mice were able to eliminate 103 CFU (Figure 37). Therefore, we 
conclude that stable infection was not achieved using this model. However, we 
demonstrated that S. aureus strains are able to form biofilm in vitro on both surfaces, 
PET and PHO (see above). 
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Figure 37. Infection stability analysis. Comparison of inicial CFU and CFU after PHO disk 
explantation. Green line represents S. aureus pAmiBLAZ strain, while blue line demonstrates 
S.aureus pAmiSPA.  
 
By means of immunohistochemistry, we analyzed macrophage (CD68) and 
neutrophil (NIMP-R14) recruitment to the implant at day 7 post implantation (Figure 
38). It was observed that as bacterial inoculums used to precolonize PHO implants was 
higher, the influx of inflammatory cells was higher being 76% for sterile implant and 
growing exponentially to 100% for implant precolonized with 107CFU/disk (Figure 38). 
Moreover, the number of both macrophages and neutrophils was increasing in the 
vincinity of PHO implant with the increasing number of cells used to precolonize 
implants.  
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Figure 38. Immunohistochemical staining for macrophages and neutrophils in implant-
associated inflammation. Quantification of CD68+, NIMP-R14 (±s.e.m.) and total number of 
inflammatory cells  stained  with DAPI.  
 
Furthermore, it was observed that as the number of bacteria used to precolonize 
increase, the implant surrounding tissue shows more signs of necrosis, being 
completely destroyed when inoculums of 1010 CFU/disk was used to precoplonize 
implant. In addition, antibodies against S. aureus were used to analyze the formed 
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biofilm in the vincinity of implants (Figure 39).
 
Figure 39. Immunohistochemical staining for S. aureus pAmiBLAZ (A-C) and S. aureus 
pAmiSPA (D-E) in PHO implant associated infection. A,D 108 CFU/implant; B,E 109 
CFU/implant; C,F 1010 CFU/implant.  
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V. Discussion 
  
Discussion 
 
122 
 
  
Discussion 
 
123 
 
 
 
Microbial polyesters play an important role in the development of second and 
third generation biomaterials, especially for biomedical applications. Various 
modification techniques were developed to improve their properties. Herein, we 
describe different strategies focused on designing new PHAs by introducing specific 
modifications that confer novel properties to the polymer (Figure 40).  
 
 
Figure 39. Strategies for added value PHA production. Two different strategies were applied, 
functionalizing of PHA nano-beads and metabolic engineering.   
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1. Nucleoid-associated PhaF phasin drives intracellular location and 
segregation of polyhydroxyalkanoate granules in Pseudomonas putida 
KT2442 
 
One of the applied approaches consists in in vivo bacterial production of tailor-
made functionalized nano-beads where proteins attached to the natural PHA granule 
have been engineered to display fusion proteins of interest (Figure 40). To refine the 
system, we try to resolve the puzzle of how functionally diverse, or even 
multifunctional set of phasins, should be combined to generate an optimal yield of in 
vivo protein immobilization onto granule surface in a coherent cell phenotype of P. 
putida KT2442. The modules of P. putida phasin proteins were proved to perform 
different functions supported by their peculiar structure distributed in separate 
domains (Figure 5). 
Nevertheless, the role of phasins in granules formation is still unrevealed (Rehm, 
2006). Two models of polyhydroxybutyrate (PHB) granule formation have been 
described in bacteria, the micelle model and the budding model, both accounting for 
the stabilized location of the synthase and phasin on the surface of the granule 
(revised in Grage et al., 2009). In the micelle model, a self-assembly process is initiated 
resulting in the formation of insoluble cytoplasmic inclusions with a phospholipid 
monolayer which contains covalently attached polyester synthases at the surface. In 
the budding model, the hydrophobic synthase binds to the inner face of the plasma 
membrane and buds from this membrane, leading to a granule surface covered with a 
lipid monolayer and phasins. However, TEM studies of granule formation and 
degradation in Cupriavidus necator H16 (formerly Ralstonia eutropha H16) revealed 
dark-stained elements ringed by small granules at early stages of PHB production. 
These structures named “mediation elements” were located near the center of cells or 
along a longitudinal strip in the center of the cells (Tian et al., 2005). These results 
were at odds with the micelle and membrane budding models, but led to an 
alternative model for granule formation, in which granule are localized and the new 
“mediation elements” function as scaffolds for the granule initiation sites. The fate of 
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granules during cell division, that is, whether they are equally distributed between 
daughter cells, is not known (Tian et al., 2005). 
We have explored the physiological role of the histone-like PhaF phasin and PhaI 
phasin from the prototype microorganism P. putida KT2442. One of the peculiarities of 
PhaF phasin is its modular organization in a PHA granule binding domain (located at 
the N-terminus) and an AKP rich domain (located at the C-terminus). In fact, we had 
previously demonstrated the abilities of PhaF from P. putida GPo1 for binding to PHA 
granule (phasin-like activity), and as transcriptional regulator, suggesting a putative 
DNA binding activity (Prieto et al., 1999; Moldes et al., 2004). This C-terminal domain 
from the PhaF protein with a DNA-binding function histone-like is unique among 
phasins. In this sense, the identified phasins from C. necator H16 (PhaP1, PhaP2, PhaP3 
and PhaP4) display an alanine-rich C-terminal region showing a very high isoelectric 
point (Neumann et al., 2008). Nevertheless, further investigations are needed to 
exclude that this positive charge might participate in the interaction with the 
mediation elements or the latter might be simply the nucleoid of the cell.  
This work demonstrates that PhaF plays a crucial role in granule localization and 
distribution, since the lack of this protein unbalance granule segregation during cell 
division (Figure 13). Similar system of localization of organelles as needle array inside 
prokaryotic cells has been observed for the intracellular organelles magnetosomes 
from Magnetospirilum gryphiswaldense (Komeili et al., 2006). They are assembled into 
a regular chain in order to achieve the maximum magnetic moment, against the 
physical tendency of magnetosome agglomeration. In this system, the protein 
responsible for this alignment is MamJ which has a high content of acidic amino acids 
and a repeated domain structure, which appears to interact with a linear cytoskeleton-
like structure composed by MamK (actin-like protein) that directs the assembly and 
localization of the prokaryotic organelles (Scheffel et al., 2006). P. putida KT2442 
(Nelson et al., 2002) posses members of all cytoskeletal systems described in bacteria 
(revised in Gitai et al., 2005 and Gerdes et al., 2010)  like the tubulin homologous FtsZ 
(annotated as PP1342 in the chromosome); ParAB (PP_0001-2) and MinCDE (PP_1732-
34) systems, where ParA and MinD are similar variant P loop ATPases that form 
cytoskeletal-like filaments on DNA and membranes, respectively, to solve different 
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problems (DNA segregation and septum placement) by analogous molecular 
mechanisms; Actin homologue MreB (PP_0934), similar to the actin-like protein 
MamK, which forms a helix essential for maintenance of cell shape, and it has been 
recently hypothesized to act as a scaffold for transporting proteins to different 
locations throughout the bacterial cell (Kimberly et al., 2010). Our work demonstrated 
PhaF as central player in the machine to control PHA granule segregation and 
localization in the cell. Moreover, whether or not P. putida KT2442 cytoeskeletal 
proteins facilitate the needle array structure by direct or indirect interaction with PhaF, 
is still an open question and at this point, the precise mechanisms by which PHA 
granules are positioned by PhaF remains elusive. Since PhaF shows a unique ability for 
binding at least two ligands, the PHA granules and the nucleoid, our work provides 
support to consider that the PhaF function localizing and segregating the PHA granules 
implies new mechanisms different to that of described for magnetosomes 
(MamK/MamJ) or DNA segregation in bacteria (ParA-like mechanism). Taking into 
account the unspecific DNA binding abilities of the C-terminal part of PhaF (Galan et al, 
2011), we cannot discard that the bacterial chromosome could play a role as granule 
carrier during the division process. In this sense, previous studies have determined the 
cellular position of different chromosomal sites demonstrating that they were 
positioned along the long axis of the cell in a linearly ordered fashion from the origin to 
the terminus (Teleman et al., 1998; Niki et al., 2000; Viollier et al., 2004). 
The unspecific PhaF-DNA interaction validates the classification of this phasin as 
histone-like protein and raises further questions about the physiological roles of PhaF 
in P. putida. Eukaryotic H1 histones are also called linker histones because they are 
chromatin-associated proteins that bind to the exterior of nucleosomes and 
dramatically stabilize the highly condensed states of chromatin fibers (Zlatanova et al., 
2000). In eukaryotic organisms, there is evidence that linker histones are also involved 
in transcriptional regulation by determining the accessibility of the nucleosomal DNA 
to the transcriptional machinery (Zlatanova et al., 2000). Furthermore, it has been 
demonstrated that histones of the H1 family provide the DNA compactation required 
by the changing physiological needs of the cell during the different stages of cell cycle 
(Kasinsky et al., 2001).  
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Examples of bi-functional proteins containing the AKP rich domain are found in 
eukaryotic organisms, such as the ribosomal proteins L22 and L23a of Drosophila 
melanogaster (Koyama et al., 1999), and in the prokaryotic organisms like AlgP from 
Pseudomonas aeruginosa (Deretic and Konyecsni, 1990) and the putative DnaK 
suppressor from Stenotrophomonas sp. It is also worth to mention the cases of the 
traslation factor IF-2 from Actinobacteria which contains an AKP rich region in its N-
terminal domain that is involved in translation initiation and binds to the ribosome by 
interacting with the initiator tRNA (Caserta et al., 2006). Also, the Hc1 and Hc2 proteins 
from Chlamydia trachomatis play a role in the chromosome condensation regulating 
the stage specific differentiation during the life cycle (Kaul et al., 1996) and BpH1 and 
BpH2 proteins from Bordetella pertussis, that are known to condense the DNA and 
protect it from digestion with DNaseI in vitro could be involved in transcriptional 
regulation (Goyard, 1996).  
 
2. Swapping of phasin modules to optimize the in vivo immobilization of 
proteins to medium-chain-length polyhydroxyalkanoate granules in 
Pseudomonas putida 
 
PhaF N- and C-terminal domains are linked via leucine zipper motif, also present in 
phasin PhaI. The leucine zipper motif is hypothesized to be a protein-protein interface. 
Moreover, it has been suggested that many of the biological properties of phasin 
proteins are dependent on multimerization via this coiled-coil region which provides a 
highly specific, physiologically relevant protein-protein interaction (Maestro et al., 
2013).  
The function of PhaI phasin, and the possibility of its substitution by PhaF phasin 
or BioF tag has been investigated in this study. We illustrate the utility of the 
PhaF/PhaI structure redundancy, being autonomous modular units working in 
harmony. Both C- and N-terminal phasin modules are revealed to be essential for the 
optimal PHA biosynthesis and accumulation in P. putida KT2442. When one of the 
modules is missing, PHA production decreases. Moreover, when strain lacks both 
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phasins, the PHA production falls to 7% of CDW, suggesting their cooperative work. 
However, BioF tag or its fusion derivatives can replace PhaI role in P. putida in terms of 
PHA production. However, the phenotype of the phasin mutant strains lacking of C-
terminal domain of PhaF differs to that of wild type strain in terms of granule 
distribution, showing population heterogeneity. PhaF N- and C-terminal domains were 
tracked in vivo via monitoring their fusions with GFP reporter. As expected, GFP::C-
PhaF co-localized with nucleoid, independently of the host strain and the presence or 
absence of the PHA granules, whereas N-terminal co-localized with PHA granules in all 
analyzed P. putida strains. Moreover, in the absence of PHA granules, BioF forms 
intracellular inclusions, mainly at the cell poles (Figure 19E,F), that could be explained 
by the existence of the short leucine zipper involved in protein oligomerization, as 
predicted in the structural, three-dimensional model. The phenotype of wild type 
strain is recovered in KT42I-BGF strain, which produces BioF::GFP fusion and PhaF at 
low dosage (Figure 17B, 18B, 19D), definitively demonstrating the essential role of C-
terminal domain of PhaF protein in granule segregation and the swappable character 
of PhaI and BioF PHA binding modules. 
It was previously demonstrated that phasins binding prevents unspecific 
attachment of other proteins not related to the PHA metabolism to the granules 
surface, and limits the space for anchoring of recombinant proteins (Neumann et al., 
2008). We confirm that the absence of natural PhaI phasin favours the binding of the 
fusion protein to the granule surface. In the absence of wild type phasins, higher 
number of molecules of recombinant tagged proteins was anchored to the granules 
surface (Table 6). This could be explained by the lack of space on the surface of wild 
type PHA granules coated with PhaI/PhaF N-terminal phasin modules. In fact, the 
protein immobilization per gram of PHA in both strains KT42I-BG and KT42I-BGF were, 
similarly, more than 6 folds higher than that of the wild type strain. However, PHA 
production in KT42I-BG strain (19.6%) is two-fold lower when compared to the one 
obtained in KT42I-BGF (42.1%). Moreover, the low dosage of PhaF protein produced in 
the strain KT42I-BGF ensures granule distribution among cell population, yielding a 
total production of 10 mg of PHA immobilized protein per liter of culture and 9.73 mg 
of protein per gram of CDW. This protein concentration has been reported till now 
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only when E. coli was used as host strain for recombinant protein production anchored 
to PHB granules. In this sense, we have also identified the key phasin factors for 
optimal PHA production in P. putida. We have addressed the minimal necessary 
amount of complete phasin proteins to achieve adequate PHA production and 
subsequently higher yield of immobilized recombinant protein. In wild type Bacillus 
megaterium, GAPs represent close to 2% of the total mass of a standard granule,35 
what is in perfect agreement with the maximum BioF fusion concentration reported in 
this work 2.2 % of recombinant protein per PHA content. 
Tagged proteins were co-produced with PHB granules in the E. coli cells. Multiple 
phasins (2-3 repeats) were used and successful purification of several proteins 
(maltose binding protein (MBP), β-galactosidase (LacZ), chloramphenicol 
acetyltransferase (CAT), and (NusA) with yields of 3.17-7.96 mg of protein/g CDW was 
reported (Banki et al., 2005). Thought E. coli can produce high PHB content (Chen, 
2009) and consequently, high recombinant protein yield, advantages of using P. putida 
as host strain should not be overlooked (Poblete-Castro et al., 2012). The growing 
understanding of model mcl-PHA producer strains such as P. puitda KT2440 gained 
from System Biology studies (“omics” data, genome scale metabolic models etc.) 
(Poblete-Castro et al., 2012a; Poblete-Castro et al., 2012b; Poblete-Castro et al., 2013; 
Follonier et al.2013, Nogales et al., 2008) and powerful genetic tools based on 
Synthetic Biology (Silva-Queiroz et al, 2009; Silva-Rocha et al., 2013) support bottom-
up approaches to design specialized P. putida strains to generate added value 
bioproducts such as active mcl-PHA based nano-beads. Its great value as autolytic 
specialized strain for mcl-PHA production has been also demonstrated (Martinez et al., 
2011). Due to its broad metabolic versatility and genetic plasticity that allow use of 
variety of renewable carbon sources for PHA production, P. putida is one of the most 
prominent candidates to be used for protein production.  Our work provides new 
findings related to phasin physiological function that will enable important insights into 
targeting the critical factors for improvement of existing models. Moreover, this work 
defines the needs for designing in vitro immobilization system to mcl-PHA where PhaI 
or BioF would be the only request tag for anchoring the recombinant protein to mcl-
PHA nano-beads. 
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3. PHACOS, a functionalized bacterial polyester with bactericidal activity 
against methicillin-resistant Staphylococcus aureus (MRSA) 
 
The second approach that was applied for polymer functionalization to obtain 
added value PHAs is based on the use of metabolic engineering to design bacterial 
strains able to produce new non-natural polyesters carrying functionalized groups at 
the side chain (Figure 39). 
Today’s polymeric and biodegradable systems used in medicine are mainly based 
on poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and on their copolymers (Gomes 
and Reis, 2004). One of the prime current candidates with potential applications in the 
medical field is the group of naturally produced bacterial polyesters, PHAs, 
representing a large class of biodegradable and biocompatible biopolymer (Chen and 
Wu, 2005). However, for packaging materials, tissue engineering, and other specific 
applications, the physical and mechanical properties of microbial polyesters need to be 
diversified and improved (Steinbuchel and Valentin, 1995; Hazer et al., 2012).  
In spite all existing application where polymers found their function a state of the 
art requirement due to increased level of emerging antibiotic-resistant bacteria 
‘superbugs’ is creating a new possible function of polymers as antimicrobial surfaces. 
In addition, the effectiveness of antibiotics is decreasing and the development of new 
antibiotics to replace those that become ineffective is slower. Moreover, current 
actions to prevent antimicrobial resistance are not sufficient. Therefore, antimicrobial 
polymers are a class of biocides that has become increasingly important as an 
alternative to existing biocides and in some cases even antibiotics (Siedenbiedel and 
Tiller, 2012). Antimicrobial surfaces that prevent growth of biofilms are considered as 
an effective strategy to inhibit the spread of microbial infections (Siedenbiedel and 
Tiller, 2012). Such surfaces either repel microbes, so they cannot attach to the surface, 
or kill microbes in the vicinity (Siedenbiedel and Tiller, 2012). Antimicrobial polymers 
have been known since 1965, when Cornell and Dunraruma described polymers and 
copolymers prepared from 2-methacryloxytroponones that kill bacteria. In the past 
decade the number of FDA-approved disinfecting polymers has significantly increased, 
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which indicates the need for alternatives to antibiotics and environmentally critical 
disinfectants (Siedenbiedel and Tiller, 2012). 
Bacterial infections are a major cause of morbidity and mortality in the hospital 
and community, and many infections can be attributed to species of the genus 
Staphylococcus (Kiedrowski and Horswill, 2011). While this group is best known for the 
acute pathogenic properties of Staphylococcus aureus (DeLeo and Chambers, 2009), 
the ability of these bacterial pathogens to cause chronic infections and persist on 
medical implants or host tissues is an area that has increasingly drawn attention as a 
significant healthcare problem (Darouiche, 2004). In fact, the ability of S. aureus to 
establish biofilms has been linked to the persistence of these chronic infections 
(Kiedrowski and Horswill, 2011). Methicillin-resistant Staphylococcus aureus (MRSA), 
also called multidrug-resistant Staphylococcus aureus, is referred to any strain of S. 
aureus that has developed resistance to beta-lactam antibiotics, which include the 
penicillins (methicillin, dicloxacillin,nafcillin, oxacillin, etc.) and the cephalosporins 
(Grundmann et al., 2006). MRSA is especially troublesome in hospitals, prisons, 
schools, and nursing homes, where patients with open wounds, invasive devices, and 
weakened immune systems are at greater risk of infection than the general public 
(Klein et al., 2009).  
Tremendous efforts have been given to developing compounds that not only show 
high efficacy, but also those that are less susceptible to resistance development in the 
bacteria. The high incidence and rapid emergence of resistance to antibiotics in various 
Gram-positive cocci makes Gram-positive pathogens a major health hazard. S. aureus 
is Gram-positive bacteria and common human pathogens that most commonly 
colonize the anterior nares. The rest of the respiratory tract, open wounds, 
intravenous catheters, and the urinary tract are also potential sites for infection. S. 
aureus causes a diversity of diseases ranging from minor skin and soft tissue infections 
to life-threatening systemic infections, including endocarditis and sepsis (Raygada and 
Levine, 2009). It has been estimated that biofilms are associated with 65% of 
nosocomial infections (Mah and O’Toole, 2001). In addition, it was reported that 
during 1999–2006 the percentage of S. aureus infections resistant to methicillin 
increased >90%, or ≈10% a year, in outpatients admitted to US hospitals  (Klein et al., 
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2009). The development of newer, stronger antibiotics which can overcome these 
acquired resistances is still a scientific challenge because a new mode of antimicrobial 
action is likely required. Antimicrobial polymers have emerged as a promising 
candidate for further development as an antimicrobial agent with decreased potential 
for resistance development (Kuroda and Caputo, 2013). 
Recently in our laboratory we produced PHACOS, a new second generation 
polymer containing thioester groups in the side chain (Figure 8). This functionalized 
bacterial polyester was obtained applying 6-ATH as precursor and decanoic acid as co-
substrate in a co-feeding strategy for Pseudomonas putida strains (Escapa et al., 2011). 
We have explored the possibilities of this second generation polymer application as 
biomedical device. One of the peculiarities of this naturally produced bacterial 
polyester is the presence of thioester groups in the side chain of the polymer. In fact, 
we show that those thioester groups play a crucial role in polymer activity against S. 
aureus clinical isolates. In this sense, we demonstrate the unique property of this P. 
putida polymer to have activity against other bacterial strains. Nevertheless, further 
modification of this second generation polymer for fine tuning of its activity and 
specific applications could be easily achieved as it is carrying functionalized side chains. 
In addition, we observed the certain inhibition of S.aureus biofilm development on 
PHACOS. 
Biofilm formation on biomaterials can generally be divided into two main stages: 
bacterial adhesion, which depends on surface properties of both substrates and cells, 
and increase of biofilm mass which depends on initial attachment and specific growth 
rate of attached cells. It was demonstrated that the biofilm formation on PHAs, varied 
depending on both bacterial strain and material quality that supported biofilm 
formation. E. coli attaches better to mcl-PHA coatings than S. aureus (Mauclaire et al., 
2010). Impurity elimination in the biopolyester coating drastically limits the biofilm 
formation (Mauclaire et al., 2010). Significant correlation was observed between 
bacterial attachment and roughness for S. aureus, a bacterium which is known to be 
sensitive to surface irregularities (Harris and Richards, 2006). Even though, PHACOS 
shows higher roughness than PHO no increase in attachment of S. aureus cells was 
observed. What is more, S. aureus biofilm formation was decreased on PHACOS when 
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compared to PHO. Interestingly, investigating the previously mentioned phenomenon 
we discovered the antimicrobial properties of PHACOS.  
The potential of pathogenic biofilm development on mcl-PHAs was evaluated, 
nevertheless antibacterial activity of PHAs not modified or mixed with other 
compounds for that purpose, was not reported (Mauclaire et al., 2010). Furthermore, 
it was not observed that PHAs posses antiadherent properties against bacteria. 
However, it is known that R3HAs, monomers derivated from PHAs, show antibacterial 
activity. Antibacterial activity of R-3-hydroxy-n-phenylalkanoic acid against Listeria 
monocytogenes was reported (Sandoval et al., 2005). Moreover, data provided by Ruth 
et al. demonstrates antibacterial activity of aliphatic (R)-3-hydroxycarboxylic acids 
against not only Listeria species, but the other bacterial strains such as S. aureus (Ruth 
et al., 2007). Even though, the antibacterial efficiency of previously mentioned 
compounds is low showing very high MICs values (Minimal Inhibitory Concentration), 
1-5 mM. 
Many commonly used antimicrobial agents active against planktonic pathogens 
have minimal or no effect against biofilm-embedded pathogens (Agarwal et al., 2005; 
Giacometti et al., 2005). Interfering with the biofilm may liberate device-colonising 
organisms and therefore increase the efficacy of antimicrobial agents. Thus, there is a 
pressing need to explore novel approaches that utilize compounds with a dual ability 
to disrupt the biofilm and to eliminate pathogens.  
Novel approaches for the development of antimicrobial polymers are an 
important area of research and many reports have been published referring to the 
synthesis of macromolecules that are inherently antimicrobial (biocidal polymers). 
These are usually positively charged macromolecules that interact with microbial cells 
that generally carry a negative net charge at the surface due to their membrane 
proteins, teichoic acids of Gram-positive bacteria, and negatively charged 
phospholipids at the outer membrane of Gram-negative bacteria (Siedenbiedel and 
Tiller, 2012). Cationic polymers have been the main focus (Waschinski and Tiller, 2005) 
including those containing ammonium (Kenawy et al., 2002), phosphonium salts (Popa 
et al., 2003), pyridinium salts (Tashiro, 2001; Worley and Sun, 1996), polyguanidines 
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and polybiguanidines (Albert et al., 2003), polylysine (Hancock and Chapple, 1999), 
polyacrylates (Kenawy et al., 1998), polystyrenes (Gelman et al., 2004) and 
polyoxazolines (Waschinski et al., 1998). Antimicrobial peptides also represent a large 
group of natural compounds with a broad spectrum of antimicrobial activity (Zasloff, 
2002). Other class of antimicrobial polymer known as polymeric biocides, that consist 
of bioactive repeating units, i.e., the polymers are just multiple interconnected 
biocides, which act similarly to the monomers. Often, the polymerization of biocidal 
monomers does not lead to active antimicrobial polymers, either, because the 
polymers are water-insoluble or the biocidal functions do not reach their target. Last 
but not least are biocide-releasing polymers, which in turn do not act through the 
actual polymeric part, instead the latter function as carriers for biocides that are 
somehow transferred to the attacked microbial cells. Such polymers are usually the 
most active systems, because they can release their biocides close to the cell in high 
local concentrations (Siedenbiedel and Tiller, 2012). These subjects have attracted the 
attention of many researchers, and significant improvement in understanding of their 
essential physiochemical properties and mode of action has been made, conversely 
there are still a number of antibacterial polymers whose exact working principles are 
unknown.  
Following our major finding, the antibacterial activity of PHACOS, we have focused 
on investigating the possible ways of its action. This work demonstrates that PHACOS 
acts as contact active surface and therefore could be considered as biocidal polymer. 
However, taking into account the antibacterial activity of PHACOS derived monomers 
we cannot discard the possibility that it is polymeric biocide, as the polymerization of 
active monomeric units leads to antimicrobial polymer. Moreover, one of the 
peculiarities of the mode of action of this polymer is the antibacterial activity of its 
precursor and monomers. Moreover, we demonstrated low level of in vitro 
degradation of the polymer. In this sense, it is possible that the releasing of monomers 
gives PHACOS antimicrobial properties. If that is the mode of action of PHACOS, it 
could be classified as biocide-releasing polymers. However, as the degradation rate of 
PHACOS is very low, we consider that the concentration of released monomers is too 
low to be the main way of polymer functioning. Nevertheless, it could certainly 
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contribute to its antibacterial activity. Other property that needs further investigations 
is the specificity of PHACOS antimicrobial effect against S. aureus. 
Several antibacterial polymers are known to be selective against S. aureus over 
other strains, although there is no report on polymers with selective activity to 
bacteria other than S. aureus. Cationic polymers including polynorbornenes (Lienkamp 
et al., 2008), oligolysins (Epand et al., 2009), and chitosan (Raafat et al., 2008) all 
showed selective activity against S. aureus over E. coli. Although the chemical 
structures of these polymers are quite different from each other, the cationic 
functionality appears to be in common, which may be the key determinant in the 
activity against S. aureus. Recently, Gibney et al. demonstrated that commercially 
available unmodified polyethyleneimines (PEIs) with branched structures (MW = 500–
12,000) also are antimicrobial with selective activity against S. aureus over E. coli 
(Gibney et al., 2012). 
Even thought, there are examples of polymers selective activity against S.aureus, 
the precise mechanisms by which PHACOS decrease biofilm formation and kills the cell 
is still an open question at this point. N-acetylcysteine NAC, an antioxidant with 
disruptive properties for disulfide bonds, has been shown not only to reduce adhesion 
but also to detach bacterial cells adhered to surfaces and to inhibit bacterial growth in 
vitro (Olofsson et al., 2003; Perez-Giraldo et al., 1997). NAC inhibits S.aureus growth at 
concentration of 2.5 mg/mL and has bactericidal properties at concentration of 5 
mg/mL (Hernandez et al, 2009). The similarity between NAC and PHACOS lies on -SH 
group. Although PHACOS does not contain free -SH group there is a possibility that its 
functionalized thioesther side chain breaks and give rise to free -SH group. The recent 
review of Timofeeva et al. thoroughly discusses the influence of relevant parameters, 
such as molecular weight, type and degree of alkylation, and distribution of charge on 
the bactericidal action of antimicrobial polymers (Timofeeva and Kleshcheva, 2011). 
Therefore, there are many factors that should be investigated to determine the mode 
of action of PHACOS. Although, there is no published data on mcl-PHA antimicrobial 
activity, their monomers, medium- and long-chain fatty acids (containing 8 to 18 
carbons) have been shown to be bactericidal to many different Gram-negative and 
Gram-positive bacteria (Bergsson et al. 1998, 1999, 2001, 2002).  
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The bioactivity of different doses of the short-chain, medium-chain and long-chain 
fatty acids against gram-positive oral bacteria Streptococcus mutans, S. gordonii and S. 
sanguis were studied (Huang et al., 2011). It was demonstrated that short-chain fatty 
acids C2-C5 exhibit minimal antimicrobial activity for this range of bacteria (estimated 
by the inhibitory concentration at 80%, IC80), while among the medium chain fatty 
acids, the IC80 decreased with increasing size of the fatty acid. IC80 values for octanoic 
acid were in a range of 2.5mM-<0.1mM, whereas IC80 values for hexanoic acid were 
2.5-0.6mM, both depending on a tested strain (Huang et al. 2011).  Similarly, in our 
study we confirm MIC values of octanoic acid and hexanoic acid for S. aureus, 3mM 
and 0.75mM respectively. While 6-acetylthiohexanoic acid, showed much lower MIC 
value (40µM), being more effective against S. aureus. 
The effect of fatty acids and monoglycerids on Gram-positive cocci was 
investigated (Bergsson et al., 2001). It was reported that 10mM caprylic acid, myristic 
acid, oleic acid, monocaprylin, monolaurin, monomyristin, monopalmitolein and 
monoolein caused only a minor inactivation of S. aureus, while lauric and palmitoleic 
acid showed an intermediate effect, reducing the viability count by 1.0 to 2.8 log10 
CFU. However, monocaprin and capric acid reduced the infectivity titres of S. aureus by 
5.0 to 7.1 log10 CFU, showing the highest activities (Bergsson et al., 2001). Bactericidal 
activity of monocaprin, capric, lauric and palmitoleic acids are reported for 
streptococci and staphylococci, and therefore may be useful for protection against or 
treatment of infections caused by Gram-positive cocci where rapid killing of the 
bacteria is desirable (Bergsson et al., 2001). Caprylic acid at concentration of 15mM 
was bactericidal for Dermatophilus congolensis (Valipe et al., 2011) and at 
concentration of 35mM for E. coli O157:H7 (Annamalai et al., 2004). 
The specificity in the activities of fatty acids and monoglycerides against various 
bacteria is notable. The difference between the activity profiles of lipids for 
streptococci and S. aureus could possibly be explained by differences in cross-linkage 
of peptidoglycan polymers in the cell wall of the bacteria. Also, the peptidoglycan of S. 
aureus is interspersed with molecules of ribitol-teichoic acid, which is relatively specific 
for this bacterium (Sherris, 1990). A further study of the reason for the difference in 
activity profiles of lipids against various bacteria would be of interest. 
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In spite the existence of many examples of different polymers higher activity of 
against S. aureus precise mechanism is still unrevealed. To compare antimicrobial 
activity of hydroxycarboxylic acids with compounds known to have antimicrobial 
properties such as quaternary ammonium salts we used dual functional biologically 
active acrylic system that bears quaternary ammonium salts ionically linked to non 
steroidal anti-inflammatory drugs (NSAID). Antimicrobial activity of the dual functional 
monomers and polymers was analyzed comparatively with those of the corresponding 
halide precursors against several Gram-negative and Gram-positive bacteria. 
Ketoprofen derivatives were tested due to their higher hydrophilic character. In 
general, the NSAID counterion had little effect on the antimicrobial activity of the 
monomeric specie, giving MIC and MBC values similar to those of the halide 
counterion. The antimicrobial effect of the monomeric compounds strongly depended 
of the substitute group of the ammonium cation as reported for 3-alkoxymethyl-1-
methylimidazolium salts (Pernak et al., 2003). The hexadecyl ammonium derivatives 
(HK, HI¯) showed the lowest MIC and MBC values for all tested strains, as published in 
other works (Caillier et al., 2009; Lu et al., 2007), while the benzyl derivatives (BK, BBr¯) 
showed the highest values (>4.0 x 10-2 mM). Naphthyl derivatives (NK, NBr¯) presented 
intermediate values. In general, MIC values coincided with MBC values for each 
compound excepting the hexadecyl derivatives monomers for P. aeruginosa, which 
showed MBC values higher than MIC ones. Obtained MBC values of the monomers 
BBr¯ and HI¯ are in perfect correlation with the data previously reported for the HI¯ 
acrylate (MIC of 275 µM) against S. aureus (Lu et al., 2007; Callier et al., 2009). For the 
polymers poly-BBr¯ and poly-BK, the incorporation of the ketoprofenate anion 
improved the bactericidal activity compared with that of the bromide anion. This effect 
was observed in all bacterial strains being more evident for the Gram-positive strains, 
in which MIC and MBC values of poly-BK were one order of magnitude lower. Both 
polymers showed much higher antibacterial activities than their corresponding 
monomers, e.g. MIC = 1.6 x 10-4 mM for poly-BK. This result could be explained by a 
different mechanism of action of polymers vs monomers. Moreover, polymerization 
might increase the density of positively charged coil in the polymer, which in turn 
could enhance the ability to be absorbed onto the negatively charged bacterial surface 
(Kenawy et al., 2002). Subsequently, this would improve the first step of cationic 
Discussion 
 
138 
 
biocides mode of action (Hugo and Longworth, 1966). In addition, the binding to the 
cytoplasmatic membrane would be enhanced due to the high density of negatively 
charged species like acidic phospholipids and membrane proteins (Ikeda et al., 1984). 
In general, all of the compounds, monomers and polymers, presented lower MIC 
values against S. epidermidis and S. aureus, suggesting that the structure of the Gram-
positive cell wall is more sensitive to their mode of action (Costerton and Cheng, 
1975). 
 
4. Real-time monitoring of bacterial infection in vivo: Development of 
bioluminescent Staplylococcal foreign-body mouse infection model 
 
Apart from the development of biomaterials with desirable antimicrobial 
properties, it is of great importance for infections to be diagnosed and treated on time. 
However, conventional methodologies for monitoring gram-positive pathogens in vivo 
are cumbersome and include biological assessment regimens. In addition, diagnosis of 
those infections with marginal laboratory and radiography evidence is difficult 
(Zimmerli et al., 2004) and there is compiling need for new sensitive diagnostic 
techniques development. Two thirds of implant infections are caused by staphylococci 
(O’Grady et al., 2011). As a general guideline, device removal is recommended for S. 
aureus infections due to the virulent nature of this pathogen (Darouiche, 2004). One of 
the reasons catheter and implant infections occur frequently is due to poor 
vascularization at implantation sites (Zimmerli et al., 2004). The inability of the innate 
and adaptive defense mechanisms to reach implantation sites makes it difficult for the 
host to fight off infection. In regions devoid of circulation, staphylococci are free to 
grow, spread, and form a resistant biofilm structure.  
When implanted the device is immediately coated with host matrix proteins 
(Francois et al., 1998; Francois et al., 2000) (Figure 10). S. aureus possesses numerous 
cell wall-bound surface proteins that contain binding domains for these matrix 
proteins (Foster and Hook, 1998), and such surface proteins are referred to as 
microbial surface components recognizing adhesive matrix components (MSCRAMMs). 
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An underappreciated explanation for the infection of implants with staphylococci is the 
low inoculums required to establish infection. Moreover, some infections, such as 
post-arthroplasty related, are associated with nonspecific signs, which subsequently 
cause the development of chronic infections with catastrophic complications (Del Pozo 
and Patel, 2009).  
Moreover, implant surface chemistry is known to be an important factor that 
contributes to bacterial adhesion and biofilm development. Higher rates of infection 
associated with stainless steel then to titanium were reported (Harris and Richards, 
2006), possibly due to better association of soft tissue with titanium surfaces. 
Biomaterials play an important role in the disease treatment and health care 
improvement (Langer and Tirrell, 2004).  
Herein we describe the use of bioluminescent noninvasive imaging strategy for 
detection and real-time monitoring of PHO implant bacterial infection in vivo. Bacterial 
adhesion and biofilm formation on mcl-PHAs have been studied before; however this 
is the first example of in vivo monitoring. Using genetically engineered bioluminescent 
S. aureus strains we were able to noninvasively monitor PHO implant-related infection 
throughout the study. However, we observed that when the implant is precolonized 
with low number of cells bioluminescent signal could not be detected. Furthermore, 
when bacteria go out from exponential phase and enter stationary phase of growth, 
bioluminescence decay indicating a decrease in growth. The same behavior was 
observed by Kadurugamuwa et al., explaining that limitation of oxygen and/or 
substrate could be possible cause since the reduced expression of bioluminescence 
within the biofilm could be restored by replacement of the culture medium with fresh 
medium every 12 h (Kadurugamuwa et al., 2003). 
As infection could not be monitored in vivo in long-term study due to the 
bioluminescence signal decrease we investigated whether fluorescent H-ICG could be 
applied for noninvasive monitoring of implant-associated infection. By measuring the 
inflammation, the correlation between inflammation intensity and bacterial number 
used to precolonize the implant was observed. The higher starting bacterial inoculums 
are applied, the higher inflammation was detected. Applying H-ICG-based fluorescence 
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imaging of ROS, we were able to precisely detect the infection even when 
bioluminescence could not be detected. Moreover, statistically important differences 
in inflammatory response between sterile PHO and control group were not detected. 
In perfect correlation with previously reported data, we demonstrate in vivo 
biocompatibility of PHO implants and good tissue integration. 
A high biocompatibility is essential for the acceptance of an incorporated object by 
humans and mammals. Several factors determine whether an object is biocompatible: 
shape, surface porosity chemistry of the material, and the environment (tissue) where 
it is incorporated (Zinn et al., 2001). PHA has the potential to become an important 
compound for medical applications. Tests have shown that PHB is biocompatible, 
which is not surprising when considering the fact that R-3-hydroxybutyric acid is a 
normal constituent of blood at concentrations between 0.3 and 1.3 mM  (Wiggam et 
al., 1997) and is also found in the cell envelope of eukaryotes (Reusch, 2000). A 
successful application of PHAs as implants has been demonstrated as well as their 
biodegradability, biocompatibility and thermoprocessibility (Chen and Wu, 2005). 
Application of PHO was mainly focused on heart valves fabrication regarding its 
mechanical and thermophisical properties. Sodian et al. constructed PHO heart valve 
scaffolds using stereolithographic models and tested in a pulsatile bioreactor. Leaflets 
opened and closed synchronously under subphysiological and supraphysiological flow 
conditions. Futrhermore, to improve constructed PHO trileaflet heart valve, scaffold 
were seeded with vascular cells harvested from ovine carotid arteries and expanded in 
vitro. Results of this study showed that tissue-engineered heart valve scaffolds 
fabricated from PHO can be used for implantation in the pulmonary position with an 
appropriate function for 120 days in lambs (Sodian et al., 2000). The biomedical 
application of PHO and other mcl-PHAs has been reported before (Hazer et. al., 2012), 
however this is the first example of in vivo monitorin of bacterial adhesion and 
infection development on mcl-PHA implant.  
From an industrial standpoint PHAs are biopolyesters attracting extensive interest 
as technical grade polymers due to their singular set of properties: (i) substitution 
potential for industrial thermoplastics such as polypropylene, polyethylene, 
polyvinylchloride and polyethylene terephtalate, (ii) biodegradability both in aerobic 
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and anaerobic conditions, including water environments, (iii) bio-based, renewable 
origin, (iv) biocompatibility with cells and tissues and (vi) structural diversity (Van der 
Walle, 2001; Chen 2009). This last characteristic is critical to define potential 
applications since the specific chemical monomer composition and molecular structure 
will determine the biological, thermal and mechanical properties of the resulting 
polymer.  
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1. A new and unexpected role of P. putida KT2442 PhaF phasin involved in the 
balanced distribution of the PHA reserve granules between daughter cells 
during cell division has been described. The particular composition of PhaF C-
terminal domain mimics histon-like proteins, and confers the protein an 
unspecific DNA binding capacity.  
2. We demonstrated a new role for phasins within the PHA apparatus that could 
be critical for cell survival under stress conditions. 
3. The key factors involved in in vivo immobilization of recombinant proteins onto 
PHA granules using the previously designed BioF system were determined.  
4. We illustrated the swappable characteristic of PhaI and BioF PHA binding 
modules.  
5. The optimal conditions that allow the highest recombinant protein immobilized 
in vivo onto PHA granules yield were achieved. A particular combination of 
phasin modules synthesis leads to optimal PHA production and granule 
distribution among cells have been defined.  
6.  We described a new and unexpected property of PHACOS, second generation 
biopolymer, showing antibacterial activity specifically against S. aureus clinical 
isolates including MRSA and decreasing S. aureus biofilm formation.  
7. Antibacterial activity of PHACOS has been ascribed to the functionalized side 
chains containing thioester groups. These findings led arguments to possible 
mode of action of PHACOS as contact active surface and opens new questions 
about the still unknown antibacterial mechanism linked to this biomaterial. 
8.  We showed the possibility of PHACOS application as implant demonstrating its 
biocompatibility and antimicrobial properties in vivo. 
9. A noninvasive method for in vivo real-time monitoring of mcl-PHA implant 
associated infection and inflammation has been developed.  
10. We describe the strategy for in vivo monitoring of mcl-PHA implant infection 
development using bioluminescent strains. 
11. We show the possibility of H-ICG sensor application for monitoring of early 
infection stages or stages when bacteria enters stationary growth phase. 
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